Progress in Retinal and Eye Research 96 (2023) 101205
Available online 15 July 2023
1350-9462/© 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ).Mitophagy in the retina: Viewing mitochondrial homeostasis through a 
new lens 
Juan Ignacio Jim˘enez-Loygorria,**, Rocío Benítez-Fern ˘andeza,b, ˘Alvaro Viedma-Poyatosa, 
Juan Zapata-Mu ~noza, Beatriz Villarejo-Zoria, Raquel G˘omez-Sintesa, Patricia Boyaa,b,* 
aAutophagy Lab, Department of Cellular and Molecular Biology, Centro de Investigaciones Biol˘ogicas Margarita Salas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain 
bDepartament of Neuroscience and Movement Science, Faculty of Science and Medicine, University of Fribourg, 1700, Fribourg, Switzerland   
ARTICLE INFO  
Keywords: 
Mitophagy 
Mitochondria 
Retinal homeostasis 
Metabolism 
Autophagy 
Retinal development 
Glaucoma 
Diabetic retinopathy 
Retinitis pigmentosa 
Age-related macular degeneration ABSTRACT  
Mitochondrial function is key to support metabolism and homeostasis in the retina, an organ that has one of the 
highest metabolic rates body-wide and is constantly exposed to photooxidative damage and external stressors. 
Mitophagy is the selective autophagic degradation of mitochondria within lysosomes, and can be triggered by 
distinct stimuli such as mitochondrial damage or hypoxia. Here, we review the importance of mitophagy in 
retinal physiology and pathology. In the developing retina, mitophagy is essential for metabolic reprogramming 
and differentiation of retina ganglion cells (RGCs). In basal conditions, mitophagy acts as a quality control 
mechanism, maintaining a healthy mitochondrial pool to meet cellular demands. We summarize the different 
autophagy- and mitophagy-deficient mouse models described in the literature, and discuss the potential role of 
mitophagy dysregulation in retinal diseases such as glaucoma, diabetic retinopathy, retinitis pigmentosa, and 
age-related macular degeneration. Finally, we provide an overview of methods used to monitor mitophagy in 
vitro, ex vivo, and in vivo. This review highlights the important role of mitophagy in sustaining visual function, 
and its potential as a putative therapeutic target for retinal and other diseases.   
1.Introduction 
1.1. Autophagy 
Autophagy is one of the main intracellular recycling pathways, in 
which the material to be degraded is delivered to the lysosome for 
digestion by acid hydrolases. Intrinsically a catabolic process, auto-
phagy was long associated with cell death until the discovery of its 
crucial pro-survival role during starvation in mammalian cells (Boya 
et al., 2005 ). Autophagy is responsible for preserving homeostasis by 
degrading damaged or superfluous intracellular components of a wide 
range of sizes, from specific proteins to whole organelles, including 
mitochondria (Aman et al., 2021 ). Three main types of autophagy are 
described, each differing in the manner in which the cargo is delivered to 
the lysosome (Fig. 1). 
Macroautophagy (henceforth referred to simply as “autophagy ”) is 
characterized by the formation of autophagosomes, a double-membrane vesicle containing the engulfed cargo, which is degraded within the 
acidic lumen of the lysosome following fusion. Autophagy initiation is 
mediated by the Atg/Ulk1 complex, which cooperates with the 
membrane-bound lipid scramblase Atg9 to trigger autophagosome for-
mation. Simultaneously, the Atg/Ulk1 complex recruits and stimulates 
the class III PI3K complex, which promotes the generation of phospha -
tidyl inositol 3-phosphate (PI3P). PI3P accumulation at the initial 
phagophore initiation site recruits proteins from the PI3P-binding WIPI 
family, thereby promoting phagophore elongation. Finally, two 
ubiquitin-like conjugation complexes (Atg12 module and LC3 lipidation 
module) mediate cargo recognition and autophagosome formation. 
Lipidation of LC3 (or other Atg8-family proteins) through conjugation to 
phosphatidylethanolamine leads to recognition by autophagic sub-
strates or by adaptors such as SQSTM1/p62, which contain a LC3- 
interacting region (LIR) motif. Once the cargo is fully enclosed, auto-
phagosomes mature through fusion with endosomes and lysosomes 
(Levine and Kroemer, 2019 ; Nakatogawa, 2020 ). 
Chaperone-mediated autophagy (CMA) is a highly selective pathway 
*Corresponding author. Autophagy Lab, Department of Cellular and Molecular Biology, Centro de Investigaciones Biol˘ogicas Margarita Salas, CSIC, Ramiro de 
Maeztu 9, 28040, Madrid, Spain. 
**Corresponding author. 
E-mail addresses: juan.ignacio.jimenez@cib.csic.es (J.I. Jim˘enez-Loygorri), patricia.boya@unifr.ch (P. Boya).  
Contents lists available at ScienceDirect 
Progress in Retinal and Eye Research 
u{�~zkw! s{yo|kr o>!ÐÐÐ1ow�o �to~1m{y2w{m k�o2|~o�oÞo ~o�!
https://doi.org/10.1016/j.preteyeres.2023.101205 
Received 21 December 2022; Received in revised form 11 July 2023; Accepted 13 July 2023   Progress in Retinal and Eye Research 96 (2023) 101205
2in which proteins containing a KFERQ-related motif are recognized by 
the chaperone Hsc70 and delivered to the lysosomal membrane, where it 
interacts with the lysosomal receptor LAMP2A, triggering its multi -
merization. The protein to be degraded is denaturalized, internalized via 
the LAMP2A multimer channel, and released into the lysosome for 
subsequent degradation (G˘omez-Sintes and Arias, 2021 ). Long thought 
to be a pathway exclusive to mammals, a recent study described the 
presence of CMA in medaka fish (Lescat et al., 2020 ). Microautophagy is 
a less studied pathway, in which material to be degraded enters the 
lysosome directly though invagination of the lysosomal or late endo-
somal membrane (Fleming et al., 2022 ). While the underlying mecha -
nisms are not fully understood, a subset of KFERQ-containing proteins 
can also be recognized by Hsc70 and delivered into late endosomes via 
this pathway, a process termed selective endosomal microautophagy 
(eMI) (Fleming et al., 2022 ). The recently described age-associated 
decline in eMI is compensated for through increased exocytic secre -
tion of superfluous or damaged proteins to maintain proteostasis (Krause 
et al., 2022 ). These three distinct pathways share a common endpoint: 
degradation of the cargo inside the lysosome by acid hydrolases and 
release of its essential components (amino acids, nucleotides, lipids) 
back into the cytoplasm. 
While autophagy is essential to maintain homeostasis in physiolog -
ical conditions, it also plays an important role in responding to internal 
and external stressors such as starvation and bacterial infection. In the 
retina, which has a high metabolic rate and contains post-mitotic neu-
rons, autophagy plays a crucial role as a housekeeping system, ensuring 
neuronal survival throughout the organism ’s lifetime, avoiding the 
accumulation of toxic cellular byproducts (Boya et al., 2016 ; Klionsky 
et al., 2021b ). Our group has demonstrated a progressive age-associated decline in autophagy in the retina, starting at middle age, that leads to 
the accumulation of undigested cargo within lysosomes (Rodri -
guez-Muela et al., 2013 ). Interestingly, we have also described simul -
taneous upregulation of CMA in aged animals, indicating that distinct 
autophagic pathways can compensate for one another to maintain 
retinal proteostasis (Rodriguez-Muela et al., 2013 ). A similar upregu -
lation of CMA has been described in the retina of Atg5flox/flox;Nestin-Cre 
mice, which selectively exhibit impairment of autophagy in neurons, 
leading to severe retinal degeneration (Hara et al., 2006 ; Rodri -
guez-Muela et al., 2013 ). 
The specificity of autophagy has also been revealed in recent years. 
While bulk autophagy describes the degradation of non-specific cyto-
plasmic material, several different subtypes of selective autophagy have 
been also observed, including lipophagy (lipid droplets), lysophagy 
(lysosomes), pexophagy (peroxisomes), and ribophagy (ribosomes) 
(Johansen and Lamark, 2020 ; Villarejo-Zori et al., 2021 ). Selective 
autophagy is usually regulated by specific receptors and adaptors and 
can act as a response to selective organelle damage or nutritional cues. 
For example, lysosomal membrane permeabilization (LMP) triggers 
specific degradation of the subset of permeabilized lysosomes through 
lysophagy (Maejima et al., 2013 ), and lipid droplet degradation supports 
fatty acid-fueled mitochondrial beta-oxidation in rapidly proliferating 
cells (Singh et al., 2009 ). 
1.2. Mitophagy 
Mitophagy is a subtype of selective autophagy that leads to the 
degradation and recycling of whole mitochondria and can be triggered 
by mitochondrial damage. Mitophagy can also degrade mitochondria Abbreviations 
ΔΨm mitochondrial membrane potential 
A2E bis-retinoid N-retinyl-N-retinylidene ethanolamine 
ADOA Autosomal dominant optic atrophy 
AGEs advanced-glycation end products 
AMD age-related macular degeneration 
ASM autophagic secretion of mitochondria 
BBB blood-brain barrier 
BRB blood-retina barrier 
CE ceramide 
CL cardiolipin 
CMA chaperone-mediated autophagy 
CNS central nervous system 
CSE cystathionine- γ lyase 
DAMPs damage-associated molecular patterns 
DMF Dimethyl fumarate 
DM diabetes mellitus 
DR Diabetic retinopathy 
ECs endothelial cells 
EM electron microscopy 
eMI endosomal microautophagy 
ER endoplasmic reticulum 
ERG electroretinography 
GCL ganglion cell layer 
GSH glutathione 
HDACs histone deacetylases 
IMCLAM intramitochondrial CLICK to asses mitophagy 
IMM inner mitochondrial membrane 
INL inner nuclear layer 
IOP intraocular pressure 
IPL inner plexiform layer 
IS inner segments KG α-ketoglutarate 
LDL low-density lipoproteins 
LHON Leber ’s hereditary optic neuropathy 
LIR LC3-interacting region 
LMP lysosomal membrane permeabilization 
MDVs mitochondria-derived vesicles 
MMS methyl methanesulfonate 
MTHFR methylenetetrahydrofolate reductase 
MTS mitochondria-targeting sequence 
OLM outer limiting membrane 
OMM outer mitochondrial membrane 
ONC optic nerve crush 
ONL outer nuclear layer 
OPL outer plexiform layer 
OS outer segment 
OxPhos oxidative phosphorylation 
PAMPs pathogen-associated molecular patterns 
PHDs prolyl-4-hydroxylases 
PI3P phosphatidyl inositol 3-phosphate 
POS Photoreceptor outer segment 
RGC retina ganglion cell 
ROS reactive oxygen species 
RP retinitis pigmentosa 
RPE retinal pigment epithelium 
SI sodium iodate 
TIM translocase of the inner membrane 
TOLLES TOLerance of Lysosomal EnvironmentS 
TOM translocase of the outer membrane 
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end 
labelling 
TXNIP Thioredoxin-interacting protein 
VLDLR very low-density lipoprotein receptor  J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
3during development and differentiation and is called programmed 
mitophagy, this has been observed during erythrocyte and RGC differ -
entiation (Esteban-Martinez and Boya, 2018 ; Fivenson et al., 2017 ). 
Mitophagy can be divided into three main subtypes: 
PINK1/Parkin-dependent, receptor-mediated, and lipid-mediated 
mitophagy (Fig. 2). 
1.2.1. PINK1/Parkin-dependent mitophagy 
PINK1/Parkin-dependent mitophagy is triggered by mitochondrial 
membrane depolarization. In steady-state conditions, newly-translated 
PINK1 is recruited by the translocase of the outer membrane (TOM) 
complex in the outer mitochondrial membrane (OMM) and transported 
to the translocase of the inner membrane (TIM) complex. PINK1 
mitochondria-targeting sequence (MTS) is then processed by mito-
chondrial peptidases (MPP, PARL) and cleaved PINK1 is finally 
degraded by the proteasome (Greene et al., 2012 ). Upon mitochondrial 
depolarization, triggered by oxidative damage (e.g. OxPhos uncoupling 
or protonophore treatment), loss of mitochondrial membrane potential 
(ΔΨm) inhibits PINK1 transport by TOM and PINK1 accumulates in the 
OMM. PINK1 then phosphorylates ubiquitinSer65 and the homologous 
residue found in the ubiquitin-like domain of Parkin, an E3 ubiquitin 
ligase that further conjugates ubiquitin to other mitochondrial sub-
strates in the OMM. These events lead to a positive feedback loop that 
amplifies the mitophagy-triggering signals. Different adaptor proteins 
with ubiquitin-binding domains, such as NDP52, OPTN, and 
SQSTM1/p62, bind to phospho-ubiquitin residues and recruit auto-
phagy initiation machinery (Nguyen et al., 2016 ). Even though several 
different adaptors are recruited to the OMM by PINK1, only NDP52 and 
OPTN are essential to link upstream autophagy effectors (Lazarou et al., 
2015 ). Recently, it has been described that OPTN is able to drive 
mitophagy initiation independently of ULK1/2, utilizing TBK1 as an 
alternative kinase to activate the PI3K complex (Nguyen et al., 2023 ). 1.2.2. Receptor-mediated mitophagy 
Receptor-mediated mitophagy is ubiquitin-independent, and can 
also be triggered by hypoxia or developmental cues (Teresak et al., 
2022 ). It is mediated by adaptor proteins that contain both a MTS and a 
LIR, namely BNIP3, BNIP3L/NIX, AMBRA1, FUNDC1, BCL2L13, PHB2, 
and FKBP8 (Teresak et al., 2022 ). Each receptor shows differential af-
finity toward distinct members of the LC3/GABARAP family such is the 
case of BNIP3L/NIX for GABARAPL1 or FUNDC1 for LC3B (Liu et al., 
2012 ; Novak et al., 2010 ; Teresak et al., 2022 ). Receptor-mediated 
mitophagy is usually regulated at the transcriptional level and is the 
most physiologically important pathway in basal conditions in highly 
metabolic tissues (McWilliams et al., 2018 ). 
1.2.3. Lipid-mediated mitophagy 
Finally, mitophagy can also be modulated by certain lipid species 
such as cardiolipin (CL) and ceramide (CE), leading to direct cargo 
recognition. In basal conditions CL is found in the inner mitochondrial 
membrane (IMM), but can be translocated to the OMM by the scram -
blase PLSCR3 upon induction of mitochondrial damage. OMM-anchored 
CL can interact directly with DNM1L, favoring mitochondrial fission, or 
BECN1 and LC3B, favoring mitophagy (Chu et al., 2013 ; Huang et al., 
2012 ; Stepanyants et al., 2015 ). Long-chain CE generated by the enzyme 
CERS1 (C18-ceramide) accumulates preferentially in the OMM and can 
also interact directly with LC3B, triggering mitophagy (Teresak et al., 
2022 ). More recently, defects in mitochondrial protein import machin -
ery, such as those caused by aberrant protein misfolding, have been 
shown to trigger mitophagy independently of ΔΨm loss (Michaelis et al., 
2022 ). An alternative mitophagy pathway that involves Rab9-associated 
autophagosomes and is triggered by nutrient starvation has also been 
described (Saito et al., 2019 ). Mitochondrial components can also be 
recycled through the formation of autophagy-independent mitochon -
dria-derived vesicles (MDVs) that are delivered directly to the lysosome 
Fig. 1.Autophagy pathways . Macroautophagy (“autophagy ”) is characterized by the engulfment of cargo inside a double-membrane organelle, the autophagosome. It 
can be further classified as bulk or selective macroautophagy. CMA degrades KFERQ-containing proteins, which are recognized in the cytoplasm by Hsc70 and 
imported into the lysosome through LAMP2A multimer channels. Microautophagy is characterized by direct cargo mediated by lysosomal membrane invagination. 
All pathways result in the degradation of autophagic cargo by lysosomal hydrolases. J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
4(Konig et al., 2021 ), lysosome-dependent autophagic secretion of 
mitochondria (ASM) (Tan et al., 2022 ), or transcellular degradation in 
phagocytic cells (Davis et al., 2014 ; Nicol ˘as-˘Avila et al., 2020 ). Whether 
these alternative pathways play a role in the retina in physiological 
conditions remains to be elucidated. 
1.3. Retinal phenotype of autophagy- and mitophagy-deficient mice 
The retina is a highly organized tissue located in the posterior region 
of the eye that converts light stimuli into electrical impulses, which in 
turn are processed to generate visual images. The neural component of 
the retina is organized into 5 layers: 3 nuclear layers and 2 synaptic 
layers. The main light-sensitive cells in the outer part of the retina are 
photoreceptors (rods and cones), the nuclei of which form the outer 
nuclear layer (ONL). Rods mediate black and white vision and vision in 
low-light/dark conditions. Cones mediate color vision and vision in high 
light conditions, and can be stimulated by different light wavelengths. 
Both share a common cytoplasmic structure called the outer segment 
(OS), which encloses a stack of membranous structures called discs. 
These contain rhodopsin and other important proteins involved in 
phototransduction. The inner nuclear layer (INL) is composed of bipolar 
cells, horizontal cells, and amacrine cells. A dense network of synapses 
involving photoreceptors, bipolar cells and horizontal cells form the 
outer plexiform layer (OPL). Amacrine cells participate in the synapses 
between bipolar cells with RGCs in the inner plexiform layer (IPL). The 
innermost layer is mainly composed of RGCs that constitute the ganglion 
cell layer (GCL). The projecting axons of the RGCs merge to form the 
optic nerve, which connects the retina with the brain. Other important 
non-neuronal cells are retinal glia: Müller cells and astrocytes. Müller 
glia span the entire retina while astrocytes are mainly located within the 
GCL. Patrolling microglia also infiltrate the retina and are present in the 
subretinal space (Boya et al., 2016 ; Villarejo-Zori et al., 2021 ). 
Located immediately outside the neuroretina, the retinal pigment 
epithelium (RPE) provides nutrients and trophic support to photore -
ceptors, and mediates recycling of photoreceptor OS, thereby elimi -
nating toxic intermediates generated in the phototransduction process 
and providing new substrates for the visual cycle (Strauss, 2005 ). Because the retina is a neural tissue it requires autophagy as a quality 
control mechanism to maintain cellular homeostasis in neurons: post- 
mitotic cells are incapable of redistributing altered proteins or 
damaged organelles in daughter cells. This was first demonstrated in 
autophagy-deficient mouse models in which Atg5 or Atg7 is specifically 
deleted in neuronal precursors (Hara et al., 2006 ; Komatsu et al., 2006 ). 
These mice exhibit early neurodegeneration and die before reaching 3 
months of age, thus highlighting the essential role of basal autophagy in 
neuronal cells. 
1.3.1. Systemic models of autophagy/mitophagy deficiency 
Selective deletion of Atg5 in retinal neuronal precursors results in 
photoreceptor cell death and gliosis, and reduced visual function as 
measured by electroretinogram (ERGs) (Rodriguez-Muela et al., 2013 ). 
AMBRA1, activating molecule in BECN1-regulated autophagy protein 1, 
is a protein involved in the initiation phase of autophagy, and has also 
been recently linked to mitophagy modulation. In 
PINK1/Parkin-dependent mitophagy, AMBRA1 promotes PINK1 stabi-
lization at the OMM, and also interacts with ATAD3A, a transmembrane 
protein that regulates PINK1 import and degradation (Di Rienzo et al., 
2022 ). Furthermore, AMBRA1 has been detected in the OMM in 
steady-state conditions, where it can also initiate mitophagy upon 
mitochondrial depolarization by direct binding to LC3 via its LIR motif 
(Strappazzon et al., 2015 ). AMBRA1-mediated mitophagy is dependent 
on its phosphorylation by IKKα and HUWE1 E3 ubiquitin ligase activity 
(Di Rita et al., 2018 ). AMBRA1 haploinsufficiency in mice obtained by 
gene-trapped allele technique (Ambra1/gt mice) results in an acceler -
ated retinal aging phenotype, with increased photoreceptor loss and 
impaired visual function, coinciding with increased inflammation, pro-
tein aggregate accumulation, and metabolic alterations in the retina 
(Ramírez-Pardo et al., 2022 ). Ambra1/gt mice also show reduced RGC 
survival after optic nerve injury and reduced photoreceptor survival 
after induction of RPE damage (Bell et al., 2020 ; Ramírez-Pardo et al., 
2022 ). Mice lacking Atg4b protease also show increased RGC vulnera -
bility to optic nerve axotomy (Rodriguez-Muela et al., 2012 ). Similarly, 
Map1lc3b / mice lacking LC3 exhibit an age-associated decrease in 
retinal thickness and function and increased gliosis, an effect linked to 
Fig. 2.Main mitophagy pathways . Mitochondria degradation through selective autophagy can be classified depending on how the cargo is recognized. Ubiquitin- 
dependent (PINK1/Parkin pathway), ubiquitin-independent (receptor-mediated pathway) or direct lipid-mediated pathway. J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
5deficits in OS processing, the visual cycle, and lipid homeostasis in the 
RPE (Dhingra et al., 2018 ). Despite an absence of retinal alterations in 
basal conditions, Becn1/ and Park2 / mice are more susceptible to 
light-induced damage (Chen et al., 2013 ). Pink1 / mice show no neu-
roretinal alterations or changes in mitophagy (McWilliams et al., 2018 ). 
However, similarly to human AMD patients, the RPE of Pink1-deficient 
mice shows disrupted mitochondrial homeostasis and undergoes 
epithelial-mesenchymal transition. This phenomenon is abolished in the 
absence of the antioxidant master regulator Nrf2/Nfe2l2 (i.e. in 
Pink1 / Nfe2l2 / mice), pointing to an as-yet unexplored crosstalk 
between the accumulation of damaged mitochondria, ROS signaling, 
and cellular reprogramming (Datta et al., 2022 ). BNIP3L/NIX-deficient 
animals also show lower numbers of differentiated RGCs due to defi-
cient developmental mitophagy and the consequent effects on meta-
bolism (Esteban-Martinez et al., 2017a ). 
Mice lacking the lysosomal hydrolase cathepsin D show outer and 
inner retina degeneration with decreases in retinal thickness of 50% by 
post-natal day 15 (P15) and 90% by P25. Degeneration is accompanied 
by inflammation markers such as astrogliosis and microgliosis and 
increased levels of structural lysosomal proteins as LAMP1 and LAMP2 
(lysosomal associated membrane protein 1 and 2) and other cathepsins 
as cathepsin Z (Bassal et al., 2021 ). Interestingly, gene therapy con-
sisting of intravitreal injection of cathepsin D rescues this degenerative 
effect (Liu et al., 2022 ). Similarly, LAMP2 deficiency leads to intracel -
lular and extracellular accumulation of cell debris, thickening of Bruch ’s 
membrane and alterations in autophagic flux similar to those observed 
in AMD (Notomi et al., 2019 ). 
1.3.2. Neuroretina-deficient models 
Different mouse models have been generated to study the role of 
autophagy in specialized cell types in the retina. In cones, Atg5 deletion 
(Atg5flox/flox;HRGP-Cre ) leads to a reduction in cone number, starting at 2 
months of age. Visual impairment is evident at 10 months, and these 
mice display increased sensitivity to light stress with a reduction in cone 
OS length and swelling of the inner segments (IS), where mitochondria 
accumulate (Zhou et al., 2015a ). In rods, deletion of Atg5 (Atg5flox/flox; 
Rhodopsin-iCre75 ) produces degeneration beginning at 20 weeks, char-
acterized by decreased ONL thickness. By 44 weeks the ONL is severely 
affected, showing terminal deoxynucleotidyl transferase dUTP nick end 
labelling (TUNEL), an apoptosis marker, and few remaining rods. De-
creases in cone OS length and cone number are observed (He et al., 
2019 ). Although this abnormal cone phenotype is not very severe, cone 
function is markedly impaired. Rod degeneration is also observed in 
dark conditions, but is not exacerbated by light exposure. Progressive 
degeneration is accompanied by the accumulation of transducin, one of 
the main proteins involved in phototransduction, suggesting that auto-
phagy regulates the removal and recycling of this protein (Zhou et al., 
2015b ). In a proof-of-concept study, crossing of this Atg5Δrod model with 
the transducin-deficient Gnat / mouse model revealed less rod 
degeneration and preserved cone function, further supporting a role of 
transducin accumulation in the degeneration resulting from defective 
autophagy (Yao et al., 2016 ). In an autophagy-deficient mouse model 
with Atg7-deficient rods (Atg7flox/flox;LOMP-Cre ), no overt alterations 
were observed in normal light conditions, but exposure to intense illu-
mination for 2 h resulted in retinal degeneration, including reduced 
photoreceptor number and increased cell death (Chen et al., 2013 ). 
RabGEF1, a protein implicated in endolysosomal function (Hargrove- -
Grimes et al., 2020 ), is also proposed to be essential for visual function. 
Rabgef1-deficient mice show autophagosome accumulation in the IS of 
photoreceptors (Hargrove-Grimes et al., 2020 ). Moreover, RabGEF1 has 
been recently linked to PINK1/Parkin-dependent mitophagy, where it is 
recruited to damaged mitochondria via its ubiquitin-binding domain 
and locally regulates Atg9a endosome formation (Yamano et al., 2018 ). 
Interestingly, selective knockout of the autophagy initiation protein 
Vps34 in rods leads to photoreceptor cell death, progressive retinal 
degeneration, and reduced visual function associated with inefficient autophagic flux (He et al., 2016a ). Rod-driven retinal degeneration in 
Vps34-deficient mice is followed by cone atrophy and loss of function. 
Interestingly, selective knockout of Vps34 in cones also leads to 
decreased visual function without rod alterations (Rajala et al., 2020 ), a 
phenomenon that may be associated with the secretion of pro-survival 
rod-derived cone viability factor (RdCVF) (Ait-Ali et al., 2015 ). 
Finally, Vps34 deficiency in bipolar cells also leads to age-associated 
visual function loss and accumulation of autophagic cargo, high-
lighting the universal role of Vps34 in maintaining homeostasis in 
different cell types (He et al., 2019 ). In summary, defective autophagy in 
the retina leads to retinal degeneration and in most cases produces 
alteration of the visual function. These effects reveal a central role of 
autophagy in well-functioning retinal cells. 
1.3.3. RPE-deficient models 
Autophagy deficiency also has deleterious effects in the RPE. In the 
mouse model of Ambra1 deficiency described above, RPE degeneration 
is observed even at early time points, with morphological alterations 
and protein aggregate accumulation in the RPE. These mice also show 
increased RPE susceptibility to sodium iodate (SI)-induced oxidative 
damage (Ramírez-Pardo et al., 2022 ). In mouse models, RPE-specific 
autophagy deficiency usually results in accelerated aging or degenera -
tion. Disrupted lysosomal processing has been described in a mouse 
model in which Atg5 is deleted in RPE cells (Atg5flox/flox;BEST1 
(VMD2)-Cre ), together with deficient photoreceptor responses to light 
stimuli and consequent impairment of visual function (Kim et al., 2013 ). 
These effects are accompanied by decreased levels of 11-cis-retinal, 
which is part of the visual cycle and essential for phototransduction. 
Interestingly, administration of an exogenous analog of the chromo -
phore restores electrophysiological responses of rods and cones. These 
findings suggest that non-canonical autophagy supports chromophore 
regeneration through the efficient processing of photoreceptor outer 
segments (POS) in the RPE (Kim et al., 2013 ). Other study used a similar 
approach to delete either Atg5 or Atg7 in a conditional manner (Atg5-
flox/flox or Atg7flox/flox;VMD2-tTA-Cre ;Tet-ON inducible), revealing accu-
mulation of SQSTM1/p62, N-Tyr, and 8-OHdG, indicating concomitant 
protein and DNA oxidization (Zhang et al., 2017 ). This resulted in a 
degenerative condition that was more severe in Atg7-deficient versus 
Atg5-deficient RPE. Contrary to the aforementioned studies, a study of 
the same RPE Atg7-deficient mouse model revealed normal retinoid 
recycling, histology, and A2E (bis-retinoid N-retinyl-N-retinylidene 
ethanolamine, a major toxic fluorophore of lipofuscin) accumulation, 
and concluded that A2E accumulation and retinoid recycling do not rely 
on Atg7-mediated autophagy, and that Atg7 deficiency does not result in 
RPE degeneration in these mice (Perusek et al., 2015 ). Alterations re-
ported in another mouse model based on FIP200 deficiency 
(Rb1cc1flox/flox;BEST1-Cre ) include decreased conversion of LC3-I to 
LC3-II, SQSTM1/p62 accumulation, decreased levels of cathepsin D and 
LAMP1, and increases in mitochondrial number and intracellular lipid 
levels (Yao et al., 2015 ). At 4 months, these mice display areas of patchy 
atrophy with subretinal hyper-reflective spots that evolve to disrupt the 
hexagonal structure of the RPE and lead to secondary loss of photore -
ceptors and retinal function at 8 months. It has been described that A2E 
induces autophagy impairment and the simultaneous upregulation of 
Rubicon, a negative regulator of autophagy, in human polarized RPE 
monolayers. Those authors demonstrated normal ERGs in mice with 
Rubicon deficiency (Rubcnflox/flox;BEST1-Cre ) and an attenuated effect of 
chronic blue light exposure on inflammation and debris accumulation. 
Based on their findings, they have proposed that Rubicon deletion may 
protect the RPE from induced or age-associated damage (Ando et al., 
2021 ). More studies are needed to better understand the importance of 
autophagy/mitophagy in RPE. 
In conclusion, the body of evidence described above highlights the 
essential role of mitophagy in maintaining retinal homeostasis, while 
the more severe phenotype observed in autophagy-deficient mice in the 
absence of upstream regulators (Vps34, Ambra1) suggests that other J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
6components of the system can compensate for a lack of downstream 
autophagy modulators (LC3, PINK1, BNIP3L/NIX) (Table 1). 
1.4. Mitochondrial dynamics 
Degradation of mitochondria through mitophagy requires fission in 
order to generate piecemeal fragments small enough to be enclosed by 
the phagophore (Tilokani et al., 2018 ). Mitochondrial fission is initiated 
through pre-constriction by the ER and actin cytoskeleton, that generate 
a binding site for the master regulator Dynamin-related protein 1 
(DRP1) (Smirnova et al., 2001 ). DRP1, recruited and bound to the OMM 
through protein adaptors MFF and FIS1, will oligomerize in a 
GTP-dependent manner eventually leading to full constriction and scission of a mitochondrial fragment, that will be sent for degradation or 
generate a new functional mitochondrion depending on its size and 
composition (Kleele et al., 2021 ). Pharmacological modulation of DRP1 
is possible using the small molecule inhibitor Mdivi-1 (Cassidy-Stone 
et al., 2008 ), and has also been shown to reduce mitophagy in a 
fission-dependent manner (Mizumura et al., 2014 ). Mdivi-1 has been 
shown to be neuroprotective in a model of acute retinal ischemia (Park 
et al., 2011 ), and represents a therapeutical opportunity in contexts 
where mitophagy plays a detrimental role. Antagonistically, mitochon -
drial fusion promotes the formation of a complex tubular mitochondrial 
network and is mediated by GTP-dependent MFN1 and MFN2 dimer -
ization at the connecting OMMs (Chen et al., 2003 ) and OPA1 within the 
IMM (Griparic et al., 2004 ). Mutations in OPA1 have been linked to a 
Table 1 
Summary of the retinal phenotype of autophagy- and mitophagy-deficient mice.  
Cell type 
affected Genotype Function Phenotype Associated disease Reference 
Systemic Ambra1/gt Phagophore nucleation Decreased RGCs survival after ONC, impaired 
antioxidant response Glaucoma Bell et al. (2020) 
Systemic Ambra1/gt Phagophore nucleation Accelerated neuroretina and RPE aging, metabolic 
impairment, increased susceptibility to RPE- 
targeted damage Age-associated 
decline, AMD Ramírez-Pardo et al. 
(2022) 
Systemic Atg4b / LC3 processing Decreased RGCs survival after axotomy Glaucoma Rodriguez-Muela et al. 
(2012) 
Systemic Becn1/ Phagophore nucleation No basal alterations, increased susceptibility to 
light-induced damage Light damage Chen et al. (2013) 
Systemic Pink1 / PINK1/Parkin-mediated 
mitophagy No morphological alterations, no changes in 
mitophagy – McWilliams et al. 
(2018) 
Systemic Park2 / PINK1/Parkin-mediated 
mitophagy No basal alterations, increased susceptibility to 
light-induced damage Light damage Chen et al. (2013) 
Systemic Bnip3l / Receptor-mediated mitophagy Decreased RGCs differentiation Developmental defects Esteban-Martinez et al. 
(2017a) 
Systemic Ctsd / Lysosomal degradation Progressive retinal degeneration, gliosis NCL Bassal et al. (2021) 
Systemic Ctsd / Lysosomal degradation Retinal degeneration, gliosis, restored with RPE-, 
Müller-targeted scAAVshH10-CTSD NCL Liu et al. (2022) 
Systemic Rabgef1 / Endolysosome trafficking, 
PINK1-Parkin mediated 
mitophagy PR degeneration, reduced visual function – Hargrove-Grimes et al. 
(2020) 
Neuronal 
precursors Atg5flox/flox;Nestin- 
Cre Phagophore elongation Increased PR cell death, gliosis, reduced visual 
function Neurodegeneration Rodriguez-Muela et al. 
(2013) 
RGCs Atg5flox/flox;AAV2- 
Cre-GFP Phagophore elongation Decreased RGCs survival after axotomy Glaucoma Rodriguez-Muela et al. 
(2012) 
ON-Bipolar Vps34flox/flox; 
Pcp2-Cre Phagophore nucleation Age-associated decreased visual function – He et al. (2019) 
Rods Vps34flox/flox; 
Rhodopsin-iCre75 Phagophore nucleation Progressive retinal degeneration, reduced visual 
function – He et al. (2016b) 
Rods Vps34flox/flox; 
Rhodopsin-iCre75 Phagophore nucleation Progressive retinal degeneration, cone atrophy, 
reduced visual function – Rajala et al. (2020) 
Rods Atg5flox/flox; 
Rhodopsin-iCre75 Phagophore elongation PR degeneration, reduced visual function – Zhou et al. (2015b) 
Rods Atg7flox/flox;LMOP- 
Cre Phagophore elongation No basal alterations, increased susceptibility to 
light-induced damage Light damage Chen et al. (2013) 
Cones Vps34flox/flox; 
HRGP-Cre Phagophore nucleation Cone degeneration, reduced visual function – Rajala et al. (2020) 
Cones Atg5flox/flox;HRGP- 
Cre Phagophore elongation Cone degeneration, reduced visual function, 
increased susceptibility to light-induced damage Light damage Zhou et al. (2015b) 
RPE Rb1cc1flox/flox; 
BEST1-Cre Autophagy initiation Progressive RPE atrophy, reduced visual function – Yao et al. (2015) 
RPE Atg5flox/flox;BEST1 
(VMD2)-Cre Phagophore elongation Imapired visual cycle, reduced visual function – Kim et al. (2013) 
RPE Atg5flox/flox; 
VMD2-rtTA-Cre Phagophore elongation RPE degeneration AMD Zhang et al. (2017) 
RPE Atg7flox/flox; 
VMD2-rtTA-Cre Phagophore elongation Severe RPE degeneration AMD Zhang et al. (2017) 
RPE Atg7flox/flox; 
VMD2-rtTA-Cre Phagophore elongation No morphological or functional alterations – Perusek et al. (2015) 
RPE Map1lc3b / Phagophore elongation Progressive retinal degeneration, reduced visual 
function, gliosis – Dhingra et al. (2018) 
RPE Rubcnflox/flox; 
BEST1-Cre Negative autophagy regulator No basal alterations, decreased impact of light- 
induced damage Light damage Ando et al. (2021) 
RPE Pink1 / PINK1/Parkin-mediated 
mitophagy RPE epithelial-mesenchymal transition AMD Datta et al. (2022) 
RPE Lamp2 / Lysosomal membrane RPE morphological alterations, thickened BrM, 
debris accumulation AMD Notomi et al. (2019)  J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
7rare retinal disease called dominant optic atrophy (ADOA) (Ito and Di 
Polo, 2017 ). Mitochondrial dynamics modulation might represent a new 
upstream pharmacological target to fine-tune mitophagy (Cassidy-Stone 
et al., 2008 ; Zacharioudakis et al., 2022 ). 
1.5. Metabolism at the retina-RPE interface 
The retina has one of the highest metabolic rates of any tissue in the 
body, a consequence of the demand for energy to support photo -
transduction, neurotransmission, and homeostasis (Ames, 1992 ). The 
metabolic interplay between the neuroretina and RPE reflects a complex 
and finely tuned symbiotic relationship. In physiological conditions, the 
outer neuroretina constitutes a semi-hypoxic niche that favors 
tumor-like Warburg metabolism, while the RPE is fueled mainly by 
mitochondrial oxidative metabolism (Fisher and Ferrington, 2018 ; Ng 
et al., 2015 ). This metabolic adaptation shared by cancer cells and the 
neuroretina may be a consequence of the latter ’s constant need to fuel 
cell growth and renew photoreceptor OS on a daily basis, despite its 
post-mitotic status (Casson et al., 2013 ). The lateral and apical mem-
branes of the RPE are rich in GLUT1 glucose transporters, which shunt 
glucose from the choroidal blood flow straight to photoreceptors. Pho-
toreceptors rely on anaerobic glycolysis, which produces lactate that can 
be shuttled back to the RPE and the neighboring Müller glia (Kanow 
et al., 2017 ). The neuroretina exhibits regional differences in meta-
bolism, with more active glycolytic (and mitochondrial) metabolism 
observed in the cone-rich macular region (Li et al., 2020 ). Fatty acid 
β-oxidation has been recently described as a major pathway contributing 
to photoreceptor energetic homeostasis (Joyal et al., 2016 ). A study in 
which palmitate was added to retinal explants reported increased oxy-
gen consumption and ATP production, and the authors identified Ffar1 
as the modulator of fuel utilization in the retina (Joyal et al., 2016 ). 
Moreover, they showed that when circulating lipid levels increase, Ffar1 
reduces glucose uptake through downregulation of Glut1 expression 
levels. In mice lacking the very low-density lipoprotein receptor 
(VLDLR), increased Ffar1 activity led to decreased glucose utilization, 
which was not compensated for by lipid uptake and β-oxidation, 
resulting in decreased levels of α-ketoglutarate (KG), followed by a 
consequent reduction in hypoxia inducible factor 1a (HIF-1 α) stabili -
zation and neoangiogenic events (Joyal et al., 2016 ). Ffar1 also appears 
to modulate autophagy in response to fatty acids, through down -
regulation of TFEB signaling, and to reduce mitochondrial respiration 
(Heckel et al., 2022 ). The crosstalk between nutrient sensing, fatty acid 
metabolism, and autophagy requires further exploration and is one 
possible avenue for the development of therapies for angiogenic and 
age-associated retinal diseases. 
Lactate and lipids derived from photoreceptor OS can be oxidized 
and are the main substrates for mitochondrial metabolism in the RPE. In 
addition, lactate dehydrogenase activity in the RPE depletes the NAD 
pool by reducing it to NADH, thereby decreasing levels of one of the key 
substrates for glycolysis and favoring glucose delivery to photoreceptors 
(Kanow et al., 2017 ). Reductive carboxylation is another major pathway 
in the RPE that sustains fatty acid synthesis and redox potential (Du 
et al., 2016 ). Mitochondrial dynamics and metabolism also vary 
throughout the light-dark cycle and in response to light stimuli (Giar-
marco et al., 2020 ; Yako et al., 2021 ). In cones, mitochondrial pop-
ulations undergo daily cycles: during day-time high mitochondrial 
activity supports phototransduction, leading to oxidative damage, and 
mitochondria associate with autophagosomes, presumably undergoing 
mitophagy; at night, mitochondrial biogenesis increases, leading to an 
increased number of smaller, more metabolically active mitochondria 
(Yako et al., 2021 ). Mitochondria have also been found in the extra -
cellular space surrounding the outer limiting membrane (OLM), where 
they are extruded by cones (Yako et al., 2021 ). 
Aged RPE cells show decreased basal mitochondrial function and loss 
of spare capacity as demonstrated by respirometry (Rohrer et al., 2016 ). 
Studies in animal models have also revealed an age-associated decline in mtDNA integrity and copy number, as well as concomitant alterations in 
fusion/fission dynamics that may further hinder mitochondria func-
tionality (Wang et al., 2019b ). However, only small alterations in 
glutamine metabolic capacity have been described in the aged RPE, in 
which neuroretinal metabolism remains stable, suggesting possible al-
terations in nutrient acquisition or RPE-retina communication rather 
than nutrient utilization (Tsantilas et al., 2021 ). 
Alterations in either photoreceptor or RPE metabolism can trigger 
degeneration in the other cell type. For example, selective stimulation of 
glycolysis in the RPE in mice through genetic manipulation of the 
hypoxia response (HIF/VHL axis) leads to decreased glucose shuttling 
and subsequent photoreceptor degeneration (Kurihara et al., 2016 ). A 
similar phenotype is described in mice lacking Glut1 (Swarup et al., 
2019 ). Mice lacking the metabolic regulator AMPK in photoreceptors 
show abnormal metabolism that leads to RPE degeneration (Xu et al., 
2020 ). Similarly, deficits in enzymes involved in fatty acid β-oxidation, 
such as PPAR α or HADHA, lead to photoreceptor degeneration and RPE 
alterations (Lawlor and Kalina, 1997 ; Pearsall et al., 2017 ). Mitochon -
drial biogenesis and removal of damaged mitochondria through 
mitophagy may therefore be essential to sustain 
metabolically-demanding visual function and preserve retinal 
homeostasis. 
2.Methods to assess mitophagy in the retina 
The retina is commonly used as a model in which to study the central 
nervous system (CNS), mainly owing to its accessibility and the fact that 
it can be cultured ex vivo in defined medium, providing researchers with 
complete control of the nutrient and growth factor exposure. Owing to 
the slightly higher permeability of the blood-retina barrier (BRB) 
compared with the blood-brain barrier (BBB), the retina is the only part 
of the CNS in which autophagic flux can be evaluated in vivo using the 
protease inhibitor leupeptin (Esteban-Martinez and Boya, 2015 ). 
2.1. Autophagy assessment 
Autophagic flux, defined as the difference between the number of 
autophagosomes/LC3-II in the presence and absence of lysosomal in-
hibitors, can be evaluated in ex vivo retinal explants by monitoring LC3- 
II levels or lipidation by Western blot and by fluorescence microscopy or 
flow cytometry in GFP-LC3 transgenic mice (Esteban-Martinez and 
Boya, 2015 ; Gomez-Sintes et al., 2017 ). Autophagy can also be evalu -
ated by monitoring the dynamics of a tandem fluorescent-tagged LC3 
vector containing both pH-sensitive and pH-insensitive fluorescent 
proteins such as GFP and mCherry, respectively (Klionsky et al., 2008 ). 
Using this method, autophagosomes are visualized as yellow puncta 
(GFPmCherry) and autolysosomes as red puncta (GFP mCherry), 
due to the quenching of GFP signal by the intra-lysosomal acidic pH 
(Klionsky et al., 2008 ). Autophagy reporter mice (CAG-RFP-EGFP- -
MAP1LC3B, mCherry-GFP-MAP1LC3B (MAP)) have been recently 
developed following this principle, and a recent publication has sum-
marized the pros and cons of this technique to assess retinal autophagy 
(McWilliams et al., 2019 ; Ramachandra Rao and Fliesler, 2022 ). Finally, 
autophagy can also be assessed by quantifying the levels of different 
autophagy regulators, such as LC3, Beclin-1, and Ambra1, as demon -
strated by our group in chick (Mell˘en et al., 2008 ) and mouse retinas 
(Figueiredo-Pereira et al., 2023 ; Gomez-Sintes et al., 2017 ). To better 
explore the dynamics of autophagic flux, our group has developed an 
immunostaining procedure to assess autophagosome and autolysosome 
levels within retinal cell types using a cytoplasmic cell type-specific 
marker for cones, LC3, and LAMP1 (Samardzija et al., 2021 ). 
2.2. Mitophagy assessment 
While the tools and methods used to study autophagy have been 
refined over time (Klionsky et al., 2021a ), the range of assays available J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
8for mitophagy assessment remains limited. 
2.2.1. Electron microscopy 
Electron microscopy (EM) is one of the traditional approaches used 
to study mitophagy, and was first used to this end to examine the cones 
of hibernating ground squirrels undergoing metabolic re-adaptation 
(Reme and Young, 1977 ). This technique requires a high level of 
expertise: it is essential to correctly identify the autophagosomes and the 
mitochondria in different stages of degradation contained within them. 
Another drawback of this method is that in the absence of lysosomal 
inhibitors mitochondria are rapidly degraded inside autophagosomes, 
and therefore the number of mitophagosomes present at a given time-
point is limited. Moreover, in contrast to optical microcopy, EM only 
visualizes a very thin section of the total cellular volume, further 
reducing the number of mitophagosomes observed. This limitation can 
be overcome by performing morphometric quantification in a large 
number of cells, although this makes the technique very laborious. 
2.2.2. Fluorescence microscopy 
While EM was once the gold standard, nowadays mitophagy is most 
commonly evaluated using fluorescence microscopy. One of the most 
widely used approaches to detect mitochondria undergoing autophagic 
degradation is to assess colocalization of mitochondrial markers with 
the autophagosomal marker LC3 or a lysosomal marker, using either a 
fluorescently-tagged protein chimera or antibodies against different 
targets in living or fixed cells, respectively (Dagda et al., 2009 ; Florey 
et al., 2011 ; Narendra et al., 2008 ; Rambold et al., 2011 ; Wang et al., 
2012 ). The different stages of mitophagy can be further dissected and 
monitored using different combinations of tagged proteins: 
EGFP-LC3Mito-DsRed to study the early phases of mitophagy and 
mitochondria-EGFP LAMP1-RFP for later stages (Indira et al., 2018 ). 
Finally, an immunofluorescence method based on monitoring mito-
chondrial translocation of an autophagy receptor (NDP52) and the for-
mation of initiation foci during PINK1/Parkin-dependent mitophagy has 
been described (Padman and Lazarou, 2022 ). These approaches may be somewhat imprecise, as it cannot be verified whether an increase in 
mitophagosome number is due to induction of mitophagy or altered 
mitophagosome degradation within lysosomes. In order to differentiate 
between these two phenomena, autophagic and mitophagic flux should 
be monitored by comparing autophagosome/mitophagosome numbers 
in the absence and presence of lysosomal inhibitors (Klionsky et al., 
2021a ). 
Reporters such as MitoTimer, mt-Keima, and mito-QC can be used in 
tandem fluorescence assays to monitor and quantify mitophagy in vitro, 
ex vivo, and in vivo (Montava-Garriga et al., 2020 ; Rosignol et al., 2020 ; 
Williams et al., 2017 ). The mt-Keima mouse, the first in vivo mitophagy 
reporter model generated, expresses the pH-sensitive dual-excitation 
protein Keima targeted to the mitochondrial matrix (Katayama et al., 
2011 ): within the acidic lysosome mt-Keima switches to its ionized state 
and is excited by long wavelengths. However, assessment of mitophagy 
in the retina of these mice is not possible due to their FVB background: 
these mice are homozygous for the Pde6brd1 mutation, which leads to 
retinal degeneration (Sun et al., 2015 ). Another drawback of mt-Keima 
mice is that fixation of retinal tissue is not possible without losing the 
fluorescence, and the rapid and meticulous sample processing required 
for these mice largely precludes assessment of mitophagy within the 
retina. 
In the more recently developed mito-QC reported mouse, which has a 
C57Bl6/J background, mitophagy is also monitored based on changes in 
pH (Fig. 3). mito-QC has a tandem mCherry-GFP tag fused to the 
mitochondria-targeting sequence of the OMM protein FIS1 (FIS1 101-152 ). 
Healthy mitochondria in mito-QC mouse tissue show green and red 
fluorescence (GFPmCherry). However, when mitophagy is activated 
and mitochondria are delivered to the lysosome, GFP is quenched by the 
acidic pH and mitolysosomes are visualized as red puncta 
(GFP-mCherry) (McWilliams et al., 2016 ). Recent reports have dis-
cussed the differences between these two mitophagy reporters: while 
mt-Keima appears to detect mitophagy with higher sensitivity in certain 
settings, such as cardiac exhaustion (Liu et al., 2021 ), the background of 
this mouse model must be taken into account (FVB mice present 
Fig. 3.Assessment of mitophagy in the retina using mito-QC reporter . (A) Scheme depicting the basis of mito-QC reporter. (B) (Left) ARPE-19 cells treated with 1 mM DFP 
for 24h. (Center) Flatmount of retinas cultured ex vivo in the presence of 25 μM CCCP for 6h. (Right) Whole retina cryosection, inset depicts high mitophagy levels 
present in the ONL. Nuclei are counterstained with DAPI. Scale bar 15 μm, 25 μm, 25 μm. J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
9hyperactivity, altered circadian rhythms, and metabolic alterations) 
(Eltokhi et al., 2020 ; Enríquez, 2019 ). Differential targeting of the re-
porters (mt-Keima, mitochondrial matrix; mito-QC, OMM) may also 
contribute to the observed differences in sensitivity. Specifically, pH 
changes in the mitochondrial matrix and cytosol, respectively, may bias 
mitophagy readouts in specific contexts. 
Using mito-QC mice, our group has demonstrated different levels of 
mitophagy in distinct retinal cell types during development and in adult 
mice (Figs. 4 and 5). In these studies, mitophagy assessment was per-
formed in parallel with autophagy evaluation using the MAP reporter, 
which is based on the same principal as the mito-QC reporter, but the 
mCherry-GFP tandem is fused to the N-terminus of the MAP1LC3B 
protein (McWilliams et al., 2019 ). RGCs isolated from reporter mice are 
also a very reliable source of primary neurons for mitophagy assessment 
(Rosignol et al., 2020 ). Our laboratory recently developed a method to 
assess mitophagic flux in retinal explants from mito-QC mouse and 
performed in vivo studies after optic nerve crush (ONC) in these mice 
(Rosignol et al., 2020 ). While an increase in mitophagy in RGCs after 
optic nerve damage had been previously hypothesized, this was very 
difficult to detect and quantify. Other groups have also analyzed 
mitophagy levels using the mito-QC reporter in models of diabetic reti-
nopathy, age-associated muscle disease, and chronic obstructive pul-
monary disease (Hombrebueno et al., 2019 ; Maremanda et al., 2019 ; 
Mito et al., 2022 ). A Cre-inducible reporter called CMMR (conditional 
mitochondrial matrix-targeting mitophagy reporter) has also been 
developed using the MTS of the mitochondrial matrix protein COXIV 
fused to a mCherry-GFP tandem (Aoyagi et al., 2022 ). Combination of 
this approach with cell-type specific promoter Cre lines will help better 
understand the relevance of mitophagy in the different components of 
the retina. Finally, certain reporters enable the monitoring of mitochondrial 
dynamics by examining their lifetime, remodeling, and biogenesis. On 
such example is MitoTimer, a mutant of dsRed that undergoes changes 
in fluorescence from green to red as the protein matures. Increased green 
fluorescence suggests alterations in mitochondrial dynamics or biogen -
esis. Changes in the expression of red fluorescent protein without 
changes in green fluorescence suggest alterations in mitochondrial 
degradation (Trudeau et al., 2014 ). This model has been used to inves -
tigate mitochondrial turnover in the heart (Stotland and Gottlieb, 2016 ). 
Mito-SRAI is another fluorescent tandem YPet-afCFP (TOLLES: 
TOLerance of Lysosomal EnvironmentS) construct that has been used to 
assess mitophagy in vivo using AAV vectors. The acid sensitivity of YPet 
allows distinction of TOLLES-positive puncta in acidic compartments, 
revealing mitophagy in a similar manner to mito-QC, and can be eval-
uated using a ratiometric approach (Katayama et al., 2020 ). An intra-
mitochondrial CLICK to assess mitophagy (IMCLAM) assay using an 
acidity-responsive ΔΨm probe and a pH-inert reference probe has 
been recently described. IMCLAM can detect the induction of mitophagy 
by measuring the levels of red fluorescence, generated upon delivery of 
mitochondria into acidic lysosomes (Shi et al., 2021 ). 
2.2.3. Flow cytometry 
The aforementioned methods to study mitophagy sometimes require 
expensive, time-consuming, and sophisticated image analysis tech-
niques in order to distinguish between healthy cytosolic mitochondria 
and those delivered to acidic lysosomes. Therefore, a fast and quanti -
tative method has been developed to evaluate mitophagy in cells by flow 
cytometry using mitochondrion-selective fluorescent probes like Mito-
Tracker Deep Red FM (Mauro-Lizcano et al., 2015 ). This approach al-
lows the determination of mitophagic flux when combined with 
Fig. 4.Hypoxia and mitophagy in the developing retina . (A) Retina cryosections from embryos at E13.5, E15.5 or E18.5 immunostained with β–III–tubulin to label 
neurons and pimonidazole to label hypoxic regions (A) or from (B) mito-QC reporter mice (B), displaying mitochondria in yellow and mitolysosomes in red, where the 
GFP fluorescence has been quenched inside the acid environment of the lysosome. Nuclei are counterstained with DAPI. Gray arrows indicate mitophagosomes. Scale 
bar, 15 μm. (C) Heatmap of hypoxia-regulated genes throughout retina development (GSE84299). J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
10
Fig. 5.Co-localization of mito-QC with cell type-specific and autophagic markers . Whole retina cryosections were immunostained with Cone Arrestin (cones), GFAP 
(astrocytes and Müller glia), LC3 (autophagosomes) and LAMP1 (lysosomes). Scale bar 25 μm. 
Table 2 
Methodology available for the study of mitophagy in vitro, ex vivo and in vivo.  
Methodology Application Readout Advantages Disadvantages Reference 
Electron 
microscopy in vitro, in 
vivo TEM imaging, 
morphometry 
quantification Reliability, ability to assess the 
different steps of mitophagy Time-consuming, requires high expertise. 
Low mitophagosome numbers unless 
lysosomal degradation is blocked Reme and Young (1977) 
EGFP- 
LC3Mito- 
DsRed in vitro Colocalization by 
fluorescence imaging, 
manual or automated 
quantification Accessible, selectively reports 
mitophagosome generation Requires confocal imaging to asess co- 
localization Indira et al. (2018) 
mito-EGFP 
LAMP1-RFP in vitro Colocalization by 
fluorescence imaging, 
manual or automated 
quantification Accessible, selectively reports 
mitolysosome formation Requires confocal imaging to asess co- 
localization, GFP pH-sensitive quenching 
might lead to underestimation of results Indira et al. (2018) 
GFP-NDP52 
foci 
formation in vitro Colocalization by 
fluorescence imaging, 
automated quantification Accessible, fast Requires confocal imaging, only measures 
NDP52-mediated mitophagy Padman and Lazarou 
(2022) 
mt-Keima in vitro, in 
vivo Fluorescence imaging, 
manual or automated 
quantification, flow 
cytometry Accessible, high sensitivity, allows 
mitophagic flux assessment Requires confocal imaging, cannot be 
fixed, requires live imaging and fast tissue 
isolation, prone to artifacts due to sample 
processing, RD background Katayama et al. (2011) 
mito-QC in vitro, ex 
vivo, in vivo Fluorescence imaging, 
manual or automated 
quantification, flow 
cytometry High sensitivity, allows mitophagic 
flux assessment, fixable, can be 
multiplexed with cell type-specific 
markers Requires confocal imaging, careful 
processing to ensure neutral pH 7.0 
throughout sample processing McWilliams et al. (2016) 
CMMR-flox in vivo Fluorescence imaging, 
manual or automated 
quantification Cell type-specific mitophagic flux 
assessment, fixable Requires confocal imaging, careful 
processing to ensure neutral pH 7.0 
throughout sample processing Aoyagi et al. (2022) 
MitoTimer in vitro, in 
vivo Fluorescence imaging, 
manual or automated 
quantification Allows tracking of mitochondrial age 
and biogenesis assessment Requires confocal imaging, co- 
localization with autophagosome and 
lysosome markers to detect mitophagy (Stotland and Gottlieb, 
2016 ; Trudeau et al., 
2014 ) 
mito-SRAI in vitro, in 
vivo Fluorescence imaging, 
manual or automated 
quantification, flow 
cytometry Accessible, fixable Requires confocal imaging, no 
constitutive reporter mice strain available Katayama et al. (2020) 
IMCLAM in vitro Fluorescence imaging, 
manual or automated 
quantification, flow 
cytometry Allows tracking of mitochondria, 
fixable Requires confocal imaging, time- 
consuming, limited availabilty, hinders 
cell proliferation, limited in vivo 
applicability Shi et al. (2021) 
MTDR in vitro, ex 
vivo Flow cytometry Accessible, fast, reproducible results, 
low cost, can be multiplexed. Flux 
determination by using protease or 
lysosomal inhibitors Requires a flow cytometer equipped with 
red/far red laser line and detectors, might 
be affected by drugs that severely disrupt 
ΔΨm (Esteban-Martinez et al., 
2017a ; Mauro-Lizcano 
et al., 2015 ) 
pUbSer65 ELISA in vivo ELISA, enzyme 
immunoassay Fast, translational approach for 
clinical use Limited to PINK1-mediated mitophagy 
detection, no commercial kits available Watzlawik et al. (2021)  J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
11lysosomal inhibitors and/or mitophagy inducers (Esteban-Martinez 
et al., 2017b ). Our group has successfully used this approach to study 
mitophagy in the developing retina, in retinitis pigmentosa models, and 
in proliferating endothelial cells (Esteban-Martinez et al., 2017a ; 
Mauro-Lizcano et al., 2015 ; Sahún-Espa ~nol et al., 2022 ). Furthermore, 
thanks to its far-red emitting properties, combination of MitoTracker 
Deep Red FM with other dyes and probes allows the determination of 
other intracellular parameters such as viability, oxidative stress, and 
ΔΨm (Esteban-Martinez et al., 2017a ). 
An innovative new approach to measure mitophagy in mouse brain 
and human clinical and pathological samples involves the use of a 
sandwich ELISA targeting the mitophagy marker pUbSer65, which holds 
promise as a potential biomarker for neurodegenerative diseases in 
clinical practice (Watzlawik et al., 2021 ). In conclusion, the develop -
ment of new tools and methods has been pivotal in furthering our 
knowledge of the basic functions of mitophagy in the retina, both ex vivo 
and in vivo (Table 2). While tandem fluorescence reporters allow us to 
monitor the dynamics of this process, there remains a need for efficient, 
fast, and reliable tools. 
3.Physiological functions of mitophagy in the retina 
3.1. Role of mitophagy in retina development 
In mammals, retinal development occurs in the anterior region of the 
neural plate, and consists of the appearance of the optic pit and evagi -
nation of the optic primordium (Chow and Lang, 2001 ). In mice this 
process begins around embryonic day (E) 7.5, with development of the 
neuroretina beginning around E12.5 (Bharti et al., 2006 ). From this 
point, a dynamic spatiotemporal process begins in which the different 
retina cell types arise from the multipotent progenitors (Zagozewski 
et al., 2014 ). The mouse embryonic retina exhibits high levels of HIF-1 α 
and pimonidazole staining (Kurihara et al., 2010 ), which are indicative 
of hypoxia, one of the main inducers of mitophagy (Zhang et al., 2008 ). 
Taking into account the energy-demanding proliferation-differentiation 
balance and its hypoxic environment, it is reasonable to speculate that 
mitophagy may play an important role in the developing retina. Indeed, 
our group has demonstrated that BNIP3L/NIX- and Atg5-dependent 
mitophagy contributes to the metabolic shift towards glycolysis that 
drives RGC differentiation (E15.5) during retinal development (Esteban-Martinez et al., 2017a ) (Fig. 6). This switch to glycolysis for 
differentiation challenges the general paradigm, as differentiation is 
usually associated with increased mitochondrial activity (Agathocleous 
et al., 2012 ; Agostini et al., 2016 ; Cedikova et al., 2016 ; Ellen Kreipke 
et al., 2016 ; Wagatsuma and Sakuma, 2013 ). However, oxygen levels 
and the hypoxic niche surrounding the developing retina may play an 
essential role in the metabolic shift toward glycolysis or oxidative 
phosphorylation (OxPhos). If hypoxia is the driver of the differentiation 
process (oxygen levels decrease over time), mitophagy-dependent 
metabolic reprogramming towards glycolysis may regulate cell differ -
entiation (Fig. 4). This could also explain the metabolic shift in the 
opposite direction (from glycolytic to a more OxPhos-dependent meta-
bolism) observed in the Xenopus retina, in which differences in oxygen 
levels were observed between proliferating and fully differentiated 
retinae (Agathocleous et al., 2012 ). Another observation supporting this 
hypothesis is the increased mitophagy and decreased mitochondrial 
activity that accompanies the differentiation of mouse skin mesen -
chymal stem cells into chondrocytes (Forni et al., 2016 ), a 
hypoxia-regulated differentiation process (Araldi and Schipani, 2010 ). 
Together, these findings indicate that mitophagy-dependent metabolic 
reprogramming appears to regulate cell differentiation in hypoxic 
conditions. 
Supporting the view that BNIP3L/NIX may participate in organelle 
degradation, BNIP3L/NIX-KO mice show accumulation of mitochondria, 
ER, and Golgi protein markers in the lens (Brennan et al., 2018 ). How-
ever, a recent study demonstrated that PLAAT phospholipases are the 
main players in organelle removal during lens development (Las-
tres-Becker et al., 2021 ; Morishita et al., 2021 ). In summary, the 
mechanism by which BNIP3L/NIX protein participates in lens degra -
dation or whether said alternative mechanisms (PLAAT) are involved in 
neighboring neuroretina development remains unclear and requires 
further research. 
Using the recently developed mito-QC reporter mouse, our group has 
generated a map of mitophagy and general macroautophagy in the 
E16.5 mouse retina (McWilliams et al., 2019 ). However, at this devel -
opmental stage mitophagy only accounts for around 25% of autophagic 
degradation within the retina, indicating that other substrates or or-
ganelles may need to be removed following the mitochondrial remod -
eling observed at E15.5 (Esteban-Martinez et al., 2017a ; McWilliams 
et al., 2019 ). Other in vitro approaches highlight the importance of the 
Fig. 6.Mitophagy mediates RGC differentiation . During retinal development neuroblasts undergo a metabolic switch from a predominant oxidative to a more glycolytic 
metabolism, mediated by BNIP3L/NIX-dependent mitophagy that regulates RGCs differentiation. Hypoxia triggers HIF-1 α stabilization and transcriptional upre-
gulation of BNIP3L/NIX, to eliminate mitochondria. Pharmacological or genetic inhibition of any of these steps hinders RGC differentiation while autophagy in-
duction increases the number of differentiated RGCs. J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
12autophagy pathway in differentiated cells versus progenitor cells (Das 
et al., 2020 ; Yazdankhah et al., 2021 ). Human retinal ganglion cells 
(hRGCs) rely more on the endo-lysosomal pathway for protein degra -
dation while stem cells predominantly use the ubiquitin-proteasome 
system (Das et al., 2020 ). Moreover, autophagic and mitophagic flux 
are higher in differentiated versus undifferentiated rat oligodendrocytes 
(Yazdankhah et al., 2021 ). If mitochondria fission is inhibited, oligo -
dendrocyte differentiation is also reduced, suggesting that mitophagy 
could also be implicated (Yazdankhah et al., 2021 ). In conclusion, 
mitophagy (and autophagy) seem to be essential for proper differenti -
ation of the retina, with BNIP3L/NIX-mediated mitophagy playing a key 
role in RGC metabolic reprogramming and neurogenesis in the devel -
oping retina, and in certain situations driving changes in metabolic 
status. 
3.2. Role of mitophagy in the adult retina 
Although mitophagy has been generally described as a mechanism to 
respond to mitochondrial damage, several recent studies have demon -
strated a basal level of mitophagy in vivo (Rodger et al., 2018 ). In our 
collaboration with Ian Ganley ’s research group, we performed an 
exhaustive comparison of autophagy and mitophagy levels in the main 
cell types in the E16.5 and adult eye using autophagy (MAP) and 
mitophagy (mito-QC) reporter mice respectively. We found that auto-
phagy was present in all areas of the eye, both in development and 
adulthood (McWilliams et al., 2019 ). However, in the adult eye 
mitophagy accounted for most of the ongoing autophagic degradation in 
the cornea and the retina (McWilliams et al., 2019 ). The highest levels of 
mitophagy were found in the ONL, which is extensively populated by 
photoreceptors and Müller glia processes. Compared to other retinal cell 
types, adult photoreceptors have a higher metabolic demand and are 
very susceptible to light-induced damage. A high mitophagy activity 
may therefore be necessary to avoid the accumulation of damaged 
mitochondria. This hypothesis is supported by the lower levels of 
mitophagy observed during the later stages of embryonic retina devel -
opment, a period during which phototransduction has not yet started 
and photo-oxidative damage is therefore absent. In stark contrast, we 
found very low levels of mitophagy during adulthood in regions such as 
the ciliary body and lens (McWilliams et al., 2019 ). While mitophagy in 
the RPE was observed in the mito-QC mice, further studies are required 
to determine its importance in this cell type, which relies on OxPhos and 
mitochondrial metabolism to sustain OS recycling (McWilliams et al., 
2019 ). Retinal mitophagy has been proposed to rely primarily on 
PINK1-independent pathways in both light and dark conditions 
(McWilliams et al., 2018 ), although this hypothesis is yet to be proven. 
In conclusion, high levels of mitophagy can be observed in the adult 
retina, particularly in photoreceptors. More studies are required to 
identify the mitophagy pathways involved in photoreceptor homeostasis 
and to unravel the physiological relevance of mitophagy in this mainly 
glycolytic cell type. While the phenotype of mitophagy-deficient ani-
mals is mild, the use of mitophagy reporter mice and breeding with 
different autophagy- and mitophagy-deficient strains (Table 1) will shed 
further light on these questions. 
4.Alterations in mitophagy in retinal disease 
4.1. Glaucoma 
Glaucoma is a multifactorial, neurodegenerative disease associated 
with aging. It is the leading cause of irreversible blindness worldwide 
and will affect over 100 million people by 2040 (Tham et al., 2014 ). 
Glaucoma is frequently associated with elevated intraocular pressure 
(IOP) that leads to progressive optic nerve damage, culminating in 
vision loss caused by RGC death. Current treatments are mainly aimed at 
reducing IOP. However, glaucoma can progress even in patients 
receiving these therapies, and some patients develop glaucoma without showing an increase in IOP. Regardless of the origin of the insult, RGCs 
will die once their axons have been damaged, and currently there are no 
treatments capable of either halting this process or inducing axonal 
regrowth. 
RGCs are very vulnerable to mitochondrial deficits, as evidenced in 
various rare inherited diseases caused by mutations in genes that regu-
late mitochondrial function, such as Leber ’s hereditary optic neuropathy 
(LHON; caused by mutations in the mitochondria-encoded subunits of 
NADH dehydrogenase MT-ND1, MT-ND4, MT-ND4L, and MT-ND6) and 
autosomal dominant optic atrophy (ADOA; caused by mutations in 
OPA1, which is involved in mitochondrial fusion). Furthermore, multi -
ple studies have described mitochondrial dysfunction in glaucoma pa-
tients and in experimental models in which reduced ATP, increased ROS 
production, and mitochondria-dependent apoptosis contribute to RGC 
damage and cell death (Ito and Di Polo, 2017 ; Jassim et al., 2021a ). High 
oxidative stress levels also lead to increased mitochondrial damage, 
triggering a pathogenic loop that could perpetuate and exacerbate 
damage caused by elevated IOP or other factors. Thus, the selective 
removal of mitochondria via mitophagy could represent a mechanism to 
stop this vicious cycle (Frank et al., 2012 ). Why RGCs are especially 
sensitive to mitochondrial damage is a focus of ongoing research, and 
may be linked to their unique morphology, i.e., very long axons and 
complex dendritic arbors that require highly-compartmentalized bio-
energetic machinery and metabolism. 
Using experimental models of severe axonal damage such as ONC or 
axotomy, several studies have highlighted how autophagy can play a 
protective role and promote RGC survival (Chang and Guarente, 2014 ; 
Kim et al., 2008 ; Lee et al., 2021 ; Rodriguez-Muela et al., 2012 ; Russo 
et al., 2013 ; Su et al., 2014 ). Supporting this cytoprotective role of 
autophagy in RGCs, animals with deficient autophagy such as the 
Atg4B –KO and the RGC-specific Atg5-KO mice, show increased suscep -
tibility to axonal damage (Rodriguez-Muela et al., 2012 ). 
Interestingly, in some autophagy-deficient models this susceptibility 
increases with age. The consequences of ONC on RGC survival in young 
(5–6 months) Ambra1 heterozygous animals (Ambra1/gt) are compa -
rable to those in wild-type littermates (Ambra1/), while in middle- 
aged animals (12–14 months) fewer RGCs survive after ONC (Bell 
et al., 2020 ). In physiological conditions, no changes in the number of 
RGCs are observed in young or middle-aged animals, while geriatric 
(22–26 months) mice show a tendency towards reduced RGC number 
(Ramírez-Pardo et al., 2022 ). Proteomic analysis of the retina of 
Ambra1-deficient animals also reveals lysosomal alterations, with de-
creases in the levels of the lysosomal proton pump subunit ATP6V1A and 
a massive reduction in the levels of crystallin molecular chaperones 
(CRYBB2, CRYAA, CRYAB), deficits which have been associated with 
impaired lysosomal function (Valapala et al., 2014 ). In the context of 
glaucoma, crystallins have been linked to neuroprotection of RGCs after 
ONC (Anders et al., 2017 ; Ying et al., 2008 ). Data from our and other 
research groups suggest that reduced autophagy renders RGCs more 
susceptible to external insult, and may therefore play an essential 
pro-survival role during glaucoma progression. 
A prominent feature of autophagy dysfunction is the accumulation of 
damaged mitochondria (Komatsu et al., 2005 ). It has been suggested 
that defective removal of mitochondria via autophagy results in 
increased oxidative stress as well as activation of immune-activating 
damage-associated molecular patterns (DAMPs) and 
pathogen-associated molecular patterns (PAMPs), and can lead to cell 
death (Frank et al., 2012 ). For example, a recent study reported that the 
antiviral defense protein TRIM5 α regulates Parkin-dependent and -in-
dependent mitophagy pathways, in which TRIM5 α recruits upstream 
autophagy regulators to damaged mitochondria (Saha et al., 2022 ). 
Thus, defects in mitophagy can result in increased inflammation and 
glial activation. Indeed, we observed increased astrocytic gliosis and 
microglial activation in the retina of old Ambra1-deficient animals, 
together with increased oxidative stress in the neuroretina and RPE in 
middle-aged mice (Ramírez-Pardo et al., 2022 ). These data further J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
13support a key pro-mitophagic function of Ambra1, preventing oxidative 
stress and inflammation and sustaining retinal homeostasis. 
Evidence also supports a cytoprotective role of mitophagy in glau-
coma. First, mitophagy increases after ONC in mito-QC mitophagy re-
porter mice, and a similar increase in mitophagy is observed in primary 
RGCs cultured in vitro under different stress conditions (Rosignol et al., 
2020 ). Second, rapamycin has been shown to reduce oxidative stress in 
vivo after axotomy, after which EM revealed mitochondria inside auto-
phagosomes and autolysosomes, suggesting mitophagic degradation 
(Rodriguez-Muela et al., 2012 ). In agreement, beneficial effects of 
rapamycin have been demonstrated in glaucoma rodent models (Harder 
et al., 2020 ; Wang et al., 2020 ), although a detrimental effect of mTOR 
(mammalian target of Rapamycin) inhibition has also been reported in 
similar models (Agostinone et al., 2018 ), and restoration of mTOR ac-
tivity protects dendrites in injured RGCs (Belforte et al., 2021 ). One 
possible explanation for these conflicting findings is that the beneficial 
effects depend on the disease stage. For example, in a model of chronic 
hypertensive glaucoma in rats the number of mitophagosomes in the 
optic nerve decreased at 3 days, but increased at 2 weeks following IOP 
elevation (Dai et al., 2018 ). In that model, Parkin overexpression 
increased RGC survival and improved mitochondrial health (Dai et al., 
2018 ). Taken together, these data suggest that mitophagy could be 
triggered to eliminate damaged mitochondria to cope with stress in early 
disease stages, but that cumulative damage over time causes the 
compensatory mechanisms to fail, resulting in impaired mitophagy and 
progressive RGC damage (Dai et al., 2018 ). Indeed, we have found that 
in basal conditions aged Ambra1/gt mice show increased transcriptional 
activation of cytoprotective pathways (e.g. the oxidative stress 
response), which could result in exhaustion of the anti-oxidant enzymes 
and consequent impairment of the response in conditions of added stress 
(Bell et al., 2020 ). Alternatively, deficient mitophagy could be a primary 
defect in Ambra1 heterozygous mice, contributing to the accumulation 
of damaged mitochondria and increasing oxidative stress. This, together 
with the deficient anti-oxidant response, could explain the accelerated 
aging of the retina observed in Ambra1 heterozygous animals. In any of 
these scenarios, the pathogenic loop of impaired mitophagy –increased 
ROS would be further exacerbated in autophagy/mitophagy-deficient 
animals, thereby increasing cell death (Ramírez-Pardo et al., 2022 ). 
IOP elevation can reduce oxygen supply to the retina, inducing 
hypoxia-triggered HIF-1 α signaling (Ergorul et al., 2010 ). As mentioned 
above, the downstream target genes of HIF-1 α include BNIP3 and 
BNIP3L/NIX, key regulators of Parkin-independent mitophagy (Teresak 
et al., 2022 ). Indeed, our group has described transcriptional upregu -
lation of BNIP3 and BNIP3L/NIX in response to ONC, an effect that was 
attenuated in Ambra1-deficient mice (Bell et al., 2020 ). A recent study 
presented evidence of hypoxia and ROS accumulation in the retina of 
DBA/2J mice (a model of high IOP glaucoma), together with a decrease 
in mitochondrial mass and citrate synthase activity (Jassim et al., 
2021b ). Mitophagic flux was not evaluated, but increased levels of Rheb 
were observed in the glaucomatous retina, suggesting increased 
mitophagy in these experimental conditions, although this hypothesis 
needs to be confirmed. Additionally, an accumulation of mitochondria 
with altered morphology was observed in the optic nerve of DBA/2J 
mice, concomitant with increased number of autophagosomes and 
LC3-II/LC3-I ratio (Coughlin et al., 2015 ; Hirt et al., 2018 ). While no 
differences were observed in PINK1 or Parkin levels, the involvement of 
other mitophagy pathways and whether these alterations are subcellular 
localization-specific remains to be studied. 
Maintenance of a fine balance between mitochondrial biogenesis and 
mitophagy is a key determinant of mitochondrial homeostasis. Excessive 
mitophagy in the absence of mitochondrial biogenesis could compro -
mise the cell’s ability to sustain metabolic demands, resulting in cell 
death (Doxaki and Palikaras, 2020 ). Thus, mitophagy triggers concom -
itant mitochondrial biogenesis, and this compensatory response allows 
them to survive under stress conditions (Palikaras et al., 2015 ). How 
mitochondrial biogenesis and mitophagy are coordinated in RGCs remains to be elucidated, as defects in mitochondrial biogenesis have 
also been observed in the aged DBA/2J mouse glaucoma model (Guo 
et al., 2014 ). A recent study uncovered important crosstalk between 
oxidative stress and mitophagy upregulation: mice deficient for the 
uncoupling protein UCP2 showed reduced RGC death in response to 
glaucoma induced by microbead injection (Hass and Barnstable, 2019b ). 
The authors showed that deletion of Ucp2 in astrocytes or RGCs 
increased the colocalization of mitochondrial proteins with LC3 and 
increased transcriptional levels of many mitophagy-related genes in vivo 
(Hass and Barnstable, 2019a ). Interestingly, these protective effects of 
Ucp2 downregulation were independent of mitochondrial biogenesis, 
and were associated with increases in mitochondrial function and 
increased mitophagy (Hass and Barnstable, 2019b ). Thus, while Ucp2 
overexpression decreases glaucomatous death (Hass and Barnstable, 
2019a ), downregulation appears to trigger a pro-mitophagy response 
that also protects RGCs from IOP-induced cell death. Interestingly, 
astrocyte-specific Ucp2 deletion induced a similar level of protection 
against cell death to that observed for Ucp2 deletion in Thy1-positive 
RGCs, suggesting that mitophagy may exert a direct cytoprotective ef-
fect in RGCs, but may also be associated with the elimination of RGC 
mitochondria within astrocytes during transmitophagy. Indeed, this 
phenomenon of transcellular mitochondria degradation had been pre-
viously described in optic nerve astrocytes (Davis et al., 2014 ) and has 
since been found in several contexts, including the heart (Nicol ˘as-˘Avila 
et al., 2020 ) and in Alzheimer ’s disease models (Lampinen et al., 2022 ). 
Supporting the relevant role of mitochondrial homeostasis in glau-
coma, mutations in the mitophagy receptor OPTN and its upstream 
activator TBK1 kinase have been associated with increased risk of 
developing open angle glaucoma (OAG), specifically normal-tension 
glaucoma (NTG). OAG can also involve reduced aqueous humor 
drainage and lead to chronically increased IOP, but presents slower 
progression nonetheless. The E50K-OPTN variant is the most prevalent 
mutation (Minegishi et al., 2016 ) and studies using RGC-differentiated 
human pluripotent stem cells (hPRCs) have shown that this mutation 
leads to increased cell death that is rescued by the TBK1 inhibitor 
Amlexanox (Sayyad et al., 2021 ). Analyses on retinal organoids revealed 
that E50K-OPTN leads to autophagosome accumulation and impaired 
autophagic flux (VanderWall et al., 2020 ). Surprisingly, similar alter-
ations were found in E50K-OPTN astrocytes, indicating that glial cells 
might also be accelerating or contributing to neurodegeneration in OAG 
(Gomes et al., 2022 ). Autophagy is also impaired in mice expressing the 
E50K-OPTN risk variant, and mTORC1 inhibition with Rapamycin 
restored autophagic flux and improved visual function (Zhang et al., 
2021 ). Less common M98K-OPTN variant also presents autophagy al-
terations and increased cell death susceptible to TBK1 modulation 
(Klionsky et al., 2021a ; Sirohi et al., 2013 ). Regarding mitochondrial 
dynamics, E50K-OPTN has been shown to increase the fission/fusion 
ratio, leading to decreased mitochondrial function and increased basal 
mitophagy (Shim et al., 2016 ). In other study, glaucoma-associated 
OPTN mutants have been shown to have similar 
PINK1/Parkin-mediated mitophagy levels to WT OPTN (Chernyshova 
et al., 2019 ). Further research is required to determine how mitophagy is 
altered in OAG involving OPTN mutants, and whether these alterations 
are indeed mutant-specific. Pharmacological TBK1 modulation might 
represent an interesting druggable target to modulate mitophagy and 
improve RGC survival. 
In conclusion, many questions remain regarding the mechanisms and 
role of mitophagy in RGCs. For example, how is defective mitochondrial 
function connected to ROS production and mitophagy in RGCs? A recent 
study found that excessive ROS production is followed by mitophagy via 
the KEAP1/PGAM5 complex (Zeb et al., 2021 ). Whether different forms 
of mitophagy occur within distinct subcellular compartments of RGCs 
also remains to be determined. Parallel induction of independent 
mitophagy pathways within different compartments could be beneficial 
for RGCs, which have long axons. Indeed, a recent report demonstrated 
that local translation of Pink1 supports local mitophagy in axons of J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
14iPSC-derived neurons (Harbauer et al., 2022 ). Understanding how the 
different mitochondrial quality control pathways, including biogenesis, 
fusion, fission, and mitophagy, are regulated will be key to help design 
new strategies for the treatment of glaucoma and other degenerative 
diseases involving RGC damage (Table 3). 
4.2. Diabetic retinopathy 
Diabetic retinopathy (DR) is the most common complication asso-
ciated with diabetes mellitus (DM), with a prevalence of 22.7% in DM 
patients (Teo et al., 2021 ). DR is characterized by long-term accumu -
lation of glucose and a chronic state of hyperglycemia, which affects the 
retinal microvasculature and causes structural abnormalities and 
cellular damage, leading to visual impairment and eventual blindness 
(Gong et al., 2021 ). However, the pathogenic mechanisms underlying 
this disease are not fully understood. Even though DR can course with no 
visual affectation, fundus imaging can help ascertain the stage of the 
disease and the occurrence of microaneurysms, microvascular alter-
ations or hemorrhages (Cheung et al., 2010 ). A chronic state of ocular 
hyperglycemia is associated with breakdown of the BRB, neo-
vascularization, and loss of tight junctions as well as the death of peri-
cytes and endothelial cells (ECs) (Duh et al., 2017 ; Roy et al., 2017 ). 
These events are accompanied by oxidative and ER stress, apoptosis, and 
dysregulation of autophagy. As DR develops, the activation of Müller 
cells and microglia promotes the production of multiple inflammatory 
mediators and various vascular growth factors (e.g. VEGF), as well as 
advanced-glycation end products (AGEs), thus exacerbating the patho -
genicity of the disease and potentially affecting other retinal cell types 
such as RGCs and RPE (Bejarano and Taylor, 2019 ; Gong et al., 2021 ). 
A growing body of evidence indicates a dual role of autophagy 
during DR. Autophagy serves as a protective mechanism, promoting cell 
survival in conditions of low glucose concentration, but can also have 
detrimental effects, exacerbating the progression and pathogenesis of 
DR in conditions of long-term exposure to and/or increasing concen -
trations of glucose (Dehdashtian et al., 2018 ). Mitochondrial dysfunc -
tion may be a key regulator during DR pathogenesis. For instance, 
studies of the human diabetic retina, as well as animal and cell models of 
DR, have described mitochondrial DNA damage, overproduction of 
mitochondrial ROS, inefficient mitochondrial DNA repair, and vacuo -
lated mitochondria with disruption of the lamellar cristae (Ferrington 
et al., 2020 ; Hombrebueno et al., 2019 ). These alterations are sufficient 
to disrupt mitochondrial homeostasis, thus leading to exacerbated levels 
of ROS and mitophagy alterations (Kowluru and Mishra, 2018 ). 
The BRB consists of ECs with tight junctions, which are almost 
impermeable to proteins. During DR, initial alterations affect the BRB, 
leading to the loss of tight junctions and increased permeability, thereby 
allowing the extravasation of proteins and molecules that disrupt retinal 
homeostasis (Duh et al., 2017 ). Tumor suppressor miR-204-5p was 
recently shown to reduce autophagic flux in diabetic rats and in vitro ECs by downregulating LC3-II expression (Mao et al., 2019 ), while 
miR-204-5p inhibition activated autophagy. Other proteins overex -
pressed in ECs during DR include matrix metalloproteinase-2 (MMP-2), 
HIF-1 α, VEGF, and insulin-growth factor-1 (IGF-1), factors usually 
associated with neovascularization and exacerbation of DR, a situation 
that can be reversed by increasing expression of the deacetylase Sirt3 
(Mao et al., 2017 ) or by treatment with the hormone melatonin 
(Do˚ganlar et al., 2021 ). More precisely, melatonin induces the expres -
sion of genes involved in mitochondrial biogenesis while inhibiting 
genes involved in mitochondrial fission (Do˚ganlar et al., 2021 ). 
Furthermore, hypoxia induced by bevacizumab (anti-VEGF) in an 
oxygen-induced mouse model of retinopathy promotes mitophagy via 
BNIP3 and FUNDC1, suggesting that this process may help mitigate 
oxidative stress and apoptosis in DR (Sun et al., 2021 ). 
ECs are protected by pericytes in the retinal capillaries. In a rat model 
of DR, glycated low-density lipoproteins (LDL) can extravasate through 
the BRB into ECs, thereby promoting oxidative and ER stress (Fu et al., 
2012 ). Accumulation of LDL in the retina shifts the protective role of 
autophagy towards cell death and apoptosis (Fu et al., 2016 ). In addi-
tion, interruption of the intercommunication between pericytes may 
account for the damage to these cells observed in DR (Alarcon-Martinez 
et al., 2022 ). Most evidence points to a key protective role of mitophagy 
in preserving BRB integrity and preventing neovascularization and 
edema in DR. 
The potential role of antioxidant defense in DR is attracting growing 
attention. It is widely accepted that circulating levels of homocysteine, a 
precursor of cysteine and therefore of glutathione (GSH), are elevated in 
diabetic patients (Malaguarnera et al., 2014 ). Moreover, homocysteine 
accumulation is known to promote photoreceptor degeneration (Chang 
et al., 2011 ) and impairment of mitochondrial function in RGCs 
(Ganapathy et al., 2011 ), and upregulates mitophagy markers and 
apoptosis (Kowluru et al., 2020 ). Interestingly, a recent study of human 
ECs and retinas from donor DR patients demonstrated accumulation of 
homocysteine in the retinal microvasculature, with a 50% reduction in 
levels of the enzymes that metabolize this non-protein amino acid, (i.e. 
methylenetetrahydrofolate reductase [MTHFR] and cystathionine- γ 
lyase [CSE], which convert homocysteine to methionine and L-cysteine, 
respectively) (Kowluru et al., 2020 ). These alterations were accompa -
nied by hypermethylation of the promoters of MTHFR and cystathionine 
β-synthase (CBS), reducing their transcription and corresponding pro-
tein levels. Furthermore, protein levels of DRP1, OPTN, and LC3 were 
upregulated while fusion machinery proteins (MFN2) were down -
regulated (Kowluru et al., 2020 ). 
Another early and key event in DR is angiogenesis resulting from 
high glucose levels. Hyperglycemic conditions in RF/6A endothelial 
cells promote tube formation and cell migration together with ROS 
production and autophagy (Coughlin et al., 2017 ; Li et al., 2019 ). These 
observations suggest that autophagy inhibition may help prevent retinal 
angiogenesis during DR. 
Table 3 
Evidence of mitophagy alterations in glaucoma models.  
Glaucoma 
Model Approach Cell types 
affected Findings Role of 
mitophagy Reference 
ONC, Ambra1/ 
gt in vivo RGCs Increased susceptibility in mitophagy-deficient mice, increased BNIP3/NIX 
expression, impaired ROS response Beneficial Bell et al. (2020) 
ONC, primary 
RGCs in vivo, in 
vitro RGCs Increased mitophagy in response to ONC and to different stressors (in vitro) – Rosignol et al. (2020) 
Axotomy in vivo RGCs Increased mitophagy, improved RGC survival an reduced ROS after rapamycin 
administration Beneficial Rodriguez-Muela et al. 
(2012) 
DBA/2J in vivo RGCs Decreased (3 days) and increased mitophagosome formation (2 weeks), 
increased RGC survival after Parkin overexpression Beneficial Dai et al. (2018) 
DBA/2J in vivo RGCs Reduced mitochondrial mass and mitophagy markers – Jassim et al. (2021b) 
IOP, Ucp2 / in vivo RGCs Reduced RGCs death, increased mitophagosome formation Beneficial Hass and Barnstable 
(2019b)  J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
15Although most studies have focused on autophagy alterations in the 
neuroretina, it is also important to assess the role of Müller cells during 
DR, as they are essential to maintain retinal homeostasis. Müller glia 
span the entire retina, and mediate the production and secretion of pro- 
angiogenic factors, leading to neovascularization, inflammation, and 
eventual cell death in DR (Coughlin et al., 2017 ). Several findings in 
retinas from DR patients suggest a pivotal role of autophagy and 
mitophagy dysfunction in Müller cells in DR. Autophagy induced by 
high glucose concentrations in Müller cells is not successfully completed 
due to autophagosome accumulation in the cytoplasm, which in turn 
leads to massive release of VEGF (Lopes de Faria et al., 2016 ). Cell 
cultures of rat Müller cells incubated with high concentrations of glucose 
(40 mM) show downregulation of autophagy and upregulation on 
apoptosis, which can be partially reversed using epigallocatechin 
gallate, a major polyphenol found in green tea (Wang et al., 2019a ). 
Furthermore, notoginsenoside R1/NGR1 markedly inhibits apoptosis, 
suppresses VEGF expression, and reduces oxidative stress and inflam -
mation in diabetic mice and Müller cells (rMc-1) cultured with high 
concentrations of glucose (60 mM for 48 h) (Zhou et al., 2019 ). This 
phenomenon occurs due to upregulation of mitophagy via PINK1. 
Thioredoxin interacting protein (TXNIP) is a pro-inflammatory and 
pro-oxidative stress mediator that is upregulated in Müller cells exposed 
to hyperglycemic stimuli, promoting oxidative stress, gliosis, inflam -
mation (Devi et al., 2012 ), and activation of autophagy and mitophagy 
(Ao et al., 2021 ; Devi et al., 2017 ; Hombrebueno et al., 2019 ). Some 
authors have proposed that this activation in hyperglycemic conditions 
is beneficial, promoting the degradation of damaged mitochondria via 
PINK1/PARKIN-mediated mitophagy and enabling cell survival (Devi 
et al., 2012 ; Huang et al., 2018 ; Su et al., 2020 ). On the other hand, 
upregulation of TXNIP in high glucose conditions (25 mM for 5 days or 
35 mM for 48 h) elicits a detrimental response by promoting mitophagy 
and cellular apoptosis (Ao et al., 2021 ; Devi et al., 2017 ). It has been 
proposed that this response is due to partial inhibition of the 
PI3K/AKT/mTOR signaling pathway (Ao et al., 2021 ). These changes in 
mitophagy do not correlate with major changes in mitochondrial 
biogenesis markers such as PGC1 α or TFAM, supporting a role of defi-
cient mitophagy in DR (Hombrebueno et al., 2019 ). Studies in the 
mitophagy reporter animals mt-Keima mice have shown that silencing 
or pharmacological inhibition of TXNIP may normalize mitophagic flux 
and NLRP3 inflammasome activation, preventing or delaying DR pro-
gression (Singh et al., 2017 ). Overall, these data points to a protective 
effect of PINK1/Parkin-mediated mitophagy in Müller glia during the 
early pathogenesis of DR and its inhibition in late stages of the disease. 
During DR, RGCs are highly sensitive to the increased concentrations 
of glucose in the retina, which cause selective death of these cells during 
early disease stages (Catalani and Cervia, 2020 ). Decreased autophagic 
flux and activation of mTOR and apoptosis have been demonstrated in 
murine retinal explants incubated with high concentrations of glucose 
(75 mM for 10 days) (Amato et al., 2018 ). Treatment with the neuro -
protectant octreotide restored autophagic flux and inhibited mTOR. 
Immunohistochemical findings suggest that this compound exerts its 
effect at the level of the GCL and the bipolar and amacrine cells (Amato 
et al., 2018 , 2020 ). Finally, Beclin-1 and LC3B-II/I ratio were slightly 
increased 4 and 8 weeks after induction of DR with streptozotocin. This 
phenomenon was accompanied by activation of AMPK and inhibition of 
mTOR (Park et al., 2018 ). These findings suggest that autophagy in-
duction in RGCs exerts a beneficial effect, preventing RGC death and 
slowing DR progression. 
Other studies have shown that in rats with streptozotocin-induced 
diabetes and in ECs treated with high doses of glucose (65 mM for 24 
h), mitophagy has a detrimental effect on RGCs (Ma et al., 2017 ; Zhang 
et al., 2022 ). This phenotype was reversed using liraglutide, a GLP-1 
analog that inhibits mitophagy via the PINK1/Parkin pathway (Zhou 
et al., 2020 ). Whether the beneficial role of autophagy and/or 
PINK1/Parkin-mediated mitophagy is indeed cell type-specific should 
be further studied. A quantitative mass spectrometry analysis showed that lysine 108 of 
OPTN is specifically succinylated in vitreous humor samples from DR 
patients (Zhang et al., 2022 ). This finding was further corroborated in 
rat and cellular models. Succinylation of OPTN was accompanied by 
blockade of autophagic flux, which was reversed by SIRT5-induced 
desuccinylation. These findings point to novel targets for the treat-
ment of RGC dysfunction during DR (Zhang et al., 2022 ). 
Interestingly, changes in mitochondrial dynamics have been 
demonstrated during progression of DR in human retinas and in the 
diabetic murine reporter mito-QC-Ins2Akita/(Hombrebueno et al., 
2019 ). This animal model recapitulates the preclinical stages of DM type 
I. Young mice (2 months) show mild retinal neurovascular dysfunction 
and increased mitophagy in the IS-OPL layers, as revealed by the 
mito-QC reporter, together with reduced mitochondrial mass as evi-
denced by COXIV and TOMM20 immunostaining. By contrast, mitoph -
agy is inhibited in 8-month-old mice, which exhibit severe retinal 
neurovascular dysfunction and with progressive senescence (Hom-
brebueno et al., 2019 ). These mice also display reduced mitochondrial 
biogenesis, which may be partially explained by mitochondrial DNA 
damage, which directly interferes with transcription (Hombrebueno 
et al., 2019 ). 
As previously mentioned, the main sources of energy for the RPE in 
physiological conditions are fatty acids and lactate derived from 
glucose-driven photoreceptor metabolism. Therefore, excessive accu-
mulation of glucose in DR directly affects this cell layer. It has been 
shown that long-term exposure of the RPE to glucose directly increased 
levels of ROS and promoted premature senescence (Chen et al., 2019 ). 
Short-term exposure of ARPE-19 cells to hyperglycemic glucose con-
centrations boosted autophagy while long-term exposure inhibited 
autophagy and enhanced apoptosis (Chen et al., 2019 ). Exposure of 
ARPE-19 cells to high concentrations of glucose (50 mM) has been re-
ported to inhibit mitophagy due to ROS-promoted inactivation of 
PINK1/Parkin-dependent mitophagy, leading to cellular death by 
apoptosis (Zhang et al., 2019 ). Conversely, it has been described 
elevated intracellular ROS levels in ARPE-19 cells, together with 
increased expression of PINK1, Parkin, BNIP3L/NIX, and LC3-II, and 
elevated mitophagy, suggesting a protective role of mitophagy against 
high glucose-induced damage in these cells (Huang et al., 2018 ). Further 
studies are needed to elucidate the role of mitophagy in the intra-retinal 
immune system (astrocytes, microglia, Müller glia) and within the BRB 
interface. 
Pharmacological modulation of autophagy and mitophagy regula -
tors such as rapamycin and 3-MA have shown beneficial effects in ani-
mal and cellular models of DR. However, translation of these approaches 
to clinical practice remains elusive. To our knowledge, there is no 
effective treatment for DR, only palliative strategies that target the later 
disease stages (Evans et al., 2014 ). Current therapies are based on laser 
photocoagulation and anti-VEGF agents such as bevacizumab. Bev-
acizumab has been shown to reduce oxidative stress and apoptosis in 
Müller cells, ECs, and photoreceptors where inhibition of VEGF pro-
motes mitophagy mediated via BNIP3 and FUNDC1 by HIF-1 α activation 
(Sun et al., 2021 ). Another proposed mitophagy enhancer is RNG1, 
which has been validated in Müller cells both in vivo and in vitro (Zhou 
et al., 2019 ). RNG1 acts via the PINK1/Parkin pathway to reduce 
inflammation, oxidative stress, apoptosis, and VEGF levels. 
Other promising drugs include the tetrapeptide elamipretide (SS-31), 
which targets mitochondrial CL and has shown promise in oxidative 
stress models (Bai et al., 2021 ; Birk et al., 2014 ). The small molecule 
SRI-37330 inhibits the expression of TXNIP and the secretion and 
function of glucagon, and may help reverse the effects of diabetes in 
mice (Thielen et al., 2020 ). In addition, dimethyl fumarate (DMF) 
attenuated vascular complications in a rat model of diabetes by acti-
vating Nrf2, decreasing oxidative stress and downregulating the 
ROS/TXNIP/NLRP3 inflammasome signaling axis (Amin et al., 2020 ). In 
recent years, mitophagy has been proposed as an upstream regulator of 
inflammasome activation through the reduction of some of its main J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
16triggers (mitochondrial ROS, mtDNA release), removal of damaged 
mitochondria, and consequent mitigation of the cGAS/STING/NLRP3 
inflammatory response (Lin et al., 2019 ; Sliter et al., 2018 ). DMF has 
also shown promise in a TNFα-induced RPE inflammation model, in 
which it also restored mitochondrial bioenergetic function and structure 
(Shu et al., 2022 ). While further studies will be necessary, current evi-
dence points to an anti-inflammatory role of mitophagy induction, and 
suggests that drug repurposing may be one possible avenue for the 
development of DR therapies. 
It is clear that autophagy and mitophagy play pivotal roles during DR 
(Table 4). However, many questions about these processes remain 
unanswered. An in-depth characterization of these processes is required, 
and will also shed further light on the pathogenesis of DR. Due to the 
dynamic nature of cell metabolism, glucose utilization by mitochondria 
and non-physiological oxygen concentrations in vitro, studies using hy-
perglycemic conditions should be interpreted carefully. Overall, in vivo 
studies with patient samples and animal models point to cell type- 
specific impaired mitophagy in DR. Standardization of animal and 
cellular models and more precise tools with which to study autophagy 
and mitophagy are other key requirements to facilitate the development 
of new and novel therapeutic strategies for DR patients. 
4.3. Retinal degeneration associated with photoreceptor damage 
Retinal dystrophies are a mixed group of diseases (global prevalence, 
approximately 1 per 4000) characterized by photoreceptor death and 
consequent progressive vision loss (Hartong et al., 2006 ). The retinal 
cells most affected in retinal dystrophies are photoreceptors, both cones 
and rods, resulting in long-term blindness once the patients reach 
mid-adulthood (Olivares-Gonz ˘alez et al., 2021 ). The phototransduction 
process to which the photoreceptors are subjected, together with the 
continuous daily turnover of POS, imposes a high metabolic demand. 
Photooxidative damage caused by capturing light, as well as the 
oxidative stress generated by recycling of photoreceptor OS membranes, 
can lead to cellular damage to photoreceptors. Other processes that can 
trigger photoreceptor death include altered calcium signaling, the cyclic 
nucleotide pathway, and cathepsin-mediated cell death (Murakami 
et al., 2013 ; Rodriguez-Muela et al., 2015 ; Wang et al., 2018 ). 
Of inherited retinal diseases, the most widely studied is retinitis 
pigmentosa (RP). RP patients experience a progressive decrease in visual 
function. In the first stages, rods are affected, leading to loss of night and 
peripheral vision. Subsequently, patients lose their central vision (Har-
tong et al., 2006 ). Studies of the P23H rhodopsin (RHOP23H) model of RP 
have indicated that balance between the autophagy and proteasome pathways is essential to ensure photoreceptor survival (Yao et al., 2018 ). 
We previously described alterations in autophagic flux in the RP rd10 
(Retinal degeneration 10) model caused by deficient lysosomal degra -
dation due to lysosomal membrane permeabilization induced by cal-
cium overload (Rodriguez-Muela et al., 2015 ). In this model, we have 
also shown that the use of cathepsin and calpain inhibitors decreases 
photoreceptor loss, pointing to autophagy inhibition as a possible 
therapeutic approach for the treatment of early rod death in RP. In 
recent years, treatments that increase autophagy have been shown to 
effectively delay photoreceptor death at different timepoints in different 
RP models. We have also shown that secondary death of cones in distinct 
RP models is correlated with an increase in the activity of histone 
deacetylases (HDACs), known upstream negative regulators of auto-
phagy (Samardzija et al., 2021 ). Specifically, a single intravitreal in-
jection of a HDAC inhibitor administered after rod death delayed cone 
death in these mice models, and also promoted transcriptomic upregu -
lation of autophagy and increased autophagosome degradation within 
lysosomes (Samardzija et al., 2021 ). These findings suggest that auto-
phagy may play a dual role, protective or detrimental, depending on the 
specific mutation and cell type affected. 
A recent report demonstrated that the miR-211/Ezrin axis was 
responsible for lysosomal biogenesis during the light-dark transition of 
RPE cells. Pharmacological inhibition of Ezrin induces autophagy, 
rescuing retinal degeneration in miR-211 / mice (Naso et al., 2020 ). A 
recent study found that by inhibiting Ezrin, and therefore increasing 
autophagy, photoreceptor death was decreased in the RHOP23H model 
via increased removal of RHOP23H aggregates and decreased ER damage 
due to oxidative stress (Intartaglia et al., 2022 ). PRPF8 (pre-mRNA 
processing factor 8), a participant in the spliceosome, is a key regulator 
of hypoxia-induced mitophagy. PRPF8 knockdown decreases mitopha -
gosome formation, resulting in mitochondria accumulation (Xu et al., 
2018 ). A similar phenomenon is observed in mice expressing the 
RP-associated PRPF8 mutant R2310K. Alterations in mitophagy caused 
by PRPF8 dysregulation therefore contribute to photoreceptor degen -
eration in these models (Xu et al., 2018 ). 
RP can also be studied in pharmacological models that phenocopy 
the disease. For example, the SN2 DNA alkylating agent methyl meth -
anesulfonate (MMS) specifically causes photoreceptor death (Meira 
et al., 2009 ). Mice treated with MMS show increased mTOR activity in 
photoreceptors, while inhibition of mTOR activity with rapamycin, 
which increases autophagy, significantly improves visual function 
(Meira et al., 2009 ). These data point to a protective role of autophagy 
and mitophagy in RP or RP-like models, repurposed drugs targeting 
mitochondria quality control could slow down or brake 
Table 4 
Evidence of mitophagy alterations in diabetic retinopathy models.  
Diabetic retinopathy 
Model Approach Cell types 
affected Findings Role of 
mitophagy Reference 
OIR in vivo, in 
vitro Müller, EC, 
PR Upregulation of BNIP3 and FUNDC1, decreased ROS and apoptotic cell death Beneficial Sun et al. (2021) 
Human samples in vivo, in 
vitro EC Upregulation of fission and mitophagy markers Beneficial Kowluru et al. 
(2020) 
High glucose, db/db in vivo, in 
vitro Müller Upregulation of PINK1-dependent mitophagy in vivo and in Müller cells in 
vitro, reduced retinal degeneration and improved visual function Beneficial Zhou et al. (2019) 
High glucose in vitro, in 
vivo Müller TXNIP-induced increase on mitophagy, concomitant with exacerbated 
astrogliosis Detrimental Devi et al. (2017) 
STZ in vitro, in 
vivo RGCs Abnormal mitochondria morphology, increased PINK1/Parkin-dependent 
mitophagy reverted upon liraglutide administration Detrimental Zhou et al. (2020) 
Human samples, 
Ins2Akita/, High 
glucose in vivo, in 
vitro Müller, PR Increased PINK1-dependent mitophagy at early stages (2 months) and 
ihibition at symptomatic stage (8 months), decreased mitochondrial 
biogenesis Beneficial Hombrebueno et al. 
(2019) 
High glucose in vitro RPE Inhibited PINK1/Parkin-mediated mitophagy concomitant with apoptotic 
cell death Beneficial Zhang et al. (2019) 
High glucose in vitro RPE Increased PINK1/Parkin-mediated mitophagy associated to elevated ROS 
production Beneficial Huang et al. (2018)  J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
17neurodegeneration in this rare disease. 
Prolonged exposure to high-intensity light can lead to severe alter-
ations in photoreceptors, mostly in the external segments of the rods and 
the RPE, leading to neurodegeneration and retinal remodeling. Long- 
term exposure to bright light results in the formation of autophago -
somes, containing damaged mitochondria and cellular debris, in the IS 
and within the synaptic bodies (Kunchithapautham and Rohrer, 2007 ). 
The extent of the damage depends on the wavelength and intensity of 
light, as well as the genetic background of the mice used (Organisciak 
and Vaughan, 2010 ). In autophagy-deficient mice, such as Beclin-1 
hemizygous or Atg7 rod-specific deletion mice (Chen et al., 2013 ), 
high-intensity light exposure results in neurodegenerative loss of pho-
toreceptors and RPE damage, accompanied by parallel mitochondrial 
impairment (Chen et al., 2013 ). This study described compromised 
photoreceptor recycling in Abca4 / Rdh8 / mice in response to 
light-induced damage, together with increased retinal levels of Parkin 
(Chen et al., 2013 ), a protein that is recruited to damaged mitochondria 
and drives PINK1/Parkin-mediated mitophagy (Narendra et al., 2010 ). 
The authors confirmed the role of mitophagy in this system using 
Parkin-deficient (Park2 / ) mice. After exposure to high intensity light, 
these mice presented massive disorganization and reduced thickness of 
the photoreceptor outer/inner segment and ONL, together with pyknotic 
photoreceptor nuclei and nucleic acid deposition, a phenotype that was 
less pronounced in Park2/animals (Chen et al., 2013 ). Rapamycin 
administration in light-damaged mice has also been shown to increase 
rod survival by reducing caspase-mediated cell death (Kunchithapau -
tham et al., 2011 ). 
Finally, retinal dystrophies also include retinal detachment, which is 
characterized by the separation of the neuroretina from the underlying 
RPE. Retinal detachment can be secondary to other pathologies such as 
AMD or DR (Chinskey et al., 2014 ). Separation of the retina from the 
RPE causes a decrease in nutrient and oxygen supply to photoreceptors, 
increasing oxidative stress and resulting in cell death (Murakami et al., 
2013 ). One study found that autophagy triggered by HIF-1 α activation 
had beneficial effects in a mouse model of retinal detachment (Shelby 
et al., 2015 ). Supporting these findings, it has been shown that under 
normoxic conditions HIF-1 α subunits are rapidly degraded by the 
ubiquitin –proteasome pathway following hydroxylation of proline res-
idues by HIF prolyl-4-hydroxylases (PHDs) (Trollmann et al., 2014 ). 
When oxygen is not available (hypoxia) PHDs are less active, and HIF-1 α 
is stabilized and translocated to the nucleus, inducing BNIP3/NIX 
transcription and promoting mitophagy (Mazure and Pouyssegur, 
2010 ). Furthermore, in mouse models of retinal detachment treatment 
with inhibitors of PHDs resulted in HIF-1 α stabilization and induction of 
mitophagy. Together these factors contributed to neuroprotection of 
photoreceptors following retinal detachment (Liu et al., 2016a ). In a 
similar fashion to RP, mitophagy also plays a neuroprotective role in 
LD-associated PR degeneration and retinal detachment. 
The aforementioned findings suggest that homeostatic autophagy is 
necessary to maintain proper photoreceptor function and sustain vision 
(Table 5). Specifically, mitophagy has been shown to play a fundamental 
physiological role in maintaining visual function, and may also consti -
tute a therapeutic target for the treatment of retinal diseases. 4.4. Age-related macular degeneration 
AMD is the most common ocular pathology in the elderly, and can 
lead to severe and permanent vision loss. Even though AMD has been 
associated with specific environmental (smoking, diet) and genetic 
factors, the main risk factor is age, and population aging is expected to 
double the incidence of AMD by 2040 (Fritsche et al., 2016 ; Wong et al., 
2014 ). It is characterized by progressive bilateral degeneration of the 
macula, the central region of the retina that contains a high density of 
cone photoreceptors and is responsible for high-resolution, color vision. 
AMD is progressive and is usually detected in late disease stages, when it 
can be classified as “dry” or “wet” AMD. Wet AMD is driven by choroidal 
neovascularization that disrupts the RPE and invades the neuroretina, 
leading to exudative edema and local inflammation, eventually trig-
gering photoreceptor cell death and vision loss. The wet form is more 
severe and accounts for approximately 10% of AMD cases, but can be 
clinically managed using anti-angiogenic immunotherapy (anti-VEGF) 
such as bevacizumab or aflibercept. Dry AMD is caused by a progressive 
buildup of extracellular debris (oxidized proteins, apolipoproteins, 
complement buildup), called drusen, in the subretinal space between the 
RPE and Bruch ’s membrane. The true origin of these structures remains 
to be elucidated. Drusen eventually disrupts the RPE monolayer, 
inducing RPE loss and cell death of adjacent photoreceptors, leading to 
geographic atrophy and central vision loss (Wong et al., 2014 ). 
The RPE of AMD patients contains reduced numbers of mitochon -
dria, which exhibit abnormal cristae, and decreased levels of ATP- 
synthase subunits (Feher et al., 2006 ; Nordgaard et al., 2008 ). Primary 
RPE cells from AMD patients also show reduced mitochondrial respi-
ration and glycolytic function (Ferrington et al., 2017 ). These findings 
suggest that the RPE of AMD patients cannot obtain energy from its 
primary (OxPhos) or alternative (glycolysis) sources, leading to an en-
ergetic imbalance that ultimately impacts the adjacent neuroretina 
(Fisher and Ferrington, 2018 ). Improving mitochondrial function with 
drugs such as the antioxidant N-acetyl-L-cysteine or nicotinamide 
mononucleotide (NMN, which facilitates OxPhos) has shown beneficial 
effect in vitro (Ebeling et al., 2020 ). AMD has also been correlated with 
higher levels of mtDNA damage in the RPE (Terluk et al., 2015 ). 
Together, these observations point to abnormal mitochondrial 
morphology, number, and function in the RPE of AMD patients. 
Owing to its dynamic nature, the study of autophagy in AMD patient 
samples is challenging and the most relevant findings have been 
observed in patient-derived in vitro cell culture systems. However, 
markers of autophagy such as ATG5 and lysosomal LAMP2 have been 
identified in drusen from donors with dry AMD (Wang et al., 2014 ). An 
age-associated increase in autophagosome number in the neuroretina 
and RPE of healthy donors, but not AMD patients, has also been 
described (Mitter et al., 2014 ). Primary RPE cell culture allows for 
manipulation of nutrient conditions and lysosomal degradation, which 
is essential to enable a more refined analysis of autophagy. In vivo, RPE 
cells from AMD patients show increased levels of LC3-II and decreased 
levels of SQSTM1/p62, suggesting induction of autophagy, together 
with enlarged autophagosomes (Golestaneh et al., 2017 ; Ye et al., 2016 ). 
However, use of protease inhibitors, revealed reduced autophagic flux in 
Table 5 
Evidence of mitophagy alterations in photoreceptor degeneration.  
Photoreceptor degeneration 
Model Approach Cell types 
affected Findings Role of 
mitophagy Reference 
Prpf8R2310K in vitro PR Impaired hypoxia-induced mitophagy, aberrant mitophagosome formation – Xu et al. 
(2018) 
LD, Park2 / in vivo PR, RPE Mitochondrial damage and accumulation of mitophagosomes, increased susceptibility 
to LD in Park2 / mice Beneficial Chen et al. 
(2013) 
RD, subretinal 
injection in vivo PR Increased BNIP3-mediated mitophagy, further boosting with PHIs alleviated ROS levels, 
mitochondrial damage and PR cell death Beneficial Liu et al. 
(2016b)  J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
18primary RPE cells, an effect that was further exacerbated upon nutrient 
starvation, pointing to inefficient autophagy (Golestaneh et al., 2017 ). 
In the same study, the authors observed swollen lysosomes in AMD 
donor cells, suggesting lysosomal stress and defective autophagic cargo 
degradation, and the accumulation of cytoplasmic glycogen and lipid 
granules (Golestaneh et al., 2017 ). Finally, stimulation of autophagy in 
AMD donor cells using rapamycin has been shown to improve mito-
chondrial function (Ebeling et al., 2020 ). Regarding mitophagy, 
decreased levels of PINK1 have been described in the perifoveal region 
of early-stage AMD patients (Datta et al., 2022 ). Similarly, alterations in 
mitochondrial dynamics have been observed in primary RPE cells from 
AMD donors in response to mitochondrial uncoupling (Fisher et al., 
2022 ). AMD patient-derived cells also presented decreased PINK1 levels 
and were more reliant on BNIP3/NIX-mediated mitophagy to sustain 
mitochondrial homeostasis (Fisher et al., 2022 ). These findings point to 
induction of autophagy, and possibly mitophagy, in dry AMD pathology 
that cannot be fulfilled due to deficient lysosomal degradation. While 
there is very little evidence regarding the involvement of mitophagy in 
wet AMD, some specific single-nucleotide polymorphisms (SNPs) in 
autophagy genes have been linked to increased occurrence and efficacy 
of antiangiogenic VEGF treatment (Paterno et al., 2020 ). 
Although evidence of autophagy dysfunction in AMD patients is 
scarce, several RPE-specific autophagy-deficient mouse models have 
been described. Deletion of the autophagy initiator RB1CC1/FIP200 
results in intracellular debris accumulation, morphological abnormal -
ities, and secondary loss of visual function (Yao et al., 2015 ). A similar 
phenotype has been observed in mice lacking the autophagy regulators 
Atg5/Atg7 or lysosomal membrane protein LAMP2 (Kim et al., 2013 ; 
Notomi et al., 2019 ; Zhang et al., 2017 ). A recent report phenotyped the 
RPE of Pink1-deficient mice and reported decreased mitophagy and 
deficient mitochondrial function, leading to transcriptional reprogram -
ming and epithelial-mesenchymal transition (EMT) (Datta et al., 2022 ). 
Surprisingly, deficit in the antioxidant Nfe2l2/Nrf2 abrogated the EMT 
phenotype and enhanced susceptibility to cell death, indicating putative 
crosstalk between mitophagy and the oxidative stress response (Datta 
et al., 2022 ). 
We recently performed an exhaustive analysis of the neuroretina and 
RPE of the Ambra1/gt mouse (Fimia et al., 2007 ), which is characterized 
by organism-wide autophagy deficiency and a slight reduction in auto-
phagic flux, but is both viable and fertile (Ramírez-Pardo et al., 2022 ). 
Defects in the RPE were already observed in young animals, which 
presented morphological alterations and disrupted proteostasis, 
concomitant with a decreased number of autophagosomes and signs of 
lysosomal damage. Decreased mitochondrial number and increased 
levels of glycolysis-related enzymes, such as the glucose transporter 
GLUT1 or GAPDH, suggest dysregulation of RPE metabolism. Aged 
Ambra1/gt mice showed exacerbated accumulation of lipofuscin, as 
revealed by λ-scan confocal technology (Ramírez-Pardo et al., 2022 ). We 
postulate that these initial RPE alterations lead to the neuroretina al-
terations observed in middle-aged Ambra1/gt mice, which are pheno -
typically characterized by mitochondrial dysfunction that leads to 
metabolic alterations. Combined with increased neuroinflammation and 
an impaired antioxidant response, this microenvironment ultimately 
leads to exacerbated age-related vision loss. 
We also assessed the response of Ambra1/gt mice to SI, a pharma -
cological model of dry AMD-associated geographic atrophy, and found 
that both the RPE and photoreceptors of autophagy-deficient mice were 
more sensitive to SI. INL thickness in SI-treated Ambra1/gt mice was 
also decreased, while no alterations were observed in untreated 
Ambra1/gt littermates, indicating increased susceptibility to oxidative 
stress even in cell types not traditionally affected in this model or in dry 
AMD (Ramírez-Pardo et al., 2022 ). Study of AMD in rodent models is 
suboptimal, as they lack a true macula, which is only found in 
non-human primates. However, the central, innermost part of the rodent 
retina does share some features with the human macula (Volland et al., 
2015 ). We also performed a transcriptomic analysis of samples from AMD patients (GSE135092) and found that, among all autophagy reg-
ulators studied, AMBRA1 was the only one for which downregulated 
gene expression was observed both in the RPE and the neuroretina of the 
macular region of AMD patients (Ramírez-Pardo et al., 2022 ). 
In conclusion, defective mitophagy may play a key role in the 
pathophysiology of AMD, and boosting this process could constitute a 
valid therapeutic strategy (Table 6). While autophagy and mitophagy 
defects have been associated with phenotypes that resemble that of dry 
AMD, evidence supporting a role of mitophagy in neovascular AMD and 
other maculopathies –such as juvenile macular dystrophy or Stargardt 
disease – is scarce and should be further studied. Mitochondrial 
dysfunction could be used as a novel biomarker to detect earlier disease 
stages, and approaches that promote the maintenance of a healthy 
mitochondrial population could slow disease progression, or even pre-
vent vision loss. 
5.Concluding remarks and future directions 
Mitophagy research is a novel and cutting-edge field that is attracting 
growing interest from the scientific community: indeed, most of the 
findings summarized in this review were published in the last decade. 
Proper mitochondrial function and integrity is essential to preserve cell 
homeostasis and ensure cell survival. Mitophagy plays an essential part 
of this process by removing damaged or superfluous mitochondria. 
While mitophagy appears to be dysregulated in most retinal diseases, 
studies using newly-developed methodologies will be required to 
confirm this association. 
Therapies aimed at boosting mitophagy and restoring mitochondrial 
homeostasis are already being developed and have shown promise in 
clinical trials (Andreux et al., 2019 ; Singh et al., 2022 ). Mitochondrial 
peptide SS-31 improves mitochondrial function and has been shown to 
ameliorate age-associated photopic vision loss in mice (Alam et al., 
2022 ) and is currently being tested in a clinical trial for dry AMD, with 
preliminary positive results (Allingham et al., 2022 ). Whether the neu-
roprotective effect of SS-31 involves mitophagy remains unknown. The 
natural mitophagy inducer Urolithin A (UA) has also been proven safe 
and is able to induce mitophagy and improve mitochondrial quality 
control in patients and animal models (Andreux et al., 2019 ; Singh et al., 
2022 ; Ryu et al., 2016 ). Furthermore, it has shown neuroprotective 
potential in Alzheimer ’s and Parkinson ’s disease models (Fang et al., 
2019 ; Qiu et al., 2022 ) which grants exploring its putative beneficial 
effects in age-associated retinal pathologies. Exploiting this approach to 
tackle age-associated and pathological vision loss is a crucial research 
avenue that warrants thorough investigation. 
CRediT authorship statement 
Juan Ignacio Jim˘enez-Loygorri: Conceptualization; Data curation; 
Formal analysis; Investigation; Visualization; Writing - original draft; 
Writing - review & editing. 
Rocío Benítez-Fern ˘andez: Conceptualization; Visualization; Writing - 
original draft; Writing - review & editing. 
˘Alvaro Viedma-Poyatos: Writing - original draft. 
Juan Zapata-Mu ~noz: Data curation; Investigation; Writing - original 
draft. 
Beatriz Villarejo-Zori: Data curation; Investigation; Writing - original 
draft. 
Raquel G˘omez-Sintes: Writing - original draft. 
Patricia Boya: Conceptualization; Formal analysis; Funding acquisi -
tion; Project administration; Resources; Supervision; Visualization; 
Writing - original draft; Writing - review & editing. 
Funding 
Research in P.B. lab is supported by grant PID2021-126864NB-I00 
(P.B.), JIN RTI2018-098990-J-I00 (R.G-S.) from MCIN (Spain) as well as J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
19the University of Fribourg and grant 310030-215271 from SNSF 
(Switzerland). J.I.J-L. and J.Z-M. are recipients of FPI (PRE2019- 
088222) and FPU (FPU19/04134) predoctoral fellowships from MCIN, 
respectively. 
Declaration of competing interest 
The authors declare no competing interests. 
Data availability 
No data was used for the research described in the article. 
Acknowledgements 
We thank Owen Howard for proof-reading and editing; Dr. Ian 
Ganley for generating and providing the mito-QC reporter mice; and the 
rest of the members of the Autophagy Lab for thoughtful discussions. 
References 
Agathocleous, M., Love, N.K., Randlett, O., Harris, J.J., Liu, J., Murray, A.J., Harris, W. 
A., 2012. Metabolic differentiation in the embryonic retina. Nat. Cell Biol. 14, 
859–864. 
Agostini, M., Romeo, F., Inoue, S., Niklison-Chirou, M.V., Elia, A.J., Dinsdale, D., 
Morone, N., Knight, R.A., Mak, T.W., Melino, G., 2016. Metabolic reprogramming 
during neuronal differentiation. Cell Death Differ. 23, 1502 –1514 . 
Agostinone, J., Alarcon-Martinez, L., Gamlin, C., Yu, W.Q., Wong, R.O.L., Di Polo, A., 
2018. Insulin signalling promotes dendrite and synapse regeneration and restores 
circuit function after axonal injury. Brain 141, 1963 –1980 . 
Ait-Ali, N., Fridlich, R., Millet-Puel, G., Clerin, E., Delalande, F., Jaillard, C., Blond, F., 
Perrocheau, L., Reichman, S., Byrne, L.C., Olivier-Bandini, A., Bellalou, J., Moyse, E., 
Bouillaud, F., Nicol, X., Dalkara, D., van Dorsselaer, A., Sahel, J.A., Leveillard, T., 
2015. Rod-derived cone viability factor promotes cone survival by stimulating 
aerobic glycolysis. Cell 161, 817–832. 
Alam, N.M., Douglas, R.M., Prusky, G.T., 2022. Treatment of age-related visual 
impairment with a peptide acting on mitochondria. Disease models & mechanisms 
15. 
Alarcon-Martinez, L., Shiga, Y., Villafranca-Baughman, D., Belforte, N., Quintero, H., 
Dotigny, F., Cueva Vargas, J.L., Di Polo, A., 2022. Pericyte dysfunction and loss of 
interpericyte tunneling nanotubes promote neurovascular deficits in glaucoma. Proc. 
Natl. Acad. Sci. U. S. A. 119. 
Allingham, M.J., Mettu, P.S., Cousins, S.W., 2022. Phase 1 clinical trial of elamipretide in 
intermediate age-related macular degeneration and high-risk drusen: ReCLAIM high- 
risk drusen study. Ophthalmol. Sci. 2, 100095 . 
Aman, Y., Schmauck-Medina, T., Hansen, M., Morimoto, R.I., Simon, A.K., Bjedov, I., 
Palikaras, K., Simonsen, A., Johansen, T., Tavernarakis, N., Rubinsztein, D.C., 
Partridge, L., Kroemer, G., Labbadia, J., Fang, E.F., 2021. Autophagy in healthy 
aging and disease. Nat. Aging 1, 634–650. 
Amato, R., Catalani, E., Dal Monte, M., Cammalleri, M., Di Renzo, I., Perrotta, C., 
Cervia, D., Casini, G., 2018. Autophagy-mediated neuroprotection induced by 
octreotide in an ex vivo model of early diabetic retinopathy. Pharmacol. Res. 128, 
167–178. 
Amato, R., Giannaccini, M., Dal Monte, M., Cammalleri, M., Pini, A., Raffa, V., Lulli, M., 
Casini, G., 2020. Association of the somatostatin analog octreotide with magnetic 
nanoparticles for intraocular delivery: a possible approach for the treatment of 
diabetic retinopathy. Front. Bioeng. Biotechnol. 8, 144. 
Ames 3rd, A., 1992. Energy requirements of CNS cells as related to their function and to 
their vulnerability to ischemia: a commentary based on studies on retina. Can. J. 
Physiol. Pharmacol. 70 (Suppl. l), S158 –S164 . 
Amin, F.M., Abdelaziz, R.R., Hamed, M.F., Nader, M.A., Shehatou, G.S.G., 2020. 
Dimethyl fumarate ameliorates diabetes-associated vascular complications through 
ROS-TXNIP-NLRP3 inflammasome pathway. Life Sci. 256, 117887 . 
Anders, F., Teister, J., Liu, A., Funke, S., Grus, F.H., Thanos, S., von Pein, H.D., 
Pfeiffer, N., Prokosch, V., 2017. Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma. PLoS 
One 12, e0175451 . 
Ando, S., Hashida, N., Yamashita, D., Kawabata, T., Asao, K., Kawasaki, S., Sakurai, K., 
Yoshimori, T., Nishida, K., 2021. Rubicon regulates A2E-induced autophagy 
impairment in the retinal pigment epithelium implicated in the pathology of age- 
related macular degeneration. Biochem. Biophys. Res. Commun. 551, 148–154. 
Andreux, P.A., Blanco-Bose, W., Ryu, D., Burdet, F., Ibberson, M., Aebischer, P., 
Auwerx, J., Singh, A., Rinsch, C., 2019. The mitophagy activator urolithin A is safe 
and induces a molecular signature of improved mitochondrial and cellular health in 
humans. Nat. Metab. 1, 595–603. 
Ao, H., Li, H., Zhao, X., Liu, B., Lu, L., 2021. TXNIP positively regulates the autophagy 
and apoptosis in the rat müller cell of diabetic retinopathy. Life Sci. 267, 118988 . 
Aoyagi, K., Yamashita, S.I., Akimoto, Y., Nishiwaki, C., Nakamichi, Y., Udagawa, H., 
Abe, M., Sakimura, K., Kanki, T., Ohara-Imaizumi, M., 2022. A new beta cell-specific 
mitophagy reporter mouse shows that metabolic stress leads to accumulation of 
dysfunctional mitochondria despite increased mitophagy. Diabetologia 66, 147–162. 
Araldi, E., Schipani, E., 2010. Hypoxia, HIFs and bone development. Bone 47, 190–196. 
Bai, J., Yang, Y., Wu, D., Yang, F., 2021. SS-31 protect retinal pigment epithelial cells 
from H(2) O(2) -induced cell injury by reducing apoptosis. Clin. Exp. Pharmacol. 
Physiol. 48, 1016 –1023 . 
Bassal, M., Liu, J., Jankowiak, W., Saftig, P., Bartsch, U., 2021. Rapid and progressive 
loss of multiple retinal cell types in cathepsin D-deficient mice-an animal model of 
CLN10 disease. Cells 10. 
Bejarano, E., Taylor, A., 2019. Too sweet: problems of protein glycation in the eye. Exp. 
Eye Res. 178, 255–262. 
Belforte, N., Agostinone, J., Alarcon-Martinez, L., Villafranca-Baughman, D., Dotigny, F., 
Cueva Vargas, J.L., Di Polo, A., 2021. AMPK hyperactivation promotes dendrite 
retraction, synaptic loss, and neuronal dysfunction in glaucoma. Mol. Neurodegener. 
16, 43. 
Bell, K., Rosignol, I., Sierra-Filardi, E., Rodriguez-Muela, N., Schmelter, C., Cecconi, F., 
Grus, F., Boya, P., 2020. Age related retinal Ganglion cell susceptibility in context of 
autophagy deficiency. Cell Death Dis. 6, 21. 
Bharti, K., Nguyen, M.T., Skuntz, S., Bertuzzi, S., Arnheiter, H., 2006. The other pigment 
cell: specification and development of the pigmented epithelium of the vertebrate 
eye. Pigm. Cell Res. 19, 380–394. 
Birk, A.V., Chao, W.M., Bracken, C., Warren, J.D., Szeto, H.H., 2014. Targeting 
mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote 
electron transport and optimize mitochondrial ATP synthesis. Br. J. Pharmacol. 171, 
2017 –2028 . 
Boya, P., Esteban-Martinez, L., Serrano-Puebla, A., Gomez-Sintes, R., Villarejo-Zori, B., 
2016. Autophagy in the eye: development, degeneration, and aging. Prog. Retin. Eye 
Res. 55, 206–245. 
Boya, P., Gonzalez-Polo, R.A., Casares, N., Perfettini, J., Dessen, P., Larochette, N., 
Metivier, D., Meley, D., Souquere, S., Yoshimori, T., Pierron, G., Codogno, P., 
Kroemer, G., 2005. Inhibition of macroautophagy triggers apoptosis. Mol. Cell Biol. 
25, 1025 –1040 . 
Brennan, L.A., McGreal-Estrada, R., Logan, C.M., Cvekl, A., Menko, A.S., Kantorow, M., 
2018. BNIP3L/NIX is required for elimination of mitochondria, endoplasmic 
reticulum and Golgi apparatus during eye lens organelle-free zone formation. Exp. 
Eye Res. 174, 173–184. 
Cassidy-Stone, A., Chipuk, J.E., Ingerman, E., Song, C., Yoo, C., Kuwana, T., Kurth, M.J., 
Shaw, J.T., Hinshaw, J.E., Green, D.R., Nunnari, J., 2008. Chemical inhibition of the 
mitochondrial division dynamin reveals its role in Bax/Bak-dependent 
mitochondrial outer membrane permeabilization. Dev. Cell 14, 193–204. 
Casson, R.J., Chidlow, G., Han, G., Wood, J.P., 2013. An explanation for the Warburg 
effect in the adult mammalian retina. Clin. Exp. Ophthalmol. 41, 517. 
Catalani, E., Cervia, D., 2020. Diabetic retinopathy: a matter of retinal ganglion cell 
homeostasis. Neural. Regen. Res. 15, 1253 –1254 . 
Cedikova, M., Kripnerova, M., Dvorakova, J., Pitule, P., Grundmanova, M., Babuska, V., 
Mullerova, D., Kuncova, J., 2016. Mitochondria in white, Brown, and beige 
adipocytes. Stem Cell. Int., 6067349, 2016 .  
Chang, H.C., Guarente, L., 2014. SIRT1 and other sirtuins in metabolism. Trends 
Endocrinol. Metabol. 25, 138–145. 
Chang, H.H., Lin, D.P., Chen, Y.S., Liu, H.J., Lin, W., Tsao, Z.J., Teng, M.C., Chen, B.Y., 
2011. Intravitreal homocysteine-thiolactone injection leads to the degeneration of 
multiple retinal cells, including photoreceptors. Mol. Vis. 17, 1946 –1956 . 
Chen, H., Detmer, S.A., Ewald, A.J., Griffin, E.E., Fraser, S.E., Chan, D.C., 2003. 
Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are 
essential for embryonic development. J. Cell Biol. 160, 189–200. 
Chen, Q., Tang, L., Xin, G., Li, S., Ma, L., Xu, Y., Zhuang, M., Xiong, Q., Wei, Z., Xing, Z., 
Niu, H., Huang, W., 2019. Oxidative stress mediated by lipid metabolism contributes Table 6 
Evidence of mitophagy alterations in age-related macular degeneration.  
Age-related macular degeneration 
Model Approach Cell types 
affected Findings Role of 
mitophagy Reference 
Human samples in vivo RPE Decreased levels of PINK1 in the perifoveal region of AMD patients – Datta et al. (2022) 
Human samples, 
Ambra1/gt in vivo RPE, retina Altered AMBRA1 levels in the macula of human dornors, abnormal mitochondrial 
homeostasis and metabolism, increased susceptibility to GA model in Ambra1/gt 
mice – Ramírez-Pardo et al. 
(2022)  J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
20to high glucose-induced senescence in retinal pigment epithelium. Free Radic. Biol. 
Med. 130, 48–58. 
Chen, Y., Sawada, O., Kohno, H., Le, Y.Z., Subauste, C., Maeda, T., Maeda, A., 2013. 
Autophagy protects the retina from light-induced degeneration. J. Biol. Chem. 288, 
7506 –7518 . 
Chernyshova, K., Inoue, K., Yamashita, S.I., Fukuchi, T., Kanki, T., 2019. Glaucoma- 
associated mutations in the optineurin gene have limited impact on parkin- 
dependent mitophagy. Invest. Ophthalmol. Vis. Sci. 60, 3625 –3635 . 
Cheung, N., Mitchell, P., Wong, T.Y., 2010. Diabetic retinopathy. Lancet 376, 124–136. 
Chinskey, N.D., Besirli, C.G., Zacks, D.N., 2014. Retinal cell death and current strategies 
in retinal neuroprotection. Curr. Opin. Ophthalmol. 25, 228–233. 
Chow, R.L., Lang, R.A., 2001. Early eye development in vertebrates. Annu. Rev. Cell Dev. 
Biol. 17, 255–296. 
Chu, C.T., Ji, J., Dagda, R.K., Jiang, J.F., Tyurina, Y.Y., Kapralov, A.A., Tyurin, V.A., 
Yanamala, N., Shrivastava, I.H., Mohammadyani, D., Qiang Wang, K.Z., Zhu, J., 
Klein-Seetharaman, J., Balasubramanian, K., Amoscato, A.A., Borisenko, G., 
Huang, Z., Gusdon, A.M., Cheikhi, A., Steer, E.K., Wang, R., Baty, C., Watkins, S., 
Bahar, I., Bayir, H., Kagan, V.E., 2013. Cardiolipin externalization to the outer 
mitochondrial membrane acts as an elimination signal for mitophagy in neuronal 
cells. Nat. Cell Biol. 15, 1197 –1205 . 
Coughlin, B.A., Feenstra, D.J., Mohr, S., 2017. Müller cells and diabetic retinopathy. Vis. 
Res. 139, 93–100. 
Coughlin, L., Morrison, R.S., Horner, P.J., Inman, D.M., 2015. Mitochondrial morphology 
differences and mitophagy deficit in murine glaucomatous optic nerve. Invest. 
Ophthalmol. Vis. Sci. 56, 1437 –1446 . 
Dagda, R.K., Cherra 3rd, S.J., Kulich, S.M., Tandon, A., Park, D., Chu, C.T., 2009. Loss of 
PINK1 function promotes mitophagy through effects on oxidative stress and 
mitochondrial fission. J. Biol. Chem. 284, 13843 –13855 . 
Dai, Y., Hu, X., Sun, X., 2018. Overexpression of parkin protects retinal ganglion cells in 
experimental glaucoma. Cell Death Dis. 9, 88. 
Das, A., Bell, C.M., Berlinicke, C.A., Marsh-Armstrong, N., Zack, D.J., 2020. Programmed 
switch in the mitochondrial degradation pathways during human retinal ganglion 
cell differentiation from stem cells is critical for RGC survival. Redox Biol. 34, 
101465 . 
Datta, S., Cano, M., Satyanarayana, G., Liu, T., Wang, L., Wang, J., Cheng, J., Itoh, K., 
Sharma, A., Bhutto, I., Kannan, R., Qian, J., Sinha, D., Handa, J.T., 2022. Mitophagy 
initiates retrograde mitochondrial-nuclear signaling to guide retinal pigment cell 
heterogeneity. Autophagy 1–18. 
Davis, C.H., Kim, K.Y., Bushong, E.A., Mills, E.A., Boassa, D., Shih, T., Kinebuchi, M., 
Phan, S., Zhou, Y., Bihlmeyer, N.A., Nguyen, J.V., Jin, Y., Ellisman, M.H., Marsh- 
Armstrong, N., 2014. Transcellular degradation of axonal mitochondria. Proc. Natl. 
Acad. Sci. U. S. A. 111, 9633 –9638 . 
Dehdashtian, E., Mehrzadi, S., Yousefi, B., Hosseinzadeh, A., Reiter, R.J., Safa, M., 
Ghaznavi, H., Naseripour, M., 2018. Diabetic retinopathy pathogenesis and the 
ameliorating effects of melatonin; involvement of autophagy, inflammation and 
oxidative stress. Life Sci. 193, 20–33. 
Devi, T.S., Lee, I., Huttemann, M., Kumar, A., Nantwi, K.D., Singh, L.P., 2012. TXNIP 
links innate host defense mechanisms to oxidative stress and inflammation in retinal 
Muller glia under chronic hyperglycemia: implications for diabetic retinopathy. Exp. 
Diabetes Res., 438238, 2012 .  
Devi, T.S., Somayajulu, M., Kowluru, R.A., Singh, L.P., 2017. TXNIP regulates mitophagy 
in retinal Müller cells under high-glucose conditions: implications for diabetic 
retinopathy. Cell Death Dis. 8, e2777 . 
Dhingra, A., Bell, B.A., Peachey, N.S., Daniele, L.L., Reyes-Reveles, J., Sharp, R.C., 
Jun, B., Bazan, N.G., Sparrow, J.R., Kim, H.J., Philp, N.J., Boesze-Battaglia, K., 2018. 
Microtubule-associated protein 1 light chain 3B, (LC3B) is necessary to maintain 
lipid-mediated homeostasis in the retinal pigment epithelium. Front. Cell. Neurosci. 
12, 351. 
Di Rienzo, M., Romagnoli, A., Ciccosanti, F., Refolo, G., Consalvi, V., Arena, G., 
Valente, E.M., Piacentini, M., Fimia, G.M., 2022. AMBRA1 regulates mitophagy by 
interacting with ATAD3A and promoting PINK1 stability. Autophagy 18, 
1752 –1762 . 
Di Rita, A., Peschiaroli, A., P, D.A., Strobbe, D., Hu, Z., Gruber, J., Nygaard, M., 
Lambrughi, M., Melino, G., Papaleo, E., Dengjel, J., El Alaoui, S., Campanella, M., 
Dotsch, V., Rogov, V.V., Strappazzon, F., Cecconi, F., 2018. HUWE1 E3 ligase 
promotes PINK1/PARKIN-independent mitophagy by regulating AMBRA1 activation 
via IKKα. Nat. Commun. 9, 3755 . 
Do˚ganlar, Z.B., Do˚ganlar, O., Kurtdere, K., Güçlü, H., Chasan, T., Turgut, E., 2021. 
Melatonin prevents blood-retinal barrier breakdown and mitochondrial dysfunction 
in high glucose and hypoxia-induced in vitro diabetic macular edema model. 
Toxicol. Vitro 75, 105191 . 
Doxaki, C., Palikaras, K., 2020. Neuronal mitophagy: friend or foe? Front. Cell Dev. Biol. 
8, 611938 . 
Du, J., Yanagida, A., Knight, K., Engel, A.L., Vo, A.H., Jankowski, C., Sadilek, M., Tran, V. 
T., Manson, M.A., Ramakrishnan, A., Hurley, J.B., Chao, J.R., 2016. Reductive 
carboxylation is a major metabolic pathway in the retinal pigment epithelium. Proc. 
Natl. Acad. Sci. U. S. A. 113, 14710 –14715 . 
Duh, E.J., Sun, J.K., Stitt, A.W., 2017. Diabetic retinopathy: current understanding, 
mechanisms, and treatment strategies. JCI insight 2. 
Ebeling, M.C., Polanco, J.R., Qu, J., Tu, C., Montezuma, S.R., Ferrington, D.A., 2020. 
Improving retinal mitochondrial function as a treatment for age-related macular 
degeneration. Redox Biol. 34, 101552 . 
Ellen Kreipke, R., Wang, Y., Miklas, J.W., Mathieu, J., Ruohola-Baker, H., 2016. 
Metabolic remodeling in early development and cardiomyocyte maturation. Semin. 
Cell Dev. Biol. 52, 84–92. Eltokhi, A., Kurpiers, B., Pitzer, C., 2020. Behavioral tests assessing neuropsychiatric 
phenotypes in adolescent mice reveal strain- and sex-specific effects. Sci. Rep. 10, 
11263 . 
Enríquez, J.A., 2019. Mind your mouse strain. Nat. Metab. 1, 5–7. 
Ergorul, C., Ray, A., Huang, W., Wang, D.Y., Ben, Y., Cantuti-Castelvetri, I., 
Grosskreutz, C.L., 2010. Hypoxia inducible factor-1 α (HIF-1 α) and some HIF-1 target 
genes are elevated in experimental glaucoma. J. Mol. Neurosci. 42, 183–191. 
Esteban-Martinez, L., Boya, P., 2015. Autophagic flux determination in vivo and ex vivo. 
Methods 75, 79–86. 
Esteban-Martinez, L., Boya, P., 2018. BNIP3L/NIX-dependent mitophagy regulates cell 
differentiation via metabolic reprogramming. Autophagy 14, 915–917. 
Esteban-Martinez, L., Sierra-Filardi, E., McGreal, R.S., Salazar-Roa, M., Marino, G., 
Seco, E., Durand, S., Enot, D., Grana, O., Malumbres, M., Cvekl, A., Cuervo, A.M., 
Kroemer, G., Boya, P., 2017a. Programmed mitophagy is essential for the glycolytic 
switch during cell differentiation. EMBO J. 36, 1688 –1706 . 
Esteban-Martinez, L., Villarejo-Zori, B., Boya, P., 2017b. Cytofluorometric assessment of 
mitophagic flux in mammalian cells and tissues. Methods Enzymol. 588, 209–217. 
Evans, J.R., Michelessi, M., Virgili, G., 2014. Laser photocoagulation for proliferative 
diabetic retinopathy. Cochrane Database Syst. Rev. Cd011234, 2014 .  
Fang, E.F., Hou, Y., Palikaras, K., Adriaanse, B.A., Kerr, J.S., Yang, B., Lautrup, S., Hasan- 
Olive, M.M., Caponio, D., Dan, X., Rockt aschel, P., Croteau, D.L., Akbari, M., 
Greig, N.H., Fladby, T., Nilsen, H., Cader, M.Z., Mattson, M.P., Tavernarakis, N., 
Bohr, V.A., 2019. Mitophagy inhibits amyloid- β and tau pathology and reverses 
cognitive deficits in models of Alzheimer ’s disease. Nat. Neurosci. 22, 401–412. 
Feher, J., Kovacs, I., Artico, M., Cavallotti, C., Papale, A., Balacco Gabrieli, C., 2006. 
Mitochondrial alterations of retinal pigment epithelium in age-related macular 
degeneration. Neurobiol. Aging 27, 983–993. 
Ferrington, D.A., Ebeling, M.C., Kapphahn, R.J., Terluk, M.R., Fisher, C.R., Polanco, J.R., 
Roehrich, H., Leary, M.M., Geng, Z., Dutton, J.R., Montezuma, S.R., 2017. Altered 
bioenergetics and enhanced resistance to oxidative stress in human retinal pigment 
epithelial cells from donors with age-related macular degeneration. Redox Biol. 13, 
255–265. 
Ferrington, D.A., Fisher, C.R., Kowluru, R.A., 2020. Mitochondrial defects drive 
degenerative retinal diseases. Trends Mol. Med. 26, 105–118. 
Figueiredo-Pereira, C., Villarejo-Zori, B., Cipriano, P.C., Tavares, D., Ramírez-Pardo, I., 
Boya, P., Vieira, H.L.A., 2023. Carbon monoxide stimulates both mitophagy and 
mitochondrial biogenesis to mediate protection against oxidative stress in astrocytes. 
Mol. Neurobiol. 60, 851–863. 
Fimia, G., Stoykova, A., Romagnoli, A., Giunta, L., Di Bartolomeo, S., Nardacci, R., 
Corazzari, M., Fuoco, C., Ucar, A., Schwartz, P., Gruss, P., Piacentini, M., 
Chowdhury, K., Cecconi, F., 2007. Ambra1 regulates autophagy and development of 
the nervous system. Nature 447, 1121 –1125 . 
Fisher, C.R., Ferrington, D.A., 2018. Perspective on AMD pathobiology: a bioenergetic 
crisis in the RPE. Invest. Ophthalmol. Vis. Sci. 59, Amd41 –amd47 . 
Fisher, C.R., Shaaeli, A.A., Ebeling, M.C., Montezuma, S.R., Ferrington, D.A., 2022. 
Investigating mitochondrial fission, fusion, and autophagy in retinal pigment 
epithelium from donors with age-related macular degeneration. Sci. Rep. 12, 21725 . 
Fivenson, E.M., Lautrup, S., Sun, N., Scheibye-Knudsen, M., Stevnsner, T., Nilsen, H., 
Bohr, V.A., Fang, E.F., 2017. Mitophagy in neurodegeneration and aging. 
Neurochem. Int. 109, 202–209. 
Fleming, A., Bourdenx, M., Fujimaki, M., Karabiyik, C., Krause, G.J., Lopez, A., Martín- 
Segura, A., Puri, C., Scrivo, A., Skidmore, J., Son, S.M., Stamatakou, E., Wrobel, L., 
Zhu, Y., Cuervo, A.M., Rubinsztein, D.C., 2022. The different autophagy degradation 
pathways and neurodegeneration. Neuron 110, 935–966. 
Florey, O., Kim, S.E., Sandoval, C.P., Haynes, C.M., Overholtzer, M., 2011. Autophagy 
machinery mediates macroendocytic processing and entotic cell death by targeting 
single membranes. Nat. Cell Biol. 13, 1335 –1343 . 
Forni, M.F., Peloggia, J., Trudeau, K., Shirihai, O., Kowaltowski, A.J., 2016. Murine 
mesenchymal stem cell commitment to differentiation is regulated by mitochondrial 
dynamics. Stem Cell. 34, 743–755. 
Frank, M., Duvezin-Caubet, S., Koob, S., Occhipinti, A., Jagasia, R., Petcherski, A., 
Ruonala, M.O., Priault, M., Salin, B., Reichert, A.S., 2012. Mitophagy is triggered by 
mild oxidative stress in a mitochondrial fission dependent manner. Biochim. 
Biophys. Acta 1823, 2297 –2310 . 
Fritsche, L.G., Igl, W., Bailey, J.N., Grassmann, F., Sengupta, S., Bragg-Gresham, J.L., 
Burdon, K.P., Hebbring, S.J., Wen, C., Gorski, M., Kim, I.K., Cho, D., Zack, D., 
Souied, E., Scholl, H.P., Bala, E., Lee, K.E., Hunter, D.J., Sardell, R.J., Mitchell, P., 
Merriam, J.E., Cipriani, V., Hoffman, J.D., Schick, T., Lechanteur, Y.T., Guymer, R. 
H., Johnson, M.P., Jiang, Y., Stanton, C.M., Buitendijk, G.H., Zhan, X., Kwong, A.M., 
Boleda, A., Brooks, M., Gieser, L., Ratnapriya, R., Branham, K.E., Foerster, J.R., 
Heckenlively, J.R., Othman, M.I., Vote, B.J., Liang, H.H., Souzeau, E., McAllister, I. 
L., Isaacs, T., Hall, J., Lake, S., Mackey, D.A., Constable, I.J., Craig, J.E., Kitchner, T. 
E., Yang, Z., Su, Z., Luo, H., Chen, D., Ouyang, H., Flagg, K., Lin, D., Mao, G., 
Ferreyra, H., Stark, K., von Strachwitz, C.N., Wolf, A., Brandl, C., Rudolph, G., 
Olden, M., Morrison, M.A., Morgan, D.J., Schu, M., Ahn, J., Silvestri, G., Tsironi, E. 
E., Park, K.H., Farrer, L.A., Orlin, A., Brucker, A., Li, M., Curcio, C.A., Mohand- 
Saïd, S., Sahel, J.A., Audo, I., Benchaboune, M., Cree, A.J., Rennie, C.A., 
Goverdhan, S.V., Grunin, M., Hagbi-Levi, S., Campochiaro, P., Katsanis, N., Holz, F. 
G., Blond, F., Blanch ˘e, H., Deleuze, J.F., Igo Jr., R.P., Truitt, B., Peachey, N.S., 
Meuer, S.M., Myers, C.E., Moore, E.L., Klein, R., Hauser, M.A., Postel, E.A., 
Courtenay, M.D., Schwartz, S.G., Kovach, J.L., Scott, W.K., Liew, G., Tan, A.G., 
Gopinath, B., Merriam, J.C., Smith, R.T., Khan, J.C., Shahid, H., Moore, A.T., 
McGrath, J.A., Laux, R., Brantley Jr., M.A., Agarwal, A., Ersoy, L., Caramoy, A., 
Langmann, T., Saksens, N.T., de Jong, E.K., Hoyng, C.B., Cain, M.S., Richardson, A. 
J., Martin, T.M., Blangero, J., Weeks, D.E., Dhillon, B., van Duijn, C.M., Doheny, K. 
F., Romm, J., Klaver, C.C., Hayward, C., Gorin, M.B., Klein, M.L., Baird, P.N., den J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
21Hollander, A.I., Fauser, S., Yates, J.R., Allikmets, R., Wang, J.J., Schaumberg, D.A., 
Klein, B.E., Hagstrom, S.A., Chowers, I., Lotery, A.J., L˘eveillard, T., Zhang, K., 
Brilliant, M.H., Hewitt, A.W., Swaroop, A., Chew, E.Y., Pericak-Vance, M.A., 
DeAngelis, M., Stambolian, D., Haines, J.L., Iyengar, S.K., Weber, B.H., Abecasis, G. 
R., Heid, I.M., 2016. A large genome-wide association study of age-related macular 
degeneration highlights contributions of rare and common variants. Nat. Genet. 48, 
134–143. 
Fu, D., Wu, M., Zhang, J., Du, M., Yang, S., Hammad, S.M., Wilson, K., Chen, J., Lyons, T. 
J., 2012. Mechanisms of modified LDL-induced pericyte loss and retinal injury in 
diabetic retinopathy. Diabetologia 55, 3128 –3140 . 
Fu, D., Yu, J.Y., Yang, S., Wu, M., Hammad, S.M., Connell, A.R., Du, M., Chen, J., 
Lyons, T.J., 2016. Survival or death: a dual role for autophagy in stress-induced 
pericyte loss in diabetic retinopathy. Diabetologia 59, 2251 –2261 . 
Ganapathy, P.S., Perry, R.L., Tawfik, A., Smith, R.M., Perry, E., Roon, P., Bozard, B.R., 
Ha, Y., Smith, S.B., 2011. Homocysteine-mediated modulation of mitochondrial 
dynamics in retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 52, 5551 –5558 . 
Giarmarco, M.M., Brock, D.C., Robbings, B.M., Cleghorn, W.M., Tsantilas, K.A., Kuch, K. 
C., Ge, W., Rutter, K.M., Parker, E.D., Hurley, J.B., Brockerhoff, S.E., 2020. Daily 
mitochondrial dynamics in cone photoreceptors. Proc. Natl. Acad. Sci. U. S. A. 117, 
28816 –28827 . 
Golestaneh, N., Chu, Y., Xiao, Y.Y., Stoleru, G.L., Theos, A.C., 2017. Dysfunctional 
autophagy in RPE, a contributing factor in age-related macular degeneration. Cell 
Death Dis. 8, e2537 . 
Gomes, C., VanderWall, K.B., Pan, Y., Lu, X., Lavekar, S.S., Huang, K.C., Fligor, C.M., 
Harkin, J., Zhang, C., Cummins, T.R., Meyer, J.S., 2022. Astrocytes modulate 
neurodegenerative phenotypes associated with glaucoma in OPTN(E50K) human 
stem cell-derived retinal ganglion cells. Stem Cell Rep. 17, 1636 –1649 . 
G˘omez-Sintes, R., Arias, E., 2021. Chaperone-mediated autophagy and disease: 
implications for cancer and neurodegeneration. Mol. Aspect. Med. 82, 101025 . 
Gomez-Sintes, R., Villarejo-Zori, B., Serrano-Puebla, A., Esteban-Martinez, L., Sierra- 
Filardi, E., Ramirez-Pardo, I., Rodriguez-Muela, N., Boya, P., 2017. Standard assays 
for the study of autophagy in the ex vivo retina. Cells 6. 
Gong, Q., Wang, H., Yu, P., Qian, T., Xu, X., 2021. Protective or harmful: the dual roles of 
autophagy in diabetic retinopathy. Front. Med. 8, 644121 . 
Greene, A.W., Grenier, K., Aguileta, M.A., Muise, S., Farazifard, R., Haque, M.E., 
McBride, H.M., Park, D.S., Fon, E.A., 2012. Mitochondrial processing peptidase 
regulates PINK1 processing, import and Parkin recruitment. EMBO Rep. 13, 
378–385. 
Griparic, L., van der Wel, N.N., Orozco, I.J., Peters, P.J., van der Bliek, A.M., 2004. Loss 
of the intermembrane space protein Mgm1/OPA1 induces swelling and localized 
constrictions along the lengths of mitochondria. J. Biol. Chem. 279, 18792 –18798 . 
Guo, X., Dason, E.S., Zanon-Moreno, V., Jiang, Q., Nahirnyj, A., Chan, D., Flanagan, J.G., 
Sivak, J.M., 2014. PGC-1 α signaling coordinates susceptibility to metabolic and 
oxidative injury in the inner retina. Am. J. Pathol. 184, 1017 –1029 . 
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., 
Yokoyama, M., Mishima, K., Saito, I., Okano, H., Mizushima, N., 2006. Suppression 
of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 
441, 885–889. 
Harbauer, A.B., Hees, J.T., Wanderoy, S., Segura, I., Gibbs, W., Cheng, Y., Ordonez, M., 
Cai, Z., Cartoni, R., Ashrafi, G., Wang, C., Perocchi, F., He, Z., Schwarz, T.L., 2022. 
Neuronal mitochondria transport Pink1 mRNA via synaptojanin 2 to support local 
mitophagy. Neuron 110, 1516 –1531.e1519 . 
Harder, J.M., Guymer, C., Wood, J.P.M., Daskalaki, E., Chidlow, G., Zhang, C., 
Balasubramanian, R., Cardozo, B.H., Foxworth, N.E., Deering, K.E., Ouellette, T.B., 
Montgomery, C., Wheelock, C.E., Casson, R.J., Williams, P.A., John, S.W.M., 2020. 
Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by 
pyruvate or rapamycin. Proc. Natl. Acad. Sci. U. S. A. 117, 33619 –33627 . 
Hargrove-Grimes, P., Mondal, A.K., Gumerson, J., Nellissery, J., Aponte, A.M., Gieser, L., 
Qian, H., Fariss, R.N., Bonifacino, J.S., Li, T., Swaroop, A., 2020. Loss of endocytosis- 
associated RabGEF1 causes aberrant morphogenesis and altered autophagy in 
photoreceptors leading to retinal degeneration. PLoS Genet. 16, e1009259 . 
Hartong, D.T., Berson, E.L., Dryja, T.P., 2006. Retinitis pigmentosa. Lancet 368, 
1795 –1809 . 
Hass, D.T., Barnstable, C.J., 2019a. Cell autonomous neuroprotection by the 
mitochondrial uncoupling protein 2 in a mouse model of glaucoma. Front. Neurosci. 
13, 201. 
Hass, D.T., Barnstable, C.J., 2019b. Mitochondrial uncoupling protein 2 knock-out 
promotes mitophagy to decrease retinal ganglion cell death in a mouse model of 
glaucoma. J. Neurosci. 39, 3582 –3596 . 
He, F., Agosto, M.A., Anastassov, I.A., Tse, D.Y., Wu, S.M., Wensel, T.G., 2016a. 
Phosphatidylinositol-3-phosphate is light-regulated and essential for survival in 
retinal rods. Sci. Rep. 6, 26978 . 
He, F., Nichols, R.M., Kailasam, L., Wensel, T.G., Agosto, M.A., 2019. Critical role for 
phosphatidylinositol-3 kinase Vps34/PIK3C3 in ON-bipolar cells. Invest. 
Ophthalmol. Vis. Sci. 60, 2861 –2874 . 
He, Q., Koprich, J.B., Wang, Y., Yu, W.B., Xiao, B.G., Brotchie, J.M., Wang, J., 2016b. 
Treatment with trehalose prevents behavioral and neurochemical deficits produced 
in an AAV alpha-synuclein rat model of Parkinson ’s disease. Mol. Neurobiol. 53, 
2258 –2268 . 
Heckel, E., Cagnone, G., Agnihotri, T., Cakir, B., Das, A., Kim, J.S., Kim, N., Lavoie, G., 
Situ, A., Pundir, S., Sun, Y., Wünnemann, F., Pierce, K.A., Dennis, C., Mitchell, G.A., 
Chemtob, S., Rezende, F.A., Andelfinger, G., Clish, C.B., Roux, P.P., Sapieha, P., 
Smith, L.E., Joyal, J.S., 2022. Triglyceride-derived fatty acids reduce autophagy in a 
model of retinal angiomatous proliferation. JCI insight 7. Hirt, J., Porter, K., Dixon, A., McKinnon, S., Liton, P.B., 2018. Contribution of autophagy 
to ocular hypertension and neurodegeneration in the DBA/2J spontaneous glaucoma 
mouse model. Cell Death Dis. 4, 14. 
Hombrebueno, J.R., Cairns, L., Dutton, L.R., Lyons, T.J., Brazil, D.P., Moynagh, P., 
Curtis, T.M., Xu, H., 2019. Uncoupled turnover disrupts mitochondrial quality 
control in diabetic retinopathy. JCI insight 4. 
Huang, C., Lu, H., Xu, J., Yu, H., Wang, X., Zhang, X., 2018. Protective roles of autophagy 
in retinal pigment epithelium under high glucose condition via regulating PINK1/ 
Parkin pathway and BNIP3L. Biol. Res. 51, 22. 
Huang, W., Choi, W., Hu, W., Mi, N., Guo, Q., Ma, M., Liu, M., Tian, Y., Lu, P., Wang, F.L., 
Deng, H., Liu, L., Gao, N., Yu, L., Shi, Y., 2012. Crystal structure and biochemical 
analyses reveal Beclin 1 as a novel membrane binding protein. Cell Res. 22, 
473–489. 
Indira, D., Varadarajan, S.N., Subhasingh Lupitha, S., Lekshmi, A., Mathew, K.A., 
Chandrasekharan, A., Rajappan Pillai, P., Pulikkal Kadamberi, I., Ramachandran, I., 
Sekar, H., Kochucherukkan Gopalakrishnan, A., Tr, S., 2018. Strategies for imaging 
mitophagy in high-resolution and high-throughput. Eur. J. Cell Biol. 97, 1–14. 
Intartaglia, D., Giamundo, G., Naso, F., Nusco, E., Di Giulio, S., Salierno, F.G., 
Polishchuk, E., Conte, I., 2022. Induction of autophagy promotes clearance of RHO 
(P23H) aggregates and protects from retinal degeneration. Front. Aging Neurosci. 
14, 878958 . 
Ito, Y.A., Di Polo, A., 2017. Mitochondrial dynamics, transport, and quality control: a 
bottleneck for retinal ganglion cell viability in optic neuropathies. Mitochondrion 
36, 186–192. 
Jassim, A.H., Fan, Y., Pappenhagen, N., Nsiah, N.Y., Inman, D.M., 2021a. Oxidative 
stress and hypoxia modify mitochondrial homeostasis during glaucoma. 
Antioxidants Redox Signal. 35, 1341 –1357 . 
Jassim, A.H., Inman, D.M., Mitchell, C.H., 2021b. Crosstalk between dysfunctional 
mitochondria and inflammation in glaucomatous neurodegeneration. Front. 
Pharmacol. 12, 699623 . 
Johansen, T., Lamark, T., 2020. Selective autophagy: ATG8 family proteins, LIR motifs 
and cargo receptors. J. Mol. Biol. 432, 80–103. 
Joyal, J.S., Sun, Y., Gantner, M.L., Shao, Z., Evans, L.P., Saba, N., Fredrick, T., Burnim, S., 
Kim, J.S., Patel, G., Juan, A.M., Hurst, C.G., Hatton, C.J., Cui, Z., Pierce, K.A., 
Bherer, P., Aguilar, E., Powner, M.B., Vevis, K., Boisvert, M., Fu, Z., Levy, E., 
Fruttiger, M., Packard, A., Rezende, F.A., Maranda, B., Sapieha, P., Chen, J., 
Friedlander, M., Clish, C.B., Smith, L.E., 2016. Retinal lipid and glucose metabolism 
dictates angiogenesis through the lipid sensor Ffar1. Nat. Med. 22, 439–445. 
Kanow, M.A., Giarmarco, M.M., Jankowski, C.S., Tsantilas, K., Engel, A.L., Du, J., 
Linton, J.D., Farnsworth, C.C., Sloat, S.R., Rountree, A., Sweet, I.R., Lindsay, K.J., 
Parker, E.D., Brockerhoff, S.E., Sadilek, M., Chao, J.R., Hurley, J.B., 2017. 
Biochemical adaptations of the retina and retinal pigment epithelium support a 
metabolic ecosystem in the vertebrate eye. Elife 6. 
Katayama, H., Hama, H., Nagasawa, K., Kurokawa, H., Sugiyama, M., Ando, R., 
Funata, M., Yoshida, N., Homma, M., Nishimura, T., Takahashi, M., Ishida, Y., 
Hioki, H., Tsujihata, Y., Miyawaki, A., 2020. Visualizing and modulating mitophagy 
for therapeutic studies of neurodegeneration. Cell 181, 1176 –1187 e1116 .  
Katayama, H., Kogure, T., Mizushima, N., Yoshimori, T., Miyawaki, A., 2011. A sensitive 
and quantitative technique for detecting autophagic events based on lysosomal 
delivery. Chem. Biol. 18, 1042 –1052 . 
Kim, J.Y., Zhao, H., Martinez, J., Doggett, T.A., Kolesnikov, A.V., Tang, P.H., 
Ablonczy, Z., Chan, C.C., Zhou, Z., Green, D.R., Ferguson, T.A., 2013. Noncanonical 
autophagy promotes the visual cycle. Cell 154, 365–376. 
Kim, S.H., Munemasa, Y., Kwong, J.M., Ahn, J.H., Mareninov, S., Gordon, L.K., 
Caprioli, J., Piri, N., 2008. Activation of autophagy in retinal ganglion cells. 
J. Neurosci. Res. 86, 2943 –2951 . 
Kleele, T., Rey, T., Winter, J., Zaganelli, S., Mahecic, D., Perreten Lambert, H., 
Ruberto, F.P., Nemir, M., Wai, T., Pedrazzini, T., Manley, S., 2021. Distinct fission 
signatures predict mitochondrial degradation or biogenesis. Nature 593, 435–439. 
Klionsky, D.J., Abdel-Aziz, A.K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., 
Abeliovich, H., Abildgaard, M.H., Abudu, Y.P., Acevedo-Arozena, A., 
Adamopoulos, I.E., Adeli, K., Adolph, T.E., Adornetto, A., Aflaki, E., Agam, G., 
Agarwal, A., Aggarwal, B.B., Agnello, M., Agostinis, P., Agrewala, J.N., Agrotis, A., 
Aguilar, P.V., Ahmad, S.T., Ahmed, Z.M., Ahumada-Castro, U., Aits, S., Aizawa, S., 
Akkoc, Y., Akoumianaki, T., Akpinar, H.A., Al-Abd, A.M., Al-Akra, L., Al- 
Gharaibeh, A., Alaoui-Jamali, M.A., Alberti, S., Alcocer-Gomez, E., Alessandri, C., 
Ali, M., Alim Al-Bari, M.A., Aliwaini, S., Alizadeh, J., Almacellas, E., Almasan, A., 
Alonso, A., Alonso, G.D., Altan-Bonnet, N., Altieri, D.C., Alvarez, E.M.C., Alves, S., 
Alves da Costa, C., Alzaharna, M.M., Amadio, M., Amantini, C., Amaral, C., 
Ambrosio, S., Amer, A.O., Ammanathan, V., An, Z., Andersen, S.U., Andrabi, S.A., 
Andrade-Silva, M., Andres, A.M., Angelini, S., Ann, D., Anozie, U.C., Ansari, M.Y., 
Antas, P., Antebi, A., Anton, Z., Anwar, T., Apetoh, L., Apostolova, N., Araki, T., 
Araki, Y., Arasaki, K., Araujo, W.L., Araya, J., Arden, C., Arevalo, M.A., Arguelles, S., 
Arias, E., Arikkath, J., Arimoto, H., Ariosa, A.R., Armstrong-James, D., Arnaune- 
Pelloquin, L., Aroca, A., Arroyo, D.S., Arsov, I., Artero, R., Asaro, D.M.L., 
Aschner, M., Ashrafizadeh, M., Ashur-Fabian, O., Atanasov, A.G., Au, A.K., 
Auberger, P., Auner, H.W., Aurelian, L., Autelli, R., Avagliano, L., Avalos, Y., 
Aveic, S., Aveleira, C.A., Avin-Wittenberg, T., Aydin, Y., Ayton, S., Ayyadevara, S., 
Azzopardi, M., Baba, M., Backer, J.M., Backues, S.K., Bae, D.H., Bae, O.N., Bae, S.H., 
Baehrecke, E.H., Baek, A., Baek, S.H., Baek, S.H., Bagetta, G., Bagniewska- 
Zadworna, A., Bai, H., Bai, J., Bai, X., Bai, Y., Bairagi, N., Baksi, S., Balbi, T., 
Baldari, C.T., Balduini, W., Ballabio, A., Ballester, M., Balazadeh, S., Balzan, R., 
Bandopadhyay, R., Banerjee, S., Banerjee, S., Banreti, A., Bao, Y., Baptista, M.S., 
Baracca, A., Barbati, C., Bargiela, A., Barila, D., Barlow, P.G., Barmada, S.J., 
Barreiro, E., Barreto, G.E., Bartek, J., Bartel, B., Bartolome, A., Barve, G.R., 
Basagoudanavar, S.H., Bassham, D.C., Bast Jr., R.C., Basu, A., Batoko, H., Batten, I., J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
22Baulieu, E.E., Baumgarner, B.L., Bayry, J., Beale, R., Beau, I., Beaumatin, F., 
Bechara, L.R.G., Beck Jr., G.R., Beers, M.F., Begun, J., Behrends, C., Behrens, G.M.N., 
Bei, R., Bejarano, E., Bel, S., Behl, C., Belaid, A., Belgareh-Touze, N., Bellarosa, C., 
Belleudi, F., Bello Perez, M., Bello-Morales, R., Beltran, J.S.O., Beltran, S., 
Benbrook, D.M., Bendorius, M., Benitez, B.A., Benito-Cuesta, I., Bensalem, J., 
Berchtold, M.W., Berezowska, S., Bergamaschi, D., Bergami, M., Bergmann, A., 
Berliocchi, L., Berlioz-Torrent, C., Bernard, A., Berthoux, L., Besirli, C.G., Besteiro, S., 
Betin, V.M., Beyaert, R., Bezbradica, J.S., Bhaskar, K., Bhatia-Kissova, I., 
Bhattacharya, R., Bhattacharya, S., Bhattacharyya, S., Bhuiyan, M.S., Bhutia, S.K., 
Bi, L., Bi, X., Biden, T.J., Bijian, K., Billes, V.A., Binart, N., Bincoletto, C., 
Birgisdottir, A.B., Bjorkoy, G., Blanco, G., Blas-Garcia, A., Blasiak, J., Blomgran, R., 
Blomgren, K., Blum, J.S., Boada-Romero, E., Boban, M., Boesze-Battaglia, K., 
Boeuf, P., Boland, B., Bomont, P., Bonaldo, P., Bonam, S.R., Bonfili, L., Bonifacino, J. 
S., Boone, B.A., Bootman, M.D., Bordi, M., Borner, C., Bornhauser, B.C., 
Borthakur, G., Bosch, J., Bose, S., Botana, L.M., Botas, J., Boulanger, C.M., 
Boulton, M.E., Bourdenx, M., Bourgeois, B., Bourke, N.M., Bousquet, G., Boya, P., 
Bozhkov, P.V., Bozi, L.H.M., Bozkurt, T.O., Brackney, D.E., Brandts, C.H., Braun, R. 
J., Braus, G.H., Bravo-Sagua, R., Bravo-San Pedro, J.M., Brest, P., Bringer, M.A., 
Briones-Herrera, A., Broaddus, V.C., Brodersen, P., Brodsky, J.L., Brody, S.L., 
Bronson, P.G., Bronstein, J.M., Brown, C.N., Brown, R.E., Brum, P.C., Brumell, J.H., 
Brunetti-Pierri, N., Bruno, D., Bryson-Richardson, R.J., Bucci, C., Buchrieser, C., 
Bueno, M., Buitrago-Molina, L.E., Buraschi, S., Buch, S., Buchan, J.R., 
Buckingham, E.M., Budak, H., Budini, M., Bultynck, G., Burada, F., Burgoyne, J.R., 
Buron, M.I., Bustos, V., Buttner, S., Butturini, E., Byrd, A., Cabas, I., Cabrera- 
Benitez, S., Cadwell, K., Cai, J., Cai, L., Cai, Q., Cairo, M., Calbet, J.A., Caldwell, G. 
A., Caldwell, K.A., Call, J.A., Calvani, R., Calvo, A.C., Calvo-Rubio Barrera, M., 
Camara, N.O., Camonis, J.H., Camougrand, N., Campanella, M., Campbell, E.M., 
Campbell-Valois, F.X., Campello, S., Campesi, I., Campos, J.C., Camuzard, O., 
Cancino, J., Candido de Almeida, D., Canesi, L., Caniggia, I., Canonico, B., Canti, C., 
Cao, B., Caraglia, M., Carames, B., Carchman, E.H., Cardenal-Munoz, E., 
Cardenas, C., Cardenas, L., Cardoso, S.M., Carew, J.S., Carle, G.F., Carleton, G., 
Carloni, S., Carmona-Gutierrez, D., Carneiro, L.A., Carnevali, O., Carosi, J.M., 
Carra, S., Carrier, A., Carrier, L., Carroll, B., Carter, A.B., Carvalho, A.N., 
Casanova, M., Casas, C., Casas, J., Cassioli, C., Castillo, E.F., Castillo, K., Castillo- 
Lluva, S., Castoldi, F., Castori, M., Castro, A.F., Castro-Caldas, M., Castro- 
Hernandez, J., Castro-Obregon, S., Catz, S.D., Cavadas, C., Cavaliere, F., 
Cavallini, G., Cavinato, M., Cayuela, M.L., Cebollada Rica, P., Cecarini, V., 
Cecconi, F., Cechowska-Pasko, M., Cenci, S., Ceperuelo-Mallafre, V., Cerqueira, J.J., 
Cerutti, J.M., Cervia, D., Cetintas, V.B., Cetrullo, S., Chae, H.J., Chagin, A.S., Chai, C. 
Y., Chakrabarti, G., Chakrabarti, O., Chakraborty, T., Chakraborty, T., Chami, M., 
Chamilos, G., Chan, D.W., Chan, E.Y.W., Chan, E.D., Chan, H.Y.E., Chan, H.H., 
Chan, H., Chan, M.T.V., Chan, Y.S., Chandra, P.K., Chang, C.P., Chang, C., Chang, H. 
C., Chang, K., Chao, J., Chapman, T., Charlet-Berguerand, N., Chatterjee, S., 
Chaube, S.K., Chaudhary, A., Chauhan, S., Chaum, E., Checler, F., Cheetham, M.E., 
Chen, C.S., Chen, G.C., Chen, J.F., Chen, L.L., Chen, L., Chen, L., Chen, M., Chen, M. 
K., Chen, N., Chen, Q., Chen, R.H., Chen, S., Chen, W., Chen, W., Chen, X.M., 
Chen, X.W., Chen, X., Chen, Y., Chen, Y.G., Chen, Y., Chen, Y., Chen, Y.J., Chen, Y. 
Q., Chen, Z.S., Chen, Z., Chen, Z.H., Chen, Z.J., Chen, Z., Cheng, H., Cheng, J., 
Cheng, S.Y., Cheng, W., Cheng, X., Cheng, X.T., Cheng, Y., Cheng, Z., Chen, Z., 
Cheong, H., Cheong, J.K., Chernyak, B.V., Cherry, S., Cheung, C.F.R., Cheung, C.H. 
A., Cheung, K.H., Chevet, E., Chi, R.J., Chiang, A.K.S., Chiaradonna, F., Chiarelli, R., 
Chiariello, M., Chica, N., Chiocca, S., Chiong, M., Chiou, S.H., Chiramel, A.I., 
Chiurchiu, V., Cho, D.H., Choe, S.K., Choi, A.M.K., Choi, M.E., Choudhury, K.R., 
Chow, N.S., Chu, C.T., Chua, J.P., Chua, J.J.E., Chung, H., Chung, K.P., Chung, S., 
Chung, S.H., Chung, Y.L., Cianfanelli, V., Ciechomska, I.A., Cifuentes, M., Cinque, L., 
Cirak, S., Cirone, M., Clague, M.J., Clarke, R., Clementi, E., Coccia, E.M., 
Codogno, P., Cohen, E., Cohen, M.M., Colasanti, T., Colasuonno, F., Colbert, R.A., 
Colell, A., Colic, M., Coll, N.S., Collins, M.O., Colombo, M.I., Colon-Ramos, D.A., 
Combaret, L., Comincini, S., Cominetti, M.R., Consiglio, A., Conte, A., Conti, F., 
Contu, V.R., Cookson, M.R., Coombs, K.M., Coppens, I., Corasaniti, M.T., Corkery, D. 
P., Cordes, N., Cortese, K., Costa, M.D.C., Costantino, S., Costelli, P., Coto- 
Montes, A., Crack, P.J., Crespo, J.L., Criollo, A., Crippa, V., Cristofani, R., 
Csizmadia, T., Cuadrado, A., Cui, B., Cui, J., Cui, Y., Cui, Y., Culetto, E., Cumino, A. 
C., Cybulsky, A.V., Czaja, M.J., Czuczwar, S.J., D’Adamo, S., D’Amelio, M., 
D’Arcangelo, D., D’Lugos, A.C., D’Orazi, G., da Silva, J.A., Dafsari, H.S., Dagda, R.K., 
Dagdas, Y., Daglia, M., Dai, X., Dai, Y., Dai, Y., Dal Col, J., Dalhaimer, P., Dalla 
Valle, L., Dallenga, T., Dalmasso, G., Damme, M., Dando, I., Dantuma, N.P., 
Darling, A.L., Das, H., Dasarathy, S., Dasari, S.K., Dash, S., Daumke, O., 
Dauphinee, A.N., Davies, J.S., Davila, V.A., Davis, R.J., Davis, T., Dayalan Naidu, S., 
De Amicis, F., De Bosscher, K., De Felice, F., De Franceschi, L., De Leonibus, C., de 
Mattos Barbosa, M.G., De Meyer, G.R.Y., De Milito, A., De Nunzio, C., De Palma, C., 
De Santi, M., De Virgilio, C., De Zio, D., Debnath, J., DeBosch, B.J., Decuypere, J.P., 
Deehan, M.A., Deflorian, G., DeGregori, J., Dehay, B., Del Rio, G., Delaney, J.R., 
Delbridge, L.M.D., Delorme-Axford, E., Delpino, M.V., Demarchi, F., Dembitz, V., 
Demers, N.D., Deng, H., Deng, Z., Dengjel, J., Dent, P., Denton, D., DePamphilis, M. 
L., Der, C.J., Deretic, V., Descoteaux, A., Devis, L., Devkota, S., Devuyst, O., 
Dewson, G., Dharmasivam, M., Dhiman, R., di Bernardo, D., Di Cristina, M., Di 
Domenico, F., Di Fazio, P., Di Fonzo, A., Di Guardo, G., Di Guglielmo, G.M., Di 
Leo, L., Di Malta, C., Di Nardo, A., Di Rienzo, M., Di Sano, F., Diallinas, G., Diao, J., 
Diaz-Araya, G., Diaz-Laviada, I., Dickinson, J.M., Diederich, M., Dieude, M., Dikic, I., 
Ding, S., Ding, W.X., Dini, L., Dinic, J., Dinic, M., Dinkova-Kostova, A.T., Dionne, M. 
S., Distler, J.H.W., Diwan, A., Dixon, I.M.C., Djavaheri-Mergny, M., Dobrinski, I., 
Dobrovinskaya, O., Dobrowolski, R., Dobson, R.C.J., Dokic, J., Dokmeci Emre, S., 
Donadelli, M., Dong, B., Dong, X., Dong, Z., Dorn Ii, G.W., Dotsch, V., Dou, H., 
Dou, J., Dowaidar, M., Dridi, S., Drucker, L., Du, A., Du, C., Du, G., Du, H.N., Du, L. 
L., du Toit, A., Duan, S.B., Duan, X., Duarte, S.P., Dubrovska, A., Dunlop, E.A., Dupont, N., Duran, R.V., Dwarakanath, B.S., Dyshlovoy, S.A., Ebrahimi-Fakhari, D., 
Eckhart, L., Edelstein, C.L., Efferth, T., Eftekharpour, E., Eichinger, L., Eid, N., 
Eisenberg, T., Eissa, N.T., Eissa, S., Ejarque, M., El Andaloussi, A., El-Hage, N., El- 
Naggar, S., Eleuteri, A.M., El-Shafey, E.S., Elgendy, M., Eliopoulos, A.G., Elizalde, M. 
M., Elks, P.M., Elsasser, H.P., Elsherbiny, E.S., Emerling, B.M., Emre, N.C.T., Eng, C. 
H., Engedal, N., Engelbrecht, A.M., Engelsen, A.S.T., Enserink, J.M., Escalante, R., 
Esclatine, A., Escobar-Henriques, M., Eskelinen, E.L., Espert, L., Eusebio, M.O., 
Fabrias, G., Fabrizi, C., Facchiano, A., Facchiano, F., Fadeel, B., Fader, C., Faesen, A. 
C., Fairlie, W.D., Falco, A., Falkenburger, B.H., Fan, D., Fan, J., Fan, Y., Fang, E.F., 
Fang, Y., Fang, Y., Fanto, M., Farfel-Becker, T., Faure, M., Fazeli, G., Fedele, A.O., 
Feldman, A.M., Feng, D., Feng, J., Feng, L., Feng, Y., Feng, Y., Feng, W., Fenz 
Araujo, T., Ferguson, T.A., Fernandez, A.F., Fernandez-Checa, J.C., Fernandez- 
Veledo, S., Fernie, A.R., Ferrante Jr., A.W., Ferraresi, A., Ferrari, M.F., Ferreira, J.C. 
B., Ferro-Novick, S., Figueras, A., Filadi, R., Filigheddu, N., Filippi-Chiela, E., 
Filomeni, G., Fimia, G.M., Fineschi, V., Finetti, F., Finkbeiner, S., Fisher, E.A., 
Fisher, P.B., Flamigni, F., Fliesler, S.J., Flo, T.H., Florance, I., Florey, O., Florio, T., 
Fodor, E., Follo, C., Fon, E.A., Forlino, A., Fornai, F., Fortini, P., Fracassi, A., 
Fraldi, A., Franco, B., Franco, R., Franconi, F., Frankel, L.B., Friedman, S.L., 
Frohlich, L.F., Fruhbeck, G., Fuentes, J.M., Fujiki, Y., Fujita, N., Fujiwara, Y., 
Fukuda, M., Fulda, S., Furic, L., Furuya, N., Fusco, C., Gack, M.U., Gaffke, L., 
Galadari, S., Galasso, A., Galindo, M.F., Gallolu Kankanamalage, S., Galluzzi, L., 
Galy, V., Gammoh, N., Gan, B., Ganley, I.G., Gao, F., Gao, H., Gao, M., Gao, P., 
Gao, S.J., Gao, W., Gao, X., Garcera, A., Garcia, M.N., Garcia, V.E., Garcia-Del 
Portillo, F., Garcia-Escudero, V., Garcia-Garcia, A., Garcia-Macia, M., Garcia- 
Moreno, D., Garcia-Ruiz, C., Garcia-Sanz, P., Garg, A.D., Gargini, R., Garofalo, T., 
Garry, R.F., Gassen, N.C., Gatica, D., Ge, L., Ge, W., Geiss-Friedlander, R., Gelfi, C., 
Genschik, P., Gentle, I.E., Gerbino, V., Gerhardt, C., Germain, K., Germain, M., 
Gewirtz, D.A., Ghasemipour Afshar, E., Ghavami, S., Ghigo, A., Ghosh, M., 
Giamas, G., Giampietri, C., Giatromanolaki, A., Gibson, G.E., Gibson, S.B., Ginet, V., 
Giniger, E., Giorgi, C., Girao, H., Girardin, S.E., Giridharan, M., Giuliano, S., 
Giulivi, C., Giuriato, S., Giustiniani, J., Gluschko, A., Goder, V., Goginashvili, A., 
Golab, J., Goldstone, D.C., Golebiewska, A., Gomes, L.R., Gomez, R., Gomez- 
Sanchez, R., Gomez-Puerto, M.C., Gomez-Sintes, R., Gong, Q., Goni, F.M., Gonzalez- 
Gallego, J., Gonzalez-Hernandez, T., Gonzalez-Polo, R.A., Gonzalez-Reyes, J.A., 
Gonzalez-Rodriguez, P., Goping, I.S., Gorbatyuk, M.S., Gorbunov, N.V., Gorgulu, K., 
Gorojod, R.M., Gorski, S.M., Goruppi, S., Gotor, C., Gottlieb, R.A., Gozes, I., 
Gozuacik, D., Graef, M., Graler, M.H., Granatiero, V., Grasso, D., Gray, J.P., 
Green, D.R., Greenhough, A., Gregory, S.L., Griffin, E.F., Grinstaff, M.W., Gros, F., 
Grose, C., Gross, A.S., Gruber, F., Grumati, P., Grune, T., Gu, X., Guan, J.L., 
Guardia, C.M., Guda, K., Guerra, F., Guerri, C., Guha, P., Guillen, C., Gujar, S., 
Gukovskaya, A., Gukovsky, I., Gunst, J., Gunther, A., Guntur, A.R., Guo, C., Guo, C., 
Guo, H., Guo, L.W., Guo, M., Gupta, P., Gupta, S.K., Gupta, S., Gupta, V.B., Gupta, V., 
Gustafsson, A.B., Gutterman, D.D., H, B.R., Haapasalo, A., Haber, J.E., Hac, A., 
Hadano, S., Hafren, A.J., Haidar, M., Hall, B.S., Hallden, G., Hamacher-Brady, A., 
Hamann, A., Hamasaki, M., Han, W., Hansen, M., Hanson, P.I., Hao, Z., Harada, M., 
Harhaji-Trajkovic, L., Hariharan, N., Haroon, N., Harris, J., Hasegawa, T., Hasima 
Nagoor, N., Haspel, J.A., Haucke, V., Hawkins, W.D., Hay, B.A., Haynes, C.M., 
Hayrabedyan, S.B., Hays, T.S., He, C., He, Q., He, R.R., He, Y.W., He, Y.Y., 
Heakal, Y., Heberle, A.M., Hejtmancik, J.F., Helgason, G.V., Henkel, V., Herb, M., 
Hergovich, A., Herman-Antosiewicz, A., Hernandez, A., Hernandez, C., Hernandez- 
Diaz, S., Hernandez-Gea, V., Herpin, A., Herreros, J., Hervas, J.H., Hesselson, D., 
Hetz, C., Heussler, V.T., Higuchi, Y., Hilfiker, S., Hill, J.A., Hlavacek, W.S., Ho, E.A., 
Ho, I.H.T., Ho, P.W., Ho, S.L., Ho, W.Y., Hobbs, G.A., Hochstrasser, M., Hoet, P.H.M., 
Hofius, D., Hofman, P., Hohn, A., Holmberg, C.I., Hombrebueno, J.R., Yi-Ren 
Hong, C.H., Hooper, L.V., Hoppe, T., Horos, R., Hoshida, Y., Hsin, I.L., Hsu, H.Y., 
Hu, B., Hu, D., Hu, L.F., Hu, M.C., Hu, R., Hu, W., Hu, Y.C., Hu, Z.W., Hua, F., 
Hua, J., Hua, Y., Huan, C., Huang, C., Huang, C., Huang, C., Huang, C., Huang, H., 
Huang, K., Huang, M.L.H., Huang, R., Huang, S., Huang, T., Huang, X., Huang, Y.J., 
Huber, T.B., Hubert, V., Hubner, C.A., Hughes, S.M., Hughes, W.E., Humbert, M., 
Hummer, G., Hurley, J.H., Hussain, S., Hussain, S., Hussey, P.J., Hutabarat, M., 
Hwang, H.Y., Hwang, S., Ieni, A., Ikeda, F., Imagawa, Y., Imai, Y., Imbriano, C., 
Imoto, M., Inman, D.M., Inoki, K., Iovanna, J., Iozzo, R.V., Ippolito, G., Irazoqui, J.E., 
Iribarren, P., Ishaq, M., Ishikawa, M., Ishimwe, N., Isidoro, C., Ismail, N., Issazadeh- 
Navikas, S., Itakura, E., Ito, D., Ivankovic, D., Ivanova, S., Iyer, A.K.V., Izquierdo, J. 
M., Izumi, M., Jaattela, M., Jabir, M.S., Jackson, W.T., Jacobo-Herrera, N., 
Jacomin, A.C., Jacquin, E., Jadiya, P., Jaeschke, H., Jagannath, C., Jakobi, A.J., 
Jakobsson, J., Janji, B., Jansen-Durr, P., Jansson, P.J., Jantsch, J., Januszewski, S., 
Jassey, A., Jean, S., Jeltsch-David, H., Jendelova, P., Jenny, A., Jensen, T.E., 
Jessen, N., Jewell, J.L., Ji, J., Jia, L., Jia, R., Jiang, L., Jiang, Q., Jiang, R., Jiang, T., 
Jiang, X., Jiang, Y., Jimenez-Sanchez, M., Jin, E.J., Jin, F., Jin, H., Jin, L., Jin, L., 
Jin, M., Jin, S., Jo, E.K., Joffre, C., Johansen, T., Johnson, G.V.W., Johnston, S.A., 
Jokitalo, E., Jolly, M.K., Joosten, L.A.B., Jordan, J., Joseph, B., Ju, D., Ju, J.S., Ju, J., 
Juarez, E., Judith, D., Juhasz, G., Jun, Y., Jung, C.H., Jung, S.C., Jung, Y.K., 
Jungbluth, H., Jungverdorben, J., Just, S., Kaarniranta, K., Kaasik, A., Kabuta, T., 
Kaganovich, D., Kahana, A., Kain, R., Kajimura, S., Kalamvoki, M., Kalia, M., 
Kalinowski, D.S., Kaludercic, N., Kalvari, I., Kaminska, J., Kaminskyy, V.O., 
Kanamori, H., Kanasaki, K., Kang, C., Kang, R., Kang, S.S., Kaniyappan, S., Kanki, T., 
Kanneganti, T.D., Kanthasamy, A.G., Kanthasamy, A., Kantorow, M., Kapuy, O., 
Karamouzis, M.V., Karim, M.R., Karmakar, P., Katare, R.G., Kato, M., Kaufmann, S. 
H.E., Kauppinen, A., Kaushal, G.P., Kaushik, S., Kawasaki, K., Kazan, K., Ke, P.Y., 
Keating, D.J., Keber, U., Kehrl, J.H., Keller, K.E., Keller, C.W., Kemper, J.K., 
Kenific, C.M., Kepp, O., Kermorgant, S., Kern, A., Ketteler, R., Keulers, T.G., 
Khalfin, B., Khalil, H., Khambu, B., Khan, S.Y., Khandelwal, V.K.M., Khandia, R., 
Kho, W., Khobrekar, N.V., Khuansuwan, S., Khundadze, M., Killackey, S.A., Kim, D., 
Kim, D.R., Kim, D.H., Kim, D.E., Kim, E.Y., Kim, E.K., Kim, H.R., Kim, H.S., Hyung- 
Ryong, K., Kim, J.H., Kim, J.K., Kim, J.H., Kim, J., Kim, J.H., Kim, K.I., Kim, P.K., J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
23Kim, S.J., Kimball, S.R., Kimchi, A., Kimmelman, A.C., Kimura, T., King, M.A., 
Kinghorn, K.J., Kinsey, C.G., Kirkin, V., Kirshenbaum, L.A., Kiselev, S.L., Kishi, S., 
Kitamoto, K., Kitaoka, Y., Kitazato, K., Kitsis, R.N., Kittler, J.T., Kjaerulff, O., 
Klein, P.S., Klopstock, T., Klucken, J., Knaevelsrud, H., Knorr, R.L., Ko, B.C.B., Ko, F., 
Ko, J.L., Kobayashi, H., Kobayashi, S., Koch, I., Koch, J.C., Koenig, U., Kogel, D., 
Koh, Y.H., Koike, M., Kohlwein, S.D., Kocaturk, N.M., Komatsu, M., Konig, J., 
Kono, T., Kopp, B.T., Korcsmaros, T., Korkmaz, G., Korolchuk, V.I., Korsnes, M.S., 
Koskela, A., Kota, J., Kotake, Y., Kotler, M.L., Kou, Y., Koukourakis, M.I., Koustas, E., 
Kovacs, A.L., Kovacs, T., Koya, D., Kozako, T., Kraft, C., Krainc, D., Kramer, H., 
Krasnodembskaya, A.D., Kretz-Remy, C., Kroemer, G., Ktistakis, N.T., Kuchitsu, K., 
Kuenen, S., Kuerschner, L., Kukar, T., Kumar, A., Kumar, A., Kumar, D., Kumar, D., 
Kumar, S., Kume, S., Kumsta, C., Kundu, C.N., Kundu, M., Kunnumakkara, A.B., 
Kurgan, L., Kutateladze, T.G., Kutlu, O., Kwak, S., Kwon, H.J., Kwon, T.K., Kwon, Y. 
T., Kyrmizi, I., La Spada, A., Labonte, P., Ladoire, S., Laface, I., Lafont, F., Lagace, D. 
C., Lahiri, V., Lai, Z., Laird, A.S., Lakkaraju, A., Lamark, T., Lan, S.H., Landajuela, A., 
Lane, D.J.R., Lane, J.D., Lang, C.H., Lange, C., Langel, U., Langer, R., Lapaquette, P., 
Laporte, J., LaRusso, N.F., Lastres-Becker, I., Lau, W.C.Y., Laurie, G.W., 
Lavandero, S., Law, B.Y.K., Law, H.K., Layfield, R., Le, W., Le Stunff, H., Leary, A.Y., 
Lebrun, J.J., Leck, L.Y.W., Leduc-Gaudet, J.P., Lee, C., Lee, C.P., Lee, D.H., Lee, E.B., 
Lee, E.F., Lee, G.M., Lee, H.J., Lee, H.K., Lee, J.M., Lee, J.S., Lee, J.A., Lee, J.Y., 
Lee, J.H., Lee, M., Lee, M.G., Lee, M.J., Lee, M.S., Lee, S.Y., Lee, S.J., Lee, S.Y., Lee, S. 
B., Lee, W.H., Lee, Y.R., Lee, Y.H., Lee, Y., Lefebvre, C., Legouis, R., Lei, Y.L., Lei, Y., 
Leikin, S., Leitinger, G., Lemus, L., Leng, S., Lenoir, O., Lenz, G., Lenz, H.J., Lenzi, P., 
Leon, Y., Leopoldino, A.M., Leschczyk, C., Leskela, S., Letellier, E., Leung, C.T., 
Leung, P.S., Leventhal, J.S., Levine, B., Lewis, P.A., Ley, K., Li, B., Li, D.Q., Li, J., 
Li, J., Li, J., Li, K., Li, L., Li, M., Li, M., Li, M., Li, M., Li, M., Li, P.L., Li, M.Q., Li, Q., 
Li, S., Li, T., Li, W., Li, W., Li, X., Li, Y.P., Li, Y., Li, Z., Li, Z., Li, Z., Lian, J., Liang, C., 
Liang, Q., Liang, W., Liang, Y., Liang, Y., Liao, G., Liao, L., Liao, M., Liao, Y.F., 
Librizzi, M., Lie, P.P.Y., Lilly, M.A., Lim, H.J., Lima, T.R.R., Limana, F., Lin, C., 
Lin, C.W., Lin, D.S., Lin, F.C., Lin, J.D., Lin, K.M., Lin, K.H., Lin, L.T., Lin, P.H., 
Lin, Q., Lin, S., Lin, S.J., Lin, W., Lin, X., Lin, Y.X., Lin, Y.S., Linden, R., Lindner, P., 
Ling, S.C., Lingor, P., Linnemann, A.K., Liou, Y.C., Lipinski, M.M., Lipovsek, S., 
Lira, V.A., Lisiak, N., Liton, P.B., Liu, C., Liu, C.H., Liu, C.F., Liu, C.H., Liu, F., Liu, H., 
Liu, H.S., Liu, H.F., Liu, H., Liu, J., Liu, J., Liu, J., Liu, L., Liu, L., Liu, M., Liu, Q., 
Liu, W., Liu, W., Liu, X.H., Liu, X., Liu, X., Liu, X., Liu, X., Liu, Y., Liu, Y., Liu, Y., 
Liu, Y., Liu, Y., Livingston, J.A., Lizard, G., Lizcano, J.M., Ljubojevic-Holzer, S., 
Me, L.L., Llobet-Navas, D., Llorente, A., Lo, C.H., Lobato-Marquez, D., Long, Q., 
Long, Y.C., Loos, B., Loos, J.A., Lopez, M.G., Lopez-Domenech, G., Lopez-Guerrero, J. 
A., Lopez-Jimenez, A.T., Lopez-Perez, O., Lopez-Valero, I., Lorenowicz, M.J., 
Lorente, M., Lorincz, P., Lossi, L., Lotersztajn, S., Lovat, P.E., Lovell, J.F., Lovy, A., 
Low, P., Lu, G., Lu, H., Lu, J.H., Lu, J.J., Lu, M., Lu, S., Luciani, A., Lucocq, J.M., 
Ludovico, P., Luftig, M.A., Luhr, M., Luis-Ravelo, D., Lum, J.J., Luna-Dulcey, L., 
Lund, A.H., Lund, V.K., Lunemann, J.D., Luningschror, P., Luo, H., Luo, R., Luo, S., 
Luo, Z., Luparello, C., Luscher, B., Luu, L., Lyakhovich, A., Lyamzaev, K.G., 
Lystad, A.H., Lytvynchuk, L., Ma, A.C., Ma, C., Ma, M., Ma, N.F., Ma, Q.H., Ma, X., 
Ma, Y., Ma, Z., MacDougald, O.A., Macian, F., MacIntosh, G.C., MacKeigan, J.P., 
Macleod, K.F., Maday, S., Madeo, F., Madesh, M., Madl, T., Madrigal-Matute, J., 
Maeda, A., Maejima, Y., Magarinos, M., Mahavadi, P., Maiani, E., Maiese, K., 
Maiti, P., Maiuri, M.C., Majello, B., Major, M.B., Makareeva, E., Malik, F., 
Mallilankaraman, K., Malorni, W., Maloyan, A., Mammadova, N., Man, G.C.W., 
Manai, F., Mancias, J.D., Mandelkow, E.M., Mandell, M.A., Manfredi, A.A., 
Manjili, M.H., Manjithaya, R., Manque, P., Manshian, B.B., Manzano, R., 
Manzoni, C., Mao, K., Marchese, C., Marchetti, S., Marconi, A.M., Marcucci, F., 
Mardente, S., Mareninova, O.A., Margeta, M., Mari, M., Marinelli, S., Marinelli, O., 
Marino, G., Mariotto, S., Marshall, R.S., Marten, M.R., Martens, S., Martin, A.P.J., 
Martin, K.R., Martin, S., Martin, S., Martin-Segura, A., Martin-Acebes, M.A., Martin- 
Burriel, I., Martin-Rincon, M., Martin-Sanz, P., Martina, J.A., Martinet, W., 
Martinez, A., Martinez, A., Martinez, J., Martinez Velazquez, M., Martinez-Lopez, N., 
Martinez-Vicente, M., Martins, D.O., Martins, J.O., Martins, W.K., Martins- 
Marques, T., Marzetti, E., Masaldan, S., Masclaux-Daubresse, C., Mashek, D.G., 
Massa, V., Massieu, L., Masson, G.R., Masuelli, L., Masyuk, A.I., Masyuk, T.V., 
Matarrese, P., Matheu, A., Matoba, S., Matsuzaki, S., Mattar, P., Matte, A., 
Mattoscio, D., Mauriz, J.L., Mauthe, M., Mauvezin, C., Maverakis, E., Maycotte, P., 
Mayer, J., Mazzoccoli, G., Mazzoni, C., Mazzulli, J.R., McCarty, N., McDonald, C., 
McGill, M.R., McKenna, S.L., McLaughlin, B., McLoughlin, F., McNiven, M.A., 
McWilliams, T.G., Mechta-Grigoriou, F., Medeiros, T.C., Medina, D.L., Megeney, L. 
A., Megyeri, K., Mehrpour, M., Mehta, J.L., Meijer, A.J., Meijer, A.H., Mejlvang, J., 
Melendez, A., Melk, A., Memisoglu, G., Mendes, A.F., Meng, D., Meng, F., Meng, T., 
Menna-Barreto, R., Menon, M.B., Mercer, C., Mercier, A.E., Mergny, J.L., Merighi, A., 
Merkley, S.D., Merla, G., Meske, V., Mestre, A.C., Metur, S.P., Meyer, C., Meyer, H., 
Mi, W., Mialet-Perez, J., Miao, J., Micale, L., Miki, Y., Milan, E., Milczarek, M., 
Miller, D.L., Miller, S.I., Miller, S., Millward, S.W., Milosevic, I., Minina, E.A., 
Mirzaei, H., Mirzaei, H.R., Mirzaei, M., Mishra, A., Mishra, N., Mishra, P.K., Misirkic 
Marjanovic, M., Misasi, R., Misra, A., Misso, G., Mitchell, C., Mitou, G., Miura, T., 
Miyamoto, S., Miyazaki, M., Miyazaki, M., Miyazaki, T., Miyazawa, K., 
Mizushima, N., Mogensen, T.H., Mograbi, B., Mohammadinejad, R., Mohamud, Y., 
Mohanty, A., Mohapatra, S., Mohlmann, T., Mohmmed, A., Moles, A., Moley, K.H., 
Molinari, M., Mollace, V., Moller, A.B., Mollereau, B., Mollinedo, F., Montagna, C., 
Monteiro, M.J., Montella, A., Montes, L.R., Montico, B., Mony, V.K., Monzio 
Compagnoni, G., Moore, M.N., Moosavi, M.A., Mora, A.L., Mora, M., Morales- 
Alamo, D., Moratalla, R., Moreira, P.I., Morelli, E., Moreno, S., Moreno-Blas, D., 
Moresi, V., Morga, B., Morgan, A.H., Morin, F., Morishita, H., Moritz, O.L., 
Moriyama, M., Moriyasu, Y., Morleo, M., Morselli, E., Moruno-Manchon, J.F., 
Moscat, J., Mostowy, S., Motori, E., Moura, A.F., Moustaid-Moussa, N., 
Mrakovcic, M., Mucino-Hernandez, G., Mukherjee, A., Mukhopadhyay, S., Mulcahy 
Levy, J.M., Mulero, V., Muller, S., Munch, C., Munjal, A., Munoz-Canoves, P., Munoz-Galdeano, T., Munz, C., Murakawa, T., Muratori, C., Murphy, B.M., 
Murphy, J.P., Murthy, A., Myohanen, T.T., Mysorekar, I.U., Mytych, J., Nabavi, S.M., 
Nabissi, M., Nagy, P., Nah, J., Nahimana, A., Nakagawa, I., Nakamura, K., 
Nakatogawa, H., Nandi, S.S., Nanjundan, M., Nanni, M., Napolitano, G., 
Nardacci, R., Narita, M., Nassif, M., Nathan, I., Natsumeda, M., Naude, R.J., 
Naumann, C., Naveiras, O., Navid, F., Nawrocki, S.T., Nazarko, T.Y., Nazio, F., 
Negoita, F., Neill, T., Neisch, A.L., Neri, L.M., Netea, M.G., Neubert, P., Neufeld, T.P., 
Neumann, D., Neutzner, A., Newton, P.T., Ney, P.A., Nezis, I.P., Ng, C.C.W., Ng, T.B., 
Nguyen, H.T.T., Nguyen, L.T., Ni, H.M., Ni Cheallaigh, C., Ni, Z., Nicolao, M.C., 
Nicoli, F., Nieto-Diaz, M., Nilsson, P., Ning, S., Niranjan, R., Nishimune, H., Niso- 
Santano, M., Nixon, R.A., Nobili, A., Nobrega, C., Noda, T., Nogueira-Recalde, U., 
Nolan, T.M., Nombela, I., Novak, I., Novoa, B., Nozawa, T., Nukina, N., Nussbaum- 
Krammer, C., Nylandsted, J., O’Donovan, T.R., O’Leary, S.M., O’Rourke, E.J., 
O’Sullivan, M.P., O’Sullivan, T.E., Oddo, S., Oehme, I., Ogawa, M., Ogier-Denis, E., 
Ogmundsdottir, M.H., Ogretmen, B., Oh, G.T., Oh, S.H., Oh, Y.J., Ohama, T., 
Ohashi, Y., Ohmuraya, M., Oikonomou, V., Ojha, R., Okamoto, K., Okazawa, H., 
Oku, M., Olivan, S., Oliveira, J.M.A., Ollmann, M., Olzmann, J.A., Omari, S., 
Omary, M.B., Onal, G., Ondrej, M., Ong, S.B., Ong, S.G., Onnis, A., Orellana, J.A., 
Orellana-Munoz, S., Ortega-Villaizan, M.D.M., Ortiz-Gonzalez, X.R., Ortona, E., 
Osiewacz, H.D., Osman, A.K., Osta, R., Otegui, M.S., Otsu, K., Ott, C., Ottobrini, L., 
Ou, J.J., Outeiro, T.F., Oynebraten, I., Ozturk, M., Pages, G., Pahari, S., Pajares, M., 
Pajvani, U.B., Pal, R., Paladino, S., Pallet, N., Palmieri, M., Palmisano, G., 
Palumbo, C., Pampaloni, F., Pan, L., Pan, Q., Pan, W., Pan, X., Panasyuk, G., 
Pandey, R., Pandey, U.B., Pandya, V., Paneni, F., Pang, S.Y., Panzarini, E., 
Papademetrio, D.L., Papaleo, E., Papinski, D., Papp, D., Park, E.C., Park, H.T., 
Park, J.M., Park, J.I., Park, J.T., Park, J., Park, S.C., Park, S.Y., Parola, A.H., Parys, J. 
B., Pasquier, A., Pasquier, B., Passos, J.F., Pastore, N., Patel, H.H., Patschan, D., 
Pattingre, S., Pedraza-Alva, G., Pedraza-Chaverri, J., Pedrozo, Z., Pei, G., Pei, J., 
Peled-Zehavi, H., Pellegrini, J.M., Pelletier, J., Penalva, M.A., Peng, D., Peng, Y., 
Penna, F., Pennuto, M., Pentimalli, F., Pereira, C.M., Pereira, G.J.S., Pereira, L.C., 
Pereira de Almeida, L., Perera, N.D., Perez-Lara, A., Perez-Oliva, A.B., Perez- 
Perez, M.E., Periyasamy, P., Perl, A., Perrotta, C., Perrotta, I., Pestell, R.G., 
Petersen, M., Petrache, I., Petrovski, G., Pfirrmann, T., Pfister, A.S., Philips, J.A., 
Pi, H., Picca, A., Pickrell, A.M., Picot, S., Pierantoni, G.M., Pierdominici, M., 
Pierre, P., Pierrefite-Carle, V., Pierzynowska, K., Pietrocola, F., Pietruczuk, M., 
Pignata, C., Pimentel-Muinos, F.X., Pinar, M., Pinheiro, R.O., Pinkas-Kramarski, R., 
Pinton, P., Pircs, K., Piya, S., Pizzo, P., Plantinga, T.S., Platta, H.W., Plaza-Zabala, A., 
Plomann, M., Plotnikov, E.Y., Plun-Favreau, H., Pluta, R., Pocock, R., Poggeler, S., 
Pohl, C., Poirot, M., Poletti, A., Ponpuak, M., Popelka, H., Popova, B., Porta, H., 
Porte Alcon, S., Portilla-Fernandez, E., Post, M., Potts, M.B., Poulton, J., Powers, T., 
Prahlad, V., Prajsnar, T.K., Pratico, D., Prencipe, R., Priault, M., Proikas-Cezanne, T., 
Promponas, V.J., Proud, C.G., Puertollano, R., Puglielli, L., Pulinilkunnil, T., Puri, D., 
Puri, R., Puyal, J., Qi, X., Qi, Y., Qian, W., Qiang, L., Qiu, Y., Quadrilatero, J., 
Quarleri, J., Raben, N., Rabinowich, H., Ragona, D., Ragusa, M.J., Rahimi, N., 
Rahmati, M., Raia, V., Raimundo, N., Rajasekaran, N.S., Ramachandra Rao, S., 
Rami, A., Ramirez-Pardo, I., Ramsden, D.B., Randow, F., Rangarajan, P.N., 
Ranieri, D., Rao, H., Rao, L., Rao, R., Rathore, S., Ratnayaka, J.A., Ratovitski, E.A., 
Ravanan, P., Ravegnini, G., Ray, S.K., Razani, B., Rebecca, V., Reggiori, F., Regnier- 
Vigouroux, A., Reichert, A.S., Reigada, D., Reiling, J.H., Rein, T., Reipert, S., 
Rekha, R.S., Ren, H., Ren, J., Ren, W., Renault, T., Renga, G., Reue, K., Rewitz, K., 
Ribeiro de Andrade Ramos, B., Riazuddin, S.A., Ribeiro-Rodrigues, T.M., Ricci, J.E., 
Ricci, R., Riccio, V., Richardson, D.R., Rikihisa, Y., Risbud, M.V., Risueno, R.M., 
Ritis, K., Rizza, S., Rizzuto, R., Roberts, H.C., Roberts, L.D., Robinson, K.J., 
Roccheri, M.C., Rocchi, S., Rodney, G.G., Rodrigues, T., Rodrigues Silva, V.R., 
Rodriguez, A., Rodriguez-Barrueco, R., Rodriguez-Henche, N., Rodriguez-Rocha, H., 
Roelofs, J., Rogers, R.S., Rogov, V.V., Rojo, A.I., Rolka, K., Romanello, V., 
Romani, L., Romano, A., Romano, P.S., Romeo-Guitart, D., Romero, L.C., 
Romero, M., Roney, J.C., Rongo, C., Roperto, S., Rosenfeldt, M.T., Rosenstiel, P., 
Rosenwald, A.G., Roth, K.A., Roth, L., Roth, S., Rouschop, K.M.A., Roussel, B.D., 
Roux, S., Rovere-Querini, P., Roy, A., Rozieres, A., Ruano, D., Rubinsztein, D.C., 
Rubtsova, M.P., Ruckdeschel, K., Ruckenstuhl, C., Rudolf, E., Rudolf, R., 
Ruggieri, A., Ruparelia, A.A., Rusmini, P., Russell, R.R., Russo, G.L., Russo, M., 
Russo, R., Ryabaya, O.O., Ryan, K.M., Ryu, K.Y., Sabater-Arcis, M., Sachdev, U., 
Sacher, M., Sachse, C., Sadhu, A., Sadoshima, J., Safren, N., Saftig, P., Sagona, A.P., 
Sahay, G., Sahebkar, A., Sahin, M., Sahin, O., Sahni, S., Saito, N., Saito, S., Saito, T., 
Sakai, R., Sakai, Y., Sakamaki, J.I., Saksela, K., Salazar, G., Salazar-Degracia, A., 
Salekdeh, G.H., Saluja, A.K., Sampaio-Marques, B., Sanchez, M.C., Sanchez- 
Alcazar, J.A., Sanchez-Vera, V., Sancho-Shimizu, V., Sanderson, J.T., Sandri, M., 
Santaguida, S., Santambrogio, L., Santana, M.M., Santoni, G., Sanz, A., Sanz, P., 
Saran, S., Sardiello, M., Sargeant, T.J., Sarin, A., Sarkar, C., Sarkar, S., Sarrias, M.R., 
Sarkar, S., Sarmah, D.T., Sarparanta, J., Sathyanarayan, A., Sathyanarayanan, R., 
Scaglione, K.M., Scatozza, F., Schaefer, L., Schafer, Z.T., Schaible, U.E., Schapira, A. 
H.V., Scharl, M., Schatzl, H.M., Schein, C.H., Scheper, W., Scheuring, D., 
Schiaffino, M.V., Schiappacassi, M., Schindl, R., Schlattner, U., Schmidt, O., 
Schmitt, R., Schmidt, S.D., Schmitz, I., Schmukler, E., Schneider, A., Schneider, B.E., 
Schober, R., Schoijet, A.C., Schott, M.B., Schramm, M., Schroder, B., Schuh, K., 
Schuller, C., Schulze, R.J., Schurmanns, L., Schwamborn, J.C., Schwarten, M., 
Scialo, F., Sciarretta, S., Scott, M.J., Scotto, K.W., Scovassi, A.I., Scrima, A., 
Scrivo, A., Sebastian, D., Sebti, S., Sedej, S., Segatori, L., Segev, N., Seglen, P.O., 
Seiliez, I., Seki, E., Selleck, S.B., Sellke, F.W., Selsby, J.T., Sendtner, M., Senturk, S., 
Seranova, E., Sergi, C., Serra-Moreno, R., Sesaki, H., Settembre, C., Setty, S.R.G., 
Sgarbi, G., Sha, O., Shacka, J.J., Shah, J.A., Shang, D., Shao, C., Shao, F., Sharbati, S., 
Sharkey, L.M., Sharma, D., Sharma, G., Sharma, K., Sharma, P., Sharma, S., Shen, H. 
M., Shen, H., Shen, J., Shen, M., Shen, W., Shen, Z., Sheng, R., Sheng, Z., Sheng, Z.H., 
Shi, J., Shi, X., Shi, Y.H., Shiba-Fukushima, K., Shieh, J.J., Shimada, Y., Shimizu, S., 
Shimozawa, M., Shintani, T., Shoemaker, C.J., Shojaei, S., Shoji, I., Shravage, B.V., J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
24Shridhar, V., Shu, C.W., Shu, H.B., Shui, K., Shukla, A.K., Shutt, T.E., Sica, V., 
Siddiqui, A., Sierra, A., Sierra-Torre, V., Signorelli, S., Sil, P., Silva, B.J.A., Silva, J.D., 
Silva-Pavez, E., Silvente-Poirot, S., Simmonds, R.E., Simon, A.K., Simon, H.U., 
Simons, M., Singh, A., Singh, L.P., Singh, R., Singh, S.V., Singh, S.K., Singh, S.B., 
Singh, S., Singh, S.P., Sinha, D., Sinha, R.A., Sinha, S., Sirko, A., Sirohi, K., 
Sivridis, E.L., Skendros, P., Skirycz, A., Slaninova, I., Smaili, S.S., Smertenko, A., 
Smith, M.D., Soenen, S.J., Sohn, E.J., Sok, S.P.M., Solaini, G., Soldati, T., 
Soleimanpour, S.A., Soler, R.M., Solovchenko, A., Somarelli, J.A., Sonawane, A., 
Song, F., Song, H.K., Song, J.X., Song, K., Song, Z., Soria, L.R., Sorice, M., Soukas, A. 
A., Soukup, S.F., Sousa, D., Sousa, N., Spagnuolo, P.A., Spector, S.A., Srinivas 
Bharath, M.M., St Clair, D., Stagni, V., Staiano, L., Stalnecker, C.A., Stankov, M.V., 
Stathopulos, P.B., Stefan, K., Stefan, S.M., Stefanis, L., Steffan, J.S., Steinkasserer, A., 
Stenmark, H., Sterneckert, J., Stevens, C., Stoka, V., Storch, S., Stork, B., 
Strappazzon, F., Strohecker, A.M., Stupack, D.G., Su, H., Su, L.Y., Su, L., Suarez- 
Fontes, A.M., Subauste, C.S., Subbian, S., Subirada, P.V., Sudhandiran, G., Sue, C.M., 
Sui, X., Summers, C., Sun, G., Sun, J., Sun, K., Sun, M.X., Sun, Q., Sun, Y., Sun, Z., 
Sunahara, K.K.S., Sundberg, E., Susztak, K., Sutovsky, P., Suzuki, H., Sweeney, G., 
Symons, J.D., Sze, S.C.W., Szewczyk, N.J., Tabecka-Lonczynska, A., Tabolacci, C., 
Tacke, F., Taegtmeyer, H., Tafani, M., Tagaya, M., Tai, H., Tait, S.W.G., 
Takahashi, Y., Takats, S., Talwar, P., Tam, C., Tam, S.Y., Tampellini, D., Tamura, A., 
Tan, C.T., Tan, E.K., Tan, Y.Q., Tanaka, M., Tanaka, M., Tang, D., Tang, J., Tang, T. 
S., Tanida, I., Tao, Z., Taouis, M., Tatenhorst, L., Tavernarakis, N., Taylor, A., 
Taylor, G.A., Taylor, J.M., Tchetina, E., Tee, A.R., Tegeder, I., Teis, D., Teixeira, N., 
Teixeira-Clerc, F., Tekirdag, K.A., Tencomnao, T., Tenreiro, S., Tepikin, A.V., 
Testillano, P.S., Tettamanti, G., Tharaux, P.L., Thedieck, K., Thekkinghat, A.A., 
Thellung, S., Thinwa, J.W., Thirumalaikumar, V.P., Thomas, S.M., Thomes, P.G., 
Thorburn, A., Thukral, L., Thum, T., Thumm, M., Tian, L., Tichy, A., Till, A., 
Timmerman, V., Titorenko, V.I., Todi, S.V., Todorova, K., Toivonen, J.M., 
Tomaipitinca, L., Tomar, D., Tomas-Zapico, C., Tomic, S., Tong, B.C., Tong, C., 
Tong, X., Tooze, S.A., Torgersen, M.L., Torii, S., Torres-Lopez, L., Torriglia, A., 
Towers, C.G., Towns, R., Toyokuni, S., Trajkovic, V., Tramontano, D., Tran, Q.G., 
Travassos, L.H., Trelford, C.B., Tremel, S., Trougakos, I.P., Tsao, B.P., Tschan, M.P., 
Tse, H.F., Tse, T.F., Tsugawa, H., Tsvetkov, A.S., Tumbarello, D.A., Tumtas, Y., 
Tunon, M.J., Turcotte, S., Turk, B., Turk, V., Turner, B.J., Tuxworth, R.I., Tyler, J.K., 
Tyutereva, E.V., Uchiyama, Y., Ugun-Klusek, A., Uhlig, H.H., Ulamek-Koziol, M., 
Ulasov, I.V., Umekawa, M., Ungermann, C., Unno, R., Urbe, S., Uribe-Carretero, E., 
Ustun, S., Uversky, V.N., Vaccari, T., Vaccaro, M.I., Vahsen, B.F., Vakifahmetoglu- 
Norberg, H., Valdor, R., Valente, M.J., Valko, A., Vallee, R.B., Valverde, A.M., Van 
den Berghe, G., van der Veen, S., Van Kaer, L., van Loosdregt, J., van Wijk, S.J.L., 
Vandenberghe, W., Vanhorebeek, I., Vannier-Santos, M.A., Vannini, N., Vanrell, M. 
C., Vantaggiato, C., Varano, G., Varela-Nieto, I., Varga, M., Vasconcelos, M.H., 
Vats, S., Vavvas, D.G., Vega-Naredo, I., Vega-Rubin-de-Celis, S., Velasco, G., 
Velazquez, A.P., Vellai, T., Vellenga, E., Velotti, F., Verdier, M., Verginis, P., 
Vergne, I., Verkade, P., Verma, M., Verstreken, P., Vervliet, T., Vervoorts, J., 
Vessoni, A.T., Victor, V.M., Vidal, M., Vidoni, C., Vieira, O.V., Vierstra, R.D., 
Vigano, S., Vihinen, H., Vijayan, V., Vila, M., Vilar, M., Villalba, J.M., Villalobo, A., 
Villarejo-Zori, B., Villarroya, F., Villarroya, J., Vincent, O., Vindis, C., Viret, C., 
Viscomi, M.T., Visnjic, D., Vitale, I., Vocadlo, D.J., Voitsekhovskaja, O.V., 
Volonte, C., Volta, M., Vomero, M., Von Haefen, C., Vooijs, M.A., Voos, W., 
Vucicevic, L., Wade-Martins, R., Waguri, S., Waite, K.A., Wakatsuki, S., Walker, D. 
W., Walker, M.J., Walker, S.A., Walter, J., Wandosell, F.G., Wang, B., Wang, C.Y., 
Wang, C., Wang, C., Wang, C., Wang, C.Y., Wang, D., Wang, F., Wang, F., Wang, F., 
Wang, G., Wang, H., Wang, H., Wang, H., Wang, H.G., Wang, J., Wang, J., Wang, J., 
Wang, J., Wang, K., Wang, L., Wang, L., Wang, M.H., Wang, M., Wang, N., Wang, P., 
Wang, P., Wang, P., Wang, P., Wang, Q.J., Wang, Q., Wang, Q.K., Wang, Q.A., 
Wang, W.T., Wang, W., Wang, X., Wang, X., Wang, Y., Wang, Y., Wang, Y., Wang, Y. 
Y., Wang, Y., Wang, Y., Wang, Y., Wang, Y., Wang, Z., Wang, Z., Wang, Z., 
Warnes, G., Warnsmann, V., Watada, H., Watanabe, E., Watchon, M., 
Wawrzynska, A., Weaver, T.E., Wegrzyn, G., Wehman, A.M., Wei, H., Wei, L., 
Wei, T., Wei, Y., Weiergraber, O.H., Weihl, C.C., Weindl, G., Weiskirchen, R., 
Wells, A., Wen, R.H., Wen, X., Werner, A., Weykopf, B., Wheatley, S.P., Whitton, J.L., 
Whitworth, A.J., Wiktorska, K., Wildenberg, M.E., Wileman, T., Wilkinson, S., 
Willbold, D., Williams, B., Williams, R.S.B., Williams, R.L., Williamson, P.R., 
Wilson, R.A., Winner, B., Winsor, N.J., Witkin, S.S., Wodrich, H., Woehlbier, U., 
Wollert, T., Wong, E., Wong, J.H., Wong, R.W., Wong, V.K.W., Wong, W.W., Wu, A. 
G., Wu, C., Wu, J., Wu, J., Wu, K.K., Wu, M., Wu, S.Y., Wu, S., Wu, S.Y., Wu, S., 
Wu, W.K.K., Wu, X., Wu, X., Wu, Y.W., Wu, Y., Xavier, R.J., Xia, H., Xia, L., Xia, Z., 
Xiang, G., Xiang, J., Xiang, M., Xiang, W., Xiao, B., Xiao, G., Xiao, H., Xiao, H.T., 
Xiao, J., Xiao, L., Xiao, S., Xiao, Y., Xie, B., Xie, C.M., Xie, M., Xie, Y., Xie, Z., Xie, Z., 
Xilouri, M., Xu, C., Xu, E., Xu, H., Xu, J., Xu, J., Xu, L., Xu, W.W., Xu, X., Xue, Y., 
Yakhine-Diop, S.M.S., Yamaguchi, M., Yamaguchi, O., Yamamoto, A., Yamashina, S., 
Yan, S., Yan, S.J., Yan, Z., Yanagi, Y., Yang, C., Yang, D.S., Yang, H., Yang, H.T., 
Yang, H., Yang, J.M., Yang, J., Yang, J., Yang, L., Yang, L., Yang, M., Yang, P.M., 
Yang, Q., Yang, S., Yang, S., Yang, S.F., Yang, W., Yang, W.Y., Yang, X., Yang, X., 
Yang, Y., Yang, Y., Yao, H., Yao, S., Yao, X., Yao, Y.G., Yao, Y.M., Yasui, T., 
Yazdankhah, M., Yen, P.M., Yi, C., Yin, X.M., Yin, Y., Yin, Z., Yin, Z., Ying, M., 
Ying, Z., Yip, C.K., Yiu, S.P.T., Yoo, Y.H., Yoshida, K., Yoshii, S.R., Yoshimori, T., 
Yousefi, B., Yu, B., Yu, H., Yu, J., Yu, J., Yu, L., Yu, M.L., Yu, S.W., Yu, V.C., Yu, W. 
H., Yu, Z., Yu, Z., Yuan, J., Yuan, L.Q., Yuan, S., Yuan, S.F., Yuan, Y., Yuan, Z., 
Yue, J., Yue, Z., Yun, J., Yung, R.L., Zacks, D.N., Zaffagnini, G., Zambelli, V.O., 
Zanella, I., Zang, Q.S., Zanivan, S., Zappavigna, S., Zaragoza, P., Zarbalis, K.S., 
Zarebkohan, A., Zarrouk, A., Zeitlin, S.O., Zeng, J., Zeng, J.D., Zerovnik, E., Zhan, L., 
Zhang, B., Zhang, D.D., Zhang, H., Zhang, H., Zhang, H., Zhang, H., Zhang, H., 
Zhang, H., Zhang, H., Zhang, H.L., Zhang, J., Zhang, J., Zhang, J.P., Zhang, K.Y.B., 
Zhang, L.W., Zhang, L., Zhang, L., Zhang, L., Zhang, L., Zhang, M., Zhang, P., 
Zhang, S., Zhang, W., Zhang, X., Zhang, X.W., Zhang, X., Zhang, X., Zhang, X., Zhang, X., Zhang, X.D., Zhang, Y., Zhang, Y., Zhang, Y., Zhang, Y.D., Zhang, Y., 
Zhang, Y.Y., Zhang, Y., Zhang, Z., Zhang, Z., Zhang, Z., Zhang, Z., Zhang, Z., 
Zhang, Z., Zhao, H., Zhao, L., Zhao, S., Zhao, T., Zhao, X.F., Zhao, Y., Zhao, Y., 
Zhao, Y., Zhao, Y., Zheng, G., Zheng, K., Zheng, L., Zheng, S., Zheng, X.L., Zheng, Y., 
Zheng, Z.G., Zhivotovsky, B., Zhong, Q., Zhou, A., Zhou, B., Zhou, C., Zhou, G., 
Zhou, H., Zhou, H., Zhou, H., Zhou, J., Zhou, J., Zhou, J., Zhou, J., Zhou, K., 
Zhou, R., Zhou, X.J., Zhou, Y., Zhou, Y., Zhou, Y., Zhou, Z.Y., Zhou, Z., Zhu, B., 
Zhu, C., Zhu, G.Q., Zhu, H., Zhu, H., Zhu, H., Zhu, W.G., Zhu, Y., Zhu, Y., Zhuang, H., 
Zhuang, X., Zientara-Rytter, K., Zimmermann, C.M., Ziviani, E., Zoladek, T., 
Zong, W.X., Zorov, D.B., Zorzano, A., Zou, W., Zou, Z., Zou, Z., Zuryn, S., 
Zwerschke, W., Brand-Saberi, B., Dong, X.C., Kenchappa, C.S., Li, Z., Lin, Y., 
Oshima, S., Rong, Y., Sluimer, J.C., Stallings, C.L., Tong, C.K., 2021a. Guidelines for 
the use and interpretation of assays for monitoring autophagy, 4th edition 
Autophagy 17 (1), 1–382. 
Klionsky, D.J., Abeliovich, H., Agostinis, P., Agrawal, D.K., Aliev, G., Askew, D.S., 
Baba, M., Baehrecke, E.H., Bahr, B.A., Ballabio, A., Bamber, B.A., Bassham, D.C., 
Bergamini, E., Bi, X., Biard-Piechaczyk, M., Blum, J.S., Bredesen, D.E., Brodsky, J.L., 
Brumell, J.H., Brunk, U.T., Bursch, W., Camougrand, N., Cebollero, E., Cecconi, F., 
Chen, Y., Chin, L.S., Choi, A., Chu, C.T., Chung, J., Clarke, P.G., Clark, R.S., Clarke, S. 
G., Clave, C., Cleveland, J.L., Codogno, P., Colombo, M.I., Coto-Montes, A., Cregg, J. 
M., Cuervo, A.M., Debnath, J., Demarchi, F., Dennis, P.B., Dennis, P.A., Deretic, V., 
Devenish, R.J., Di Sano, F., Dice, J.F., Difiglia, M., Dinesh-Kumar, S., Distelhorst, C. 
W., Djavaheri-Mergny, M., Dorsey, F.C., Droge, W., Dron, M., Dunn Jr., W.A., 
Duszenko, M., Eissa, N.T., Elazar, Z., Esclatine, A., Eskelinen, E.L., Fesus, L., 
Finley, K.D., Fuentes, J.M., Fueyo, J., Fujisaki, K., Galliot, B., Gao, F.B., Gewirtz, D. 
A., Gibson, S.B., Gohla, A., Goldberg, A.L., Gonzalez, R., Gonzalez-Estevez, C., 
Gorski, S., Gottlieb, R.A., Haussinger, D., He, Y.W., Heidenreich, K., Hill, J.A., Hoyer- 
Hansen, M., Hu, X., Huang, W.P., Iwasaki, A., Jaattela, M., Jackson, W.T., Jiang, X., 
Jin, S., Johansen, T., Jung, J.U., Kadowaki, M., Kang, C., Kelekar, A., Kessel, D.H., 
Kiel, J.A., Kim, H.P., Kimchi, A., Kinsella, T.J., Kiselyov, K., Kitamoto, K., Knecht, E., 
Komatsu, M., Kominami, E., Kondo, S., Kovacs, A.L., Kroemer, G., Kuan, C.Y., 
Kumar, R., Kundu, M., Landry, J., Laporte, M., Le, W., Lei, H.Y., Lenardo, M.J., 
Levine, B., Lieberman, A., Lim, K.L., Lin, F.C., Liou, W., Liu, L.F., Lopez-Berestein, G., 
Lopez-Otin, C., Lu, B., Macleod, K.F., Malorni, W., Martinet, W., Matsuoka, K., 
Mautner, J., Meijer, A.J., Melendez, A., Michels, P., Miotto, G., Mistiaen, W.P., 
Mizushima, N., Mograbi, B., Monastyrska, I., Moore, M.N., Moreira, P.I., 
Moriyasu, Y., Motyl, T., Munz, C., Murphy, L.O., Naqvi, N.I., Neufeld, T.P., 
Nishino, I., Nixon, R.A., Noda, T., Nurnberg, B., Ogawa, M., Oleinick, N.L., Olsen, L. 
J., Ozpolat, B., Paglin, S., Palmer, G.E., Papassideri, I., Parkes, M., Perlmutter, D.H., 
Perry, G., Piacentini, M., Pinkas-Kramarski, R., Prescott, M., Proikas-Cezanne, T., 
Raben, N., Rami, A., Reggiori, F., Rohrer, B., Rubinsztein, D.C., Ryan, K.M., 
Sadoshima, J., Sakagami, H., Sakai, Y., Sandri, M., Sasakawa, C., Sass, M., 
Schneider, C., Seglen, P.O., Seleverstov, O., Settleman, J., Shacka, J.J., Shapiro, I.M., 
Sibirny, A., Silva-Zacarin, E.C., Simon, H.U., Simone, C., Simonsen, A., Smith, M.A., 
Spanel-Borowski, K., Srinivas, V., Steeves, M., Stenmark, H., Stromhaug, P.E., 
Subauste, C.S., Sugimoto, S., Sulzer, D., Suzuki, T., Swanson, M.S., Tabas, I., 
Takeshita, F., Talbot, N.J., Talloczy, Z., Tanaka, K., Tanaka, K., Tanida, I., Taylor, G. 
S., Taylor, J.P., Terman, A., Tettamanti, G., Thompson, C.B., Thumm, M., 
Tolkovsky, A.M., Tooze, S.A., Truant, R., Tumanovska, L.V., Uchiyama, Y., Ueno, T., 
Uzcategui, N.L., van der Klei, I., Vaquero, E.C., Vellai, T., Vogel, M.W., Wang, H.G., 
Webster, P., Wiley, J.W., Xi, Z., Xiao, G., Yahalom, J., Yang, J.M., Yap, G., Yin, X.M., 
Yoshimori, T., Yu, L., Yue, Z., Yuzaki, M., Zabirnyk, O., Zheng, X., Zhu, X., Deter, R. 
L., 2008. Guidelines for the use and interpretation of assays for monitoring 
autophagy in higher eukaryotes. Autophagy 4, 151–175. 
Klionsky, D.J., Petroni, G., Amaravadi, R.K., Baehrecke, E.H., Ballabio, A., Boya, P., 
Bravo-San Pedro, J.M., Cadwell, K., Cecconi, F., Choi, A.M.K., Choi, M.E., Chu, C.T., 
Codogno, P., Colombo, M.I., Cuervo, A.M., Deretic, V., Dikic, I., Elazar, Z., 
Eskelinen, E.L., Fimia, G.M., Gewirtz, D.A., Green, D.R., Hansen, M., Jaattela, M., 
Johansen, T., Juhasz, G., Karantza, V., Kraft, C., Kroemer, G., Ktistakis, N.T., 
Kumar, S., Lopez-Otin, C., Macleod, K.F., Madeo, F., Martinez, J., Melendez, A., 
Mizushima, N., Munz, C., Penninger, J.M., Perera, R.M., Piacentini, M., Reggiori, F., 
Rubinsztein, D.C., Ryan, K.M., Sadoshima, J., Santambrogio, L., Scorrano, L., 
Simon, H.U., Simon, A.K., Simonsen, A., Stolz, A., Tavernarakis, N., Tooze, S.A., 
Yoshimori, T., Yuan, J., Yue, Z., Zhong, Q., Galluzzi, L., Pietrocola, F., 2021b. 
Autophagy in major human diseases. EMBO J. 40, e108863 . 
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Koike, M., 
Uchiyama, Y., Kominami, E., Tanaka, K., 2006. Loss of autophagy in the central 
nervous system causes neurodegeneration in mice. Nature 441, 880–884. 
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., 
Mizushima, N., Ohsumi, Y., Uchiyama, Y., Kominami, E., Tanaka, K., Chiba, T., 
2005. Impairment of starvation-induced and constitutive autophagy in Atg7- 
deficient mice. J. Cell Biol. 169, 425–434. 
Konig, T., Nolte, H., Aaltonen, M.J., Tatsuta, T., Krols, M., Stroh, T., Langer, T., 
McBride, H.M., 2021. MIROs and DRP1 drive mitochondrial-derived vesicle 
biogenesis and promote quality control. Nat. Cell Biol. 23, 1271 –1286 . 
Kowluru, R.A., Mishra, M., 2018. Therapeutic targets for altering mitochondrial 
dysfunction associated with diabetic retinopathy. Expert Opin. Ther. Targets 22, 
233–245. 
Kowluru, R.A., Mohammad, G., Sahajpal, N., 2020. Faulty homocysteine recycling in 
diabetic retinopathy. Eye Vis (Lond) 7, 4. 
Krause, G.J., Diaz, A., Jafari, M., Khawaja, R.R., Agullo-Pascual, E., Santiago- 
Fern˘andez, O., Richards, A.L., Chen, K.H., Dmitriev, P., Sun, Y., See, S.K., 
Abdelmohsen, K., Mazan-Mamczarz, K., Krogan, N.J., Gorospe, M., Swaney, D.L., 
Sidoli, S., Bravo-Cordero, J.J., Kampmann, M., Cuervo, A.M., 2022. Reduced 
endosomal microautophagy activity in aging associates with enhanced exocyst- 
mediated protein secretion. Aging Cell, e13713 . J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
25Kunchithapautham, K., Coughlin, B., Lemasters, J.J., Rohrer, B., 2011. Differential 
effects of rapamycin on rods and cones during light-induced stress in albino mice. 
Investig. Ophthalmol. Vis. Sci. 52, 2967 –2975 . 
Kunchithapautham, K., Rohrer, B., 2007. Apoptosis and autophagy in photoreceptors 
exposed to oxidative stress. Autophagy 3, 433–441. 
Kurihara, T., Kubota, Y., Ozawa, Y., Takubo, K., Noda, K., Simon, M.C., Johnson, R.S., 
Suematsu, M., Tsubota, K., Ishida, S., Goda, N., Suda, T., Okano, H., 2010. von 
Hippel-Lindau protein regulates transition from the fetal to the adult circulatory 
system in retina. Development 137, 1563 –1571 . 
Kurihara, T., Westenskow, P.D., Gantner, M.L., Usui, Y., Schultz, A., Bravo, S., 
Aguilar, E., Wittgrove, C., Friedlander, M., Paris, L.P., Chew, E., Siuzdak, G., 
Friedlander, M., 2016. Hypoxia-induced metabolic stress in retinal pigment 
epithelial cells is sufficient to induce photoreceptor degeneration. Elife 5. 
Lampinen, R., Belaya, I., Saveleva, L., Liddell, J.R., Rait, D., Huuskonen, M.T., 
Giniatullina, R., Sorvari, A., Soppela, L., Mikhailov, N., Boccuni, I., Giniatullin, R., 
Cruz-Haces, M., Konovalova, J., Koskuvi, M., Domanskyi, A., Hamalainen, R.H., 
Goldsteins, G., Koistinaho, J., Malm, T., Chew, S., Rilla, K., White, A.R., Marsh- 
Armstrong, N., Kanninen, K.M., 2022. Neuron-astrocyte transmitophagy is altered in 
Alzheimer ’s disease. Neurobiol. Dis. 170, 105753 . 
Lastres-Becker, I., Porras, G., Arribas-Blazquez, M., Maestro, I., Borrego-Hernandez, D., 
Boya, P., Cerdan, S., Garcia-Redondo, A., Martinez, A., Martin-Requero, A., 2021. 
Molecular alterations in sporadic and SOD1-ALS immortalized lymphocytes: towards 
a personalized therapy. Int. J. Mol. Sci. 22. 
Lawlor, D.P., Kalina, R.E., 1997. Pigmentary retinopathy in long chain 3-hydroxyacyl- 
coenzyme A dehydrogenase deficiency. Am. J. Ophthalmol. 123, 846–848. 
Lazarou, M., Sliter, D.A., Kane, L.A., Sarraf, S.A., Wang, C., Burman, J.L., Sideris, D.P., 
Fogel, A.I., Youle, R.J., 2015. The ubiquitin kinase PINK1 recruits autophagy 
receptors to induce mitophagy. Nature 524, 309–314. 
Lee, S.H., Shim, K.S., Kim, C.Y., Park, T.K., 2021. Characterization of the role of 
autophagy in retinal ganglion cell survival over time using a rat model of chronic 
ocular hypertension. Sci. Rep. 11, 5767 . 
Lescat, L., V˘eron, V., Mourot, B., P˘eron, S., Chenais, N., Dias, K., Riera-Heredia, N., 
Beaumatin, F., Pinel, K., Priault, M., Panserat, S., Salin, B., Guiguen, Y., Bobe, J., 
Herpin, A., Seiliez, I., 2020. Chaperone-mediated autophagy in the light of evolution: 
insight from fish. Mol. Biol. Evol. 37, 2887 –2899 . 
Levine, B., Kroemer, G., 2019. Biological functions of autophagy genes: a disease 
perspective. Cell 176, 11–42. 
Li, B., Zhang, T., Liu, W., Wang, Y., Xu, R., Zeng, S., Zhang, R., Zhu, S., Gillies, M.C., 
Zhu, L., Du, J., 2020. Metabolic features of mouse and human retinas: rods versus 
cones, macula versus periphery, retina versus RPE. iScience 23, 101672 . 
Li, R., Du, J., Yao, Y., Yao, G., Wang, X., 2019. Adiponectin inhibits high glucose-induced 
angiogenesis via inhibiting autophagy in RF/6A cells. J. Cell. Physiol. 234, 
20566 –20576 . 
Lin, Q., Li, S., Jiang, N., Shao, X., Zhang, M., Jin, H., Zhang, Z., Shen, J., Zhou, Y., 
Zhou, W., Gu, L., Lu, R., Ni, Z., 2019. PINK1-parkin pathway of mitophagy protects 
against contrast-induced acute kidney injury via decreasing mitochondrial ROS and 
NLRP3 inflammasome activation. Redox Biol. 26, 101254 . 
Liu, H., Zhu, H., Li, T., Zhang, P., Wang, N., Sun, X., 2016a. Prolyl-4-Hydroxylases 
inhibitor stabilizes HIF-1 α and increases mitophagy to reduce cell death after 
experimental retinal detachment. Invest. Ophthalmol. Vis. Sci. 57, 1807 –1815 . 
Liu, J., Bassal, M., Schlichting, S., Braren, I., Di Spiezio, A., Saftig, P., Bartsch, U., 2022. 
Intravitreal gene therapy restores the autophagy-lysosomal pathway and attenuates 
retinal degeneration in cathepsin D-deficient mice. Neurobiol. Dis. 164, 105628 . 
Liu, J., Copland, D.A., Theodoropoulou, S., Chiu, H.A., Barba, M.D., Mak, K.W., 
Mack, M., Nicholson, L.B., Dick, A.D., 2016b. Impairing autophagy in retinal 
pigment epithelium leads to inflammasome activation and enhanced macrophage- 
mediated angiogenesis. Sci. Rep. 6, 20639 . 
Liu, L., Feng, D., Chen, G., Chen, M., Zheng, Q., Song, P., Ma, Q., Zhu, C., Wang, R., 
Qi, W., Huang, L., Xue, P., Li, B., Wang, X., Jin, H., Wang, J., Yang, F., Liu, P., 
Zhu, Y., Sui, S., Chen, Q., 2012. Mitochondrial outer-membrane protein FUNDC1 
mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 14, 
177–185. 
Liu, Y.T., Sliter, D.A., Shammas, M.K., Huang, X., Wang, C., Calvelli, H., Maric, D.S., 
Narendra, D.P., 2021. Mt-Keima detects PINK1-PRKN mitophagy in vivo with 
greater sensitivity than mito-QC. Autophagy 17, 3753 –3762 . 
Lopes de Faria, J.M., Duarte, D.A., Montemurro, C., Papadimitriou, A., Consonni, S.R., 
Lopes de Faria, J.B., 2016. Defective autophagy in diabetic retinopathy. Invest. 
Ophthalmol. Vis. Sci. 57, 4356 –4366 . 
Ma, X., Lin, W., Lin, Z., Hao, M., Gao, X., Zhang, Y., Kuang, H., 2017. Liraglutide 
alleviates H(2)O(2)-induced retinal ganglion cells injury by inhibiting autophagy 
through mitochondrial pathways. Peptides 92, 1–8. 
Maejima, I., Takahashi, A., Omori, H., Kimura, T., Takabatake, Y., Saitoh, T., 
Yamamoto, A., Hamasaki, M., Noda, T., Isaka, Y., Yoshimori, T., 2013. Autophagy 
sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. 
EMBO J. 32, 2336 –2347 . 
Malaguarnera, G., Gagliano, C., Giordano, M., Salomone, S., Vacante, M., Bucolo, C., 
Caraci, F., Reibaldi, M., Drago, F., Avitabile, T., Motta, M., 2014. Homocysteine 
serum levels in diabetic patients with non proliferative, proliferative and without 
retinopathy. BioMed Res. Int., 191497, 2014 .  
Mao, X.B., Cheng, Y.H., Xu, Y.Y., 2019. miR-204-5p promotes diabetic retinopathy 
development via downregulation of microtubule-associated protein 1 light chain 3. 
Exp. Ther. Med. 17, 2945 –2952 . 
Mao, X.B., You, Z.P., Wu, C., Huang, J., 2017. Potential suppression of the high glucose 
and insulin-induced retinal neovascularization by Sirtuin 3 in the human retinal 
endothelial cells. Biochem. Biophys. Res. Commun. 482, 341–345. Maremanda, K.P., Sundar, I.K., Rahman, I., 2019. Protective role of mesenchymal stem 
cells and mesenchymal stem cell-derived exosomes in cigarette smoke-induced 
mitochondrial dysfunction in mice. Toxicol. Appl. Pharmacol. 385, 114788 . 
Mauro-Lizcano, M., Esteban-Martinez, L., Seco, E., Serrano-Puebla, A., Garcia-Ledo, L., 
Figueiredo-Pereira, C., Vieira, H.L., Boya, P., 2015. New method to assess mitophagy 
flux by flow cytometry. Autophagy 11, 833–843. 
Mazure, N.M., Pouyssegur, J., 2010. Hypoxia-induced autophagy: cell death or cell 
survival? Curr. Opin. Cell Biol. 22, 177–180. 
McWilliams, T.G., Prescott, A.R., Allen, G.F., Tamjar, J., Munson, M.J., Thomson, C., 
Muqit, M.M., Ganley, I.G., 2016. mito-QC illuminates mitophagy and mitochondrial 
architecture in vivo. J. Cell Biol. 214, 333–345. 
McWilliams, T.G., Prescott, A.R., Montava-Garriga, L., Ball, G., Singh, F., Barini, E., 
Muqit, M.M.K., Brooks, S.P., Ganley, I.G., 2018. Basal mitophagy occurs 
independently of PINK1 in mouse tissues of high metabolic demand. Cell Metabol. 
27, 439–449.e435 . 
McWilliams, T.G., Prescott, A.R., Villarejo-Zori, B., Ball, G., Boya, P., Ganley, I.G., 2019. 
A comparative map of macroautophagy and mitophagy in the vertebrate eye. 
Autophagy 15, 1296 –1308 . 
Meira, L.B., Moroski-Erkul, C.A., Green, S.L., Calvo, J.A., Bronson, R.T., Shah, D., 
Samson, L.D., 2009. Aag-initiated base excision repair drives alkylation-induced 
retinal degeneration in mice. Proc. Natl. Acad. Sci. U. S. A. 106, 888–893. 
Mell˘en, M.A., de la Rosa, E.J., Boya, P., 2008. The autophagic machinery is necessary for 
removal of cell corpses from the developing retinal neuroepithelium. Cell Death 
Differ. 15, 1279 –1290 . 
Michaelis, J.B., Brunstein, M.E., Bozkurt, S., Alves, L., Wegner, M., Kaulich, M., Pohl, C., 
Münch, C., 2022. Protein import motor complex reacts to mitochondrial misfolding 
by reducing protein import and activating mitophagy. Nat. Commun. 13, 5164 . 
Minegishi, Y., Nakayama, M., Iejima, D., Kawase, K., Iwata, T., 2016. Significance of 
optineurin mutations in glaucoma and other diseases. Prog. Retin. Eye Res. 55, 
149–181. 
Mito, T., Vincent, A.E., Faitg, J., Taylor, R.W., Khan, N.A., McWilliams, T.G., 
Suomalainen, A., 2022. Mosaic dysfunction of mitophagy in mitochondrial muscle 
disease. Cell Metabol. 34, 197–208.e195 . 
Mitter, S.K., Song, C., Qi, X., Mao, H., Rao, H., Akin, D., Lewin, A., Grant, M., 
Dunn Jr., W., Ding, J., Bowes Rickman, C., Boulton, M., 2014. Dysregulated 
autophagy in the RPE is associated with increased susceptibility to oxidative stress 
and AMD. Autophagy 10, 1989 –2005 . 
Mizumura, K., Cloonan, S.M., Nakahira, K., Bhashyam, A.R., Cervo, M., Kitada, T., 
Glass, K., Owen, C.A., Mahmood, A., Washko, G.R., Hashimoto, S., Ryter, S.W., 
Choi, A.M., 2014. Mitophagy-dependent necroptosis contributes to the pathogenesis 
of COPD. J. Clin. Invest. 124, 3987 –4003 . 
Montava-Garriga, L., Singh, F., Ball, G., Ganley, I.G., 2020. Semi-automated quantitation 
of mitophagy in cells and tissues. Mech. Ageing Dev. 185, 111196 . 
Morishita, H., Eguchi, T., Tsukamoto, S., Sakamaki, Y., Takahashi, S., Saito, C., Koyama- 
Honda, I., Mizushima, N., 2021. Organelle degradation in the lens by PLAAT 
phospholipases. Nature 592, 634–638. 
Murakami, Y., Notomi, S., Hisatomi, T., Nakazawa, T., Ishibashi, T., Miller, J.W., 
Vavvas, D.G., 2013. Photoreceptor cell death and rescue in retinal detachment and 
degenerations. Prog. Retin. Eye Res. 37, 114–140. 
Nakatogawa, H., 2020. Mechanisms governing autophagosome biogenesis. Nat. Rev. 
Mol. Cell Biol. 21, 439–458. 
Narendra, D., Tanaka, A., Suen, D.F., Youle, R.J., 2008. Parkin is recruited selectively to 
impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795–803. 
Narendra, D.P., Jin, S.M., Tanaka, A., Suen, D.F., Gautier, C.A., Shen, J., Cookson, M.R., 
Youle, R.J., 2010. PINK1 is selectively stabilized on impaired mitochondria to 
activate Parkin. PLoS Biol. 8, e1000298 . 
Naso, F., Intartaglia, D., Falanga, D., Soldati, C., Polishchuk, E., Giamundo, G., Tiberi, P., 
Marrocco, E., Scudieri, P., Di Malta, C., Trapani, I., Nusco, E., Salierno, F.G., 
Surace, E.M., Galietta, L.J., Banfi, S., Auricchio, A., Ballabio, A., Medina, D.L., 
Conte, I., 2020. Light-responsive microRNA miR-211 targets Ezrin to modulate 
lysosomal biogenesis and retinal cell clearance. EMBO J. 39, e102468 . 
Ng, S.K., Wood, J.P., Chidlow, G., Han, G., Kittipassorn, T., Peet, D.J., Casson, R.J., 2015. 
Cancer-like metabolism of the mammalian retina. Clin. Exp. Ophthalmol. 43, 
367–376. 
Nguyen, T.N., Padman, B.S., Lazarou, M., 2016. Deciphering the molecular signals of 
PINK1/parkin mitophagy. Trends Cell Biol. 26, 733–744. 
Nguyen, T.N., Sawa-Makarska, J., Khuu, G., Lam, W.K., Adriaenssens, E., Fracchiolla, D., 
Shoebridge, S., Bernklau, D., Padman, B.S., Skulsuppaisarn, M., Lindblom, R.S.J., 
Martens, S., Lazarou, M., 2023. Unconventional initiation of PINK1/Parkin 
mitophagy by Optineurin. Mol. Cell. 83, 1693 –1709.e1699 . 
Nicol ˘as-˘Avila, J.A., Lechuga-Vieco, A.V., Esteban-Martínez, L., S˘anchez-Díaz, M., Díaz- 
García, E., Santiago, D.J., Rubio-Ponce, A., Li, J.L., Balachander, A., Quintana, J.A., 
Martínez-de-Mena, R., Castej ˘on-Vega, B., Pun-García, A., Trav˘es, P.G., Bonz ˘on- 
Kulichenko, E., García-Marqu ˘es, F., Cuss˘o, L., N, A.G., Gonz ˘alez-Guerra, A., Roche- 
Molina, M., Martin-Salamanca, S., Crainiciuc, G., Guzm ˘an, G., Larrazabal, J., 
Herrero-Gal ˘an, E., Alegre-Cebollada, J., Lemke, G., Rothlin, C.V., Jimenez- 
Borreguero, L.J., Reyes, G., Castrillo, A., Desco, M., Mu~noz-C ˘anoves, P., Ib˘a~nez, B., 
Torres, M., Ng, L.G., Priori, S.G., Bueno, H., V˘azquez, J., Cordero, M.D., Bernal, J.A., 
Enríquez, J.A., Hidalgo, A., 2020. A network of macrophages supports mitochondrial 
homeostasis in the heart. Cell 183, 94–109.e123 . 
Nordgaard, C.L., Karunadharma, P.P., Feng, X., Olsen, T.W., Ferrington, D.A., 2008. 
Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of 
age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 49, 2848 –2855 . 
Notomi, S., Ishihara, K., Efstathiou, N.E., Lee, J.J., Hisatomi, T., Tachibana, T., 
Konstantinou, E.K., Ueta, T., Murakami, Y., Maidana, D.E., Ikeda, Y., Kume, S., 
Terasaki, H., Sonoda, S., Blanz, J., Young, L., Sakamoto, T., Sonoda, K.H., Saftig, P., J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
26Ishibashi, T., Miller, J.W., Kroemer, G., Vavvas, D.G., 2019. Genetic LAMP2 
deficiency accelerates the age-associated formation of basal laminar deposits in the 
retina. Proc. Natl. Acad. Sci. U. S. A. 116, 23724 –23734 . 
Novak, I., Kirkin, V., McEwan, D.G., Zhang, J., Wild, P., Rozenknop, A., Rogov, V., 
Lohr, F., Popovic, D., Occhipinti, A., Reichert, A.S., Terzic, J., Dotsch, V., Ney, P.A., 
Dikic, I., 2010. Nix is a selective autophagy receptor for mitochondrial clearance. 
EMBO Rep. 11, 45–51. 
Olivares-Gonz ˘alez, L., Velasco, S., Campillo, I., Rodrigo, R., 2021. Retinal inflammation, 
cell death and inherited retinal dystrophies. Int. J. Mol. Sci. 22. 
Organisciak, D.T., Vaughan, D.K., 2010. Retinal light damage: mechanisms and 
protection. Prog. Retin. Eye Res. 29, 113–134. 
Padman, B.S., Lazarou, M., 2022. Immunofluorescence-based measurement of 
autophagosome formation during mitophagy. Methods Mol. Biol. 2445, 207–226. 
Palikaras, K., Lionaki, E., Tavernarakis, N., 2015. Coordination of mitophagy and 
mitochondrial biogenesis during ageing in C. elegans. Nature 521, 525–528. 
Park, H.L., Kim, J.H., Park, C.K., 2018. Different contributions of autophagy to retinal 
ganglion cell death in the diabetic and glaucomatous retinas. Sci. Rep. 8, 13321 . 
Park, S.W., Kim, K.Y., Lindsey, J.D., Dai, Y., Heo, H., Nguyen, D.H., Ellisman, M.H., 
Weinreb, R.N., Ju, W.K., 2011. A selective inhibitor of drp1, mdivi-1, increases 
retinal ganglion cell survival in acute ischemic mouse retina. Invest. Ophthalmol. 
Vis. Sci. 52, 2837 –2843 . 
Paterno, J.J., Koskela, A., Hyttinen, J.M.T., Vattulainen, E., Synowiec, E., Tuuminen, R., 
Watala, C., Blasiak, J., Kaarniranta, K., 2020. Autophagy genes for wet age-related 
macular degeneration in a Finnish case-control study. Genes 11. 
Pearsall, E.A., Cheng, R., Zhou, K., Takahashi, Y., Matlock, H.G., Vadvalkar, S.S., 
Shin, Y., Fredrick, T.W., Gantner, M.L., Meng, S., Fu, Z., Gong, Y., Kinter, M., 
Humphries, K.M., Szweda, L.I., Smith, L.E.H., Ma, J.X., 2017. PPAR α is essential for 
retinal lipid metabolism and neuronal survival. BMC Biol. 15, 113. 
Perusek, L., Sahu, B., Parmar, T., Maeno, H., Arai, E., Le, Y.Z., Subauste, C.S., Chen, Y., 
Palczewski, K., Maeda, A., 2015. Di-retinoid-pyridinium-ethanolamine (A2E) 
accumulation and the maintenance of the visual cycle are independent of atg7- 
mediated autophagy in the retinal pigmented epithelium. J. Biol. Chem. 290, 
29035 –29044 . 
Qiu, Y., Wang, J., Li, H., Yang, B., Wang, J., He, Q., Weng, Q., 2022. Emerging views of 
OPTN (optineurin) function in the autophagic process associated with disease. 
Autophagy 18, 73–85. 
Rajala, A., He, F., Anderson, R.E., Wensel, T.G., Rajala, R.V.S., 2020. Loss of class III 
phosphoinositide 3-kinase Vps34 results in cone degeneration. Biology 9. 
Ramachandra Rao, S., Fliesler, S.J., 2022. Monitoring basal autophagy in the retina 
utilizing CAG-mRFP-EGFP-MAP1LC3B reporter mouse: technical and biological 
considerations. Autophagy 18, 1187 –1201 . 
Rambold, A.S., Kostelecky, B., Elia, N., Lippincott-Schwartz, J., 2011. Tubular Network 
Formation Protects Mitochondria from Autophagosomal Degradation during 
Nutrient Starvation, vol. 108, pp. 10190 –10195 . 
Ramírez-Pardo, I., Villarejo-Zori, B., Jim˘enez-Loygorri, J.I., Sierra-Filardi, E., Alonso- 
Gil, S., Mari ~no, G., de la Villa, P., Fitze, P.S., Fuentes, J.M., García-Escudero, R., 
Ferrington, D.A., Gomez-Sintes, R., Boya, P., 2022. Ambra1 haploinsufficiency in 
CD1 mice results in metabolic alterations and exacerbates age-associated retinal 
degeneration. Autophagy 1–21. 
Reme, C.E., Young, R.W., 1977. The effects of hibernation on cone visual cells in the 
ground squirrel. Invest. Ophthalmol. Vis. Sci. 16, 815–840. 
Rodger, C.E., McWilliams, T.G., Ganley, I.G., 2018. Mammalian mitophagy - from in 
vitro molecules to in vivo models. FEBS J. 285, 1185 –1202 . 
Rodriguez-Muela, N., Germain, F., Marino, G., Fitze, P.S., Boya, P., 2012. Autophagy 
promotes survival of retinal ganglion cells after optic nerve axotomy in mice. Cell 
Death Differ. 19, 162–169. 
Rodriguez-Muela, N., Hernandez-Pinto, A.M., Serrano-Puebla, A., Garcia-Ledo, L., 
Latorre, S.H., de la Rosa, E.J., Boya, P., 2015. Lysosomal membrane 
permeabilization and autophagy blockade contribute to photoreceptor cell death in a 
mouse model of retinitis pigmentosa. Cell Death Differ. 22, 476–487. 
Rodriguez-Muela, N., Koga, H., Garcia-Ledo, L., de la Villa, P., de la Rosa, E.J., Cuervo, A. 
M., Boya, P., 2013. Balance between autophagic pathways preserves retinal 
homeostasis. Aging Cell 12, 478–488. 
Rohrer, B., Bandyopadhyay, M., Beeson, C., 2016. Reduced metabolic capacity in aged 
primary retinal pigment epithelium (RPE) is correlated with increased susceptibility 
to oxidative stress. Adv. Exp. Med. Biol. 854, 793–798. 
Rosignol, I., Villarejo-Zori, B., Teresak, P., Sierra-Filardi, E., Pereiro, X., Rodriguez- 
Muela, N., Vecino, E., Vieira, H.L.A., Bell, K., Boya, P., 2020. The mito-QC reporter 
for quantitative mitophagy assessment in primary retinal ganglion cells and 
experimental glaucoma models. Int. J. Mol. Sci. 21. 
Roy, S., Kern, T.S., Song, B., Stuebe, C., 2017. Mechanistic insights into pathological 
changes in the diabetic retina: implications for targeting diabetic retinopathy. Am. J. 
Pathol. 187, 9–19. 
Russo, R., Berliocchi, L., Adornetto, A., Amantea, D., Nucci, C., Tassorelli, C., Morrone, L. 
A., Bagetta, G., Corasaniti, M.T., 2013. In search of new targets for retinal 
neuroprotection: is there a role for autophagy? Curr. Opin. Pharmacol. 13, 72–77. 
Ryu, D., Mouchiroud, L., Andreux, P.A., Katsyuba, E., Moullan, N., Nicolet-Dit-Felix, A. 
A., Williams, E.G., Jha, P., Lo Sasso, G., Huzard, D., Aebischer, P., Sandi, C., 
Rinsch, C., Auwerx, J., 2016. Urolithin A induces mitophagy and prolongs lifespan in 
C. elegans and increases muscle function in rodents. Nat. Med. 22, 879–888. 
Saha, B., Salemi, M., Williams, G.L., Oh, S., Paffett, M.L., Phinney, B., Mandell, M.A., 
2022. Interactomic analysis reveals a homeostatic role for the HIV restriction factor 
TRIM5 α in mitophagy. Cell Rep. 39, 110797 . 
Sahún-Espa ~nol, ˘A., Clemente, C., Jim˘enez-Loygorri, J.I., Sierra-Filardi, E., Herrera- 
Melle, L., G˘omez-Dur ˘an, A., Sabio, G., Monsalve, M., Boya, P., Arroyo, A.G., 2022. p38 MAPK priming boosts VSMC proliferation and arteriogenesis by promoting 
PGC1 α-dependent mitochondrial dynamics. Sci. Rep. 12, 5938 . 
Saito, T., Nah, J., Oka, S.I., Mukai, R., Monden, Y., Maejima, Y., Ikeda, Y., Sciarretta, S., 
Liu, T., Li, H., Baljinnyam, E., Fraidenraich, D., Fritzky, L., Zhai, P., Ichinose, S., 
Isobe, M., Hsu, C.P., Kundu, M., Sadoshima, J., 2019. An alternative mitophagy 
pathway mediated by Rab9 protects the heart against ischemia. J. Clin. Invest. 129, 
802–819. 
Samardzija, M., Corna, A., Gomez-Sintes, R., Jarboui, M.A., Armento, A., Roger, J.E., 
Petridou, E., Haq, W., Paquet-Durand, F., Zrenner, E., de la Villa, P., Zeck, G., 
Grimm, C., Boya, P., Ueffing, M., Trifunovic, D., 2021. HDAC inhibition ameliorates 
cone survival in retinitis pigmentosa mice. Cell Death Differ. 28, 1317 –1332 . 
Sayyad, Z., Vishwakarma, S., Dave, T.V., Naik, M.N., Radha, V., Kaur, I., Swarup, G., 
2021. Human primary retinal cells as an in-vitro model for investigating defective 
signalling caused by OPTN mutants associated with glaucoma. Neurochem. Int. 148, 
105075 . 
Shelby, S.J., Angadi, P.S., Zheng, Q.D., Yao, J., Jia, L., Zacks, D.N., 2015. Hypoxia 
inducible factor 1alpha contributes to regulation of autophagy in retinal detachment. 
Exp. Eye Res. 137, 84–93. 
Shi, Y., Zou, X., Wen, S., Gao, L., Li, J., Han, J., Han, S., 2021. An organelle-directed 
chemical ligation approach enables dual-color detection of mitophagy. Autophagy 
17, 3475 –3490 . 
Shim, M.S., Takihara, Y., Kim, K.Y., Iwata, T., Yue, B.Y., Inatani, M., Weinreb, R.N., 
Perkins, G.A., Ju, W.K., 2016. Mitochondrial pathogenic mechanism and 
degradation in optineurin E50K mutation-mediated retinal ganglion cell 
degeneration. Sci. Rep. 6, 33830 . 
Shu, D.Y., Frank, S.I., Fitch, T.C., Karg, M.M., Butcher, E.R., Nnuji-John, E., Kim, L.A., 
Saint-Geniez, M., 2022. Dimethyl fumarate blocks tumor necrosis factor-alpha- 
driven inflammation and metabolic rewiring in the retinal pigment epithelium. 
Front. Mol. Neurosci. 15, 896786 . 
Singh, A., D’Amico, D., Andreux, P.A., Fouassier, A.M., Blanco-Bose, W., Evans, M., 
Aebischer, P., Auwerx, J., Rinsch, C., 2022. Urolithin A improves muscle strength, 
exercise performance, and biomarkers of mitochondrial health in a randomized trial 
in middle-aged adults. Cell. Rep. Med. 3, 100633 . 
Singh, L.P., Devi, T.S., Yumnamcha, T., 2017. The role of txnip in mitophagy 
dysregulation and inflammasome activation in diabetic retinopathy: a new 
perspective. JOJ Ophthalmol. 4. 
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. 
M., Czaja, M.J., 2009. Autophagy regulates lipid metabolism. Nature 458, 
1131 –1135 . 
Sirohi, K., Chalasani, M.L., Sudhakar, C., Kumari, A., Radha, V., Swarup, G., 2013. M98K- 
OPTN induces transferrin receptor degradation and RAB12-mediated autophagic 
death in retinal ganglion cells. Autophagy 9, 510–527. 
Sliter, D.A., Martinez, J., Hao, L., Chen, X., Sun, N., Fischer, T.D., Burman, J.L., Li, Y., 
Zhang, Z., Narendra, D.P., Cai, H., Borsche, M., Klein, C., Youle, R.J., 2018. Parkin 
and PINK1 mitigate STING-induced inflammation. Nature 561, 258–262. 
Smirnova, E., Griparic, L., Shurland, D.L., van der Bliek, A.M., 2001. Dynamin-related 
protein Drp1 is required for mitochondrial division in mammalian cells. Mol. Biol. 
Cell 12, 2245 –2256 . 
Stepanyants, N., Macdonald, P.J., Francy, C.A., Mears, J.A., Qi, X., Ramachandran, R., 
2015. Cardiolipin ’s propensity for phase transition and its reorganization by 
dynamin-related protein 1 form a basis for mitochondrial membrane fission. Mol. 
Biol. Cell 26, 3104 –3116 . 
Stotland, A., Gottlieb, R.A., 2016. α-MHC MitoTimer mouse: in vivo mitochondrial 
turnover model reveals remarkable mitochondrial heterogeneity in the heart. J. Mol. 
Cell. Cardiol. 90, 53–58. 
Strappazzon, F., Nazio, F., Corrado, M., Cianfanelli, V., Romagnoli, A., Fimia, G.M., 
Campello, S., Nardacci, R., Piacentini, M., Campanella, M., Cecconi, F., 2015. 
AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and 
p62/SQSTM1. Cell Death Differ. 22, 517. 
Strauss, O., 2005. The retinal pigment epithelium in visual function. Physiol. Rev. 85, 
845–881. 
Su, C.J., Shen, Z., Cui, R.X., Huang, Y., Xu, D.L., Zhao, F.L., Pan, J., Shi, A.M., Liu, T., 
Yu, Y.L., 2020. Thioredoxin-interacting protein (TXNIP) regulates parkin/PINK1- 
mediated mitophagy in dopaminergic neurons under high-glucose conditions: 
implications for molecular links between Parkinson ’s disease and diabetes. Neurosci. 
Bull. 36, 346–358. 
Su, W., Li, Z., Jia, Y., Zhuo, Y., 2014. Rapamycin is neuroprotective in a rat chronic 
hypertensive glaucoma model. PLoS One 9, e99719 . 
Sun, N., Yun, J., Liu, J., Malide, D., Liu, C., Rovira II, Holmstr om, K.M., Fergusson, M.M., 
Yoo, Y.H., Combs, C.A., Finkel, T., 2015. Measuring in vivo mitophagy. Mol. Cell. 60, 
685–696. 
Sun, Y., Wen, F., Yan, C., Su, L., Luo, J., Chi, W., Zhang, S., 2021. Mitophagy protects the 
retina against anti-vascular endothelial growth factor therapy-driven hypoxia via 
hypoxia-inducible factor-1 α signaling. Front. Cell Dev. Biol. 9, 727822 . 
Swarup, A., Samuels, I.S., Bell, B.A., Han, J.Y.S., Du, J., Massenzio, E., Abel, E.D., Boesze- 
Battaglia, K., Peachey, N.S., Philp, N.J., 2019. Modulating GLUT1 expression in 
retinal pigment epithelium decreases glucose levels in the retina: impact on 
photoreceptors and Müller glial cells. Am. J. Physiol. Cell Physiol. 316, C121 –c133. 
Tan, H.W.S., Lu, G., Dong, H., Cho, Y.L., Natalia, A., Wang, L., Chan, C., Kappei, D., 
Taneja, R., Ling, S.C., Shao, H., Tsai, S.Y., Ding, W.X., Shen, H.M., 2022. 
A degradative to secretory autophagy switch mediates mitochondria clearance in the 
absence of the mATG8-conjugation machinery. Nat. Commun. 13, 3720 . 
Teo, Z.L., Tham, Y.C., Yu, M., Chee, M.L., Rim, T.H., Cheung, N., Bikbov, M.M., Wang, Y. 
X., Tang, Y., Lu, Y., Wong, I.Y., Ting, D.S.W., Tan, G.S.W., Jonas, J.B., 
Sabanayagam, C., Wong, T.Y., Cheng, C.Y., 2021. Global prevalence of diabetic J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    Progress in Retinal and Eye Research 96 (2023) 101205
27retinopathy and projection of burden through 2045: systematic review and meta- 
analysis. Ophthalmology 128, 1580 –1591 . 
Teresak, P., Lapao, A., Subic, N., Boya, P., Elazar, Z., Simonsen, A., 2022. Regulation of 
PRKN-independent mitophagy. Autophagy 18, 24–39. 
Terluk, M.R., Kapphahn, R.J., Soukup, L.M., Gong, H., Gallardo, C., Montezuma, S.R., 
Ferrington, D.A., 2015. Investigating mitochondria as a target for treating age- 
related macular degeneration. J. Neurosci. 35, 7304 –7311 . 
Tham, Y.-C., Li, X., Wong, T.Y., Quigley, H.A., Aung, T., Cheng, C.-Y., 2014. Global 
prevalence of glaucoma and projections of glaucoma burden through 2040. 
Ophthalmology 121, 2081 –2090 . 
Thielen, L.A., Chen, J., Jing, G., Moukha-Chafiq, O., Xu, G., Jo, S., Grayson, T.B., Lu, B., 
Li, P., Augelli-Szafran, C.E., Suto, M.J., Kanke, M., Sethupathy, P., Kim, J.K., 
Shalev, A., 2020. Identification of an anti-diabetic, orally available small molecule 
that regulates TXNIP expression and glucagon action. Cell Metabol. 32, 353–365. 
e358. 
Tilokani, L., Nagashima, S., Paupe, V., Prudent, J., 2018. Mitochondrial dynamics: 
overview of molecular mechanisms. Essays Biochem. 62, 341–360. 
Trollmann, R., Richter, M., Jung, S., Walkinshaw, G., Brackmann, F., 2014. 
Pharmacologic stabilization of hypoxia-inducible transcription factors protects 
developing mouse brain from hypoxia-induced apoptotic cell death. Neuroscience 
278, 327–342. 
Trudeau, K.M., Gottlieb, R.A., Shirihai, O.S., 2014. Measurement of mitochondrial 
turnover and life cycle using MitoTimer. Methods Enzymol. 547, 21–38. 
Tsantilas, K.A., Cleghorn, W.M., Bisbach, C.M., Whitson, J.A., Hass, D.T., Robbings, B.M., 
Sadilek, M., Linton, J.D., Rountree, A.M., Valencia, A.P., Sweetwyne, M.T., 
Campbell, M.D., Zhang, H., Jankowski, C.S.R., Sweet, I.R., Marcinek, D.J., 
Rabinovitch, P.S., Hurley, J.B., 2021. An analysis of metabolic changes in the retina 
and retinal pigment epithelium of aging mice. Invest. Ophthalmol. Vis. Sci. 62, 20. 
Valapala, M., Wilson, C., Hose, S., Bhutto, I.A., Grebe, R., Dong, A., Greenbaum, S., 
Gu, L., Sengupta, S., Cano, M., Hackett, S., Xu, G., Lutty, G.A., Dong, L., Sergeev, Y., 
Handa, J.T., Campochiaro, P., Wawrousek, E., Zigler Jr., J.S., Sinha, D., 2014. 
Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated 
by CRYBA1/betaA3/A1-crystallin via V-ATPase-MTORC1 signaling. Autophagy 10, 
480–496. 
VanderWall, K.B., Huang, K.C., Pan, Y., Lavekar, S.S., Fligor, C.M., Allsop, A.R., 
Lentsch, K.A., Dang, P., Zhang, C., Tseng, H.C., Cummins, T.R., Meyer, J.S., 2020. 
Retinal ganglion cells with a glaucoma OPTN(E50K) mutation exhibit 
neurodegenerative phenotypes when derived from three-dimensional retinal 
organoids. Stem Cell Rep. 15, 52–66. 
Villarejo-Zori, B., Jimenez-Loygorri, J.I., Zapata-Munoz, J., Bell, K., Boya, P., 2021. New 
insights into the role of autophagy in retinal and eye diseases. Mol. Aspect. Med. 82, 
101038 . 
Volland, S., Esteve-Rudd, J., Hoo, J., Yee, C., Williams, D.S., 2015. A comparison of some 
organizational characteristics of the mouse central retina and the human macula. 
PLoS One 10, e0125631 . 
Wagatsuma, A., Sakuma, K., 2013. Mitochondria as a potential regulator of myogenesis. 
Sci. World J., 593267, 2013 .  
Wang, F., Gomez-Sintes, R., Boya, P., 2018. Lysosomal membrane permeabilization and 
cell death. Traffic 19, 918–931. 
Wang, F., Ma, F., Song, Y., Li, N., Li, X., Pang, Y., Hu, P., Shao, A., Deng, C., Zhang, X., 
2020. Topical administration of rapamycin promotes retinal ganglion cell survival 
and reduces intraocular pressure in a rat glaucoma model. Eur. J. Pharmacol. 884, 
173369 . 
Wang, L., Cano, M., Handa, J.T., 2014. p62 provides dual cytoprotection against 
oxidative stress in the retinal pigment epithelium. Biochim. Biophys. Acta 1843, 
1248 –1258 . 
Wang, L., Sun, X., Zhu, M., Du, J., Xu, J., Qin, X., Xu, X., Song, E., 2019a. 
Epigallocatechin-3-gallate stimulates autophagy and reduces apoptosis levels in 
retinal Müller cells under high-glucose conditions. Exp. Cell Res. 380, 149–158. 
Wang, N., Luo, Z., Jin, M., Sheng, W., Wang, H.T., Long, X., Wu, Y., Hu, P., Xu, H., 
Zhang, X., 2019b. Exploration of age-related mitochondrial dysfunction and the anti- 
aging effects of resveratrol in zebrafish retina. Aging (Albany NY) 11, 3117 –3137 . 
Wang, Y., Nartiss, Y., Steipe, B., McQuibban, G.A., Kim, P.K., 2012. ROS-induced 
mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial 
degradation by autophagy. Autophagy 8, 1462 –1476 . 
Watzlawik, J.O., Hou, X., Fricova, D., Ramnarine, C., Barodia, S.K., Gendron, T.F., 
Heckman, M.G., DeTure, M., Siuda, J., Wszolek, Z.K., Scherzer, C.R., Ross, O.A., 
Bu, G., Dickson, D.W., Goldberg, M.S., Fiesel, F.C., Springer, W., 2021. Sensitive 
ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, 
autopsy brain, and blood samples. Autophagy 17, 2613 –2628 . 
Williams, J.A., Zhao, K., Jin, S., Ding, W.X., 2017. New methods for monitoring 
mitochondrial biogenesis and mitophagy in vitro and in vivo. Exp. Biol. Med. 242, 
781–787. 
Wong, W.L., Su, X., Li, X., Cheung, C.M., Klein, R., Cheng, C.Y., Wong, T.Y., 2014. Global 
prevalence of age-related macular degeneration and disease burden projection for 
2020 and 2040: a systematic review and meta-analysis. Lancet Global Health 2, 
e106 –e116. Xu, G., Li, T., Chen, J., Li, C., Zhao, H., Yao, C., Dong, H., Wen, K., Wang, K., Zhao, J., 
Xia, Q., Zhou, T., Zhang, H., Gao, P., Li, A., Pan, X., 2018. Autosomal dominant 
retinitis pigmentosa-associated gene PRPF8 is essential for hypoxia-induced 
mitophagy through regulating ULK1 mRNA splicing. Autophagy 14, 1818 –1830 . 
Xu, L., Brown, E.E., Keuthan, C.J., Gubbi, H., Grellier, E.-K., Roger, J., Swaroop, A., 
Du, J., Ash, J.D., 2020. AMP-activated-protein kinase (AMPK) is an essential sensor 
and metabolic regulator of retinal neurons and their integrated metabolism with 
RPE. bioRxiv, 109165, 2020.2005.2022 .  
Yako, T., Nakamura, M., Otsu, W., Nakamura, S., Shimazawa, M., Hara, H., 2021. 
Mitochondria dynamics in the aged mice eye and the role in the RPE phagocytosis. 
Exp. Eye Res. 213, 108800 . 
Yamano, K., Wang, C., Sarraf, S.A., Münch, C., Kikuchi, R., Noda, N.N., Hizukuri, Y., 
Kanemaki, M.T., Harper, W., Tanaka, K., Matsuda, N., Youle, R.J., 2018. Endosomal 
Rab cycles regulate Parkin-mediated mitophagy. Elife 7. 
Yao, J., Jia, L., Feathers, K., Lin, C., Khan, N.W., Klionsky, D.J., Ferguson, T.A., Zacks, D. 
N., 2016. Autophagy-mediated catabolism of visual transduction proteins prevents 
retinal degeneration. Autophagy 12, 2439 –2450 . 
Yao, J., Jia, L., Khan, N., Lin, C., Mitter, S.K., Boulton, M.E., Dunaief, J.L., Klionsky, D.J., 
Guan, J.L., Thompson, D.A., Zacks, D.N., 2015. Deletion of autophagy inducer 
RB1CC1 results in degeneration of the retinal pigment epithelium. Autophagy 11, 
939–953. 
Yao, J., Qiu, Y., Frontera, E., Jia, L., Khan, N.W., Klionsky, D.J., Ferguson, T.A., 
Thompson, D.A., Zacks, D.N., 2018. Inhibiting autophagy reduces retinal 
degeneration caused by protein misfolding. Autophagy 14, 1226 –1238 . 
Yazdankhah, M., Ghosh, S., Shang, P., Stepicheva, N., Hose, S., Liu, H., Chamling, X., 
Tian, S., Sullivan, M.L.G., Calderon, M.J., Fitting, C.S., Weiss, J., Jayagopal, A., 
Handa, J.T., Sahel, J.A., Zigler Jr., J.S., Kinchington, P.R., Zack, D.J., Sinha, D., 
2021. BNIP3L-mediated mitophagy is required for mitochondrial remodeling during 
the differentiation of optic nerve oligodendrocytes. Autophagy 17, 3140 –3159 . 
Ye, F., Kaneko, H., Hayashi, Y., Takayama, K., Hwang, S.J., Nishizawa, Y., Kimoto, R., 
Nagasaka, Y., Tsunekawa, T., Matsuura, T., Yasukawa, T., Kondo, T., Terasaki, H., 
2016. Malondialdehyde induces autophagy dysfunction and VEGF secretion in the 
retinal pigment epithelium in age-related macular degeneration. Free Radic. Biol. 
Med. 94, 121–134. 
Ying, X., Zhang, J., Wang, Y., Wu, N., Wang, Y., Yew, D.T., 2008. Alpha-crystallin 
protected axons from optic nerve degeneration after crushing in rats. J. Mol. 
Neurosci. 35, 253–258. 
Zacharioudakis, E., Agianian, B., Kumar Mv, V., Biris, N., Garner, T.P., Rabinovich- 
Nikitin, I., Ouchida, A.T., Margulets, V., Nordstrom, L.U., Riley, J.S., Dolgalev, I., 
Chen, Y., Wittig, A.J.H., Pekson, R., Mathew, C., Wei, P., Tsirigos, A., Tait, S.W.G., 
Kirshenbaum, L.A., Kitsis, R.N., Gavathiotis, E., 2022. Modulating mitofusins to 
control mitochondrial function and signaling. Nat. Commun. 13, 3775 . 
Zagozewski, J.L., Zhang, Q., Eisenstat, D.D., 2014. Genetic regulation of vertebrate eye 
development. Clin. Genet. 86, 453–460. 
Zeb, A., Choubey, V., Gupta, R., Kuum, M., Safiulina, D., Vaarmann, A., 
Gogichaishvili, N., Liiv, M., Ilves, I., Tamm, K., Veksler, V., Kaasik, A., 2021. A novel 
role of KEAP1/PGAM5 complex: ROS sensor for inducing mitophagy. Redox Biol. 48, 
102186 . 
Zhang, H., Bosch-Marce, M., Shimoda, L.A., Tan, Y.S., Baek, J.H., Wesley, J.B., 
Gonzalez, F.J., Semenza, G.L., 2008. Mitochondrial autophagy is an HIF-1- 
dependent adaptive metabolic response to hypoxia. J. Biol. Chem. 283, 
10892 –10903 . 
Zhang, S., Shao, Z., Liu, X., Hou, M., Cheng, F., Lei, D., Yuan, H., 2021. The E50K 
optineurin mutation impacts autophagy-mediated degradation of TDP-43 and leads 
to RGC apoptosis in vivo and in vitro. Cell Death Dis. 7, 49. 
Zhang, Y., Cross, S.D., Stanton, J.B., Marmorstein, A.D., Le, Y.Z., Marmorstein, L.Y., 
2017. Early AMD-like defects in the RPE and retinal degeneration in aged mice with 
RPE-specific deletion of Atg5 or Atg7. Mol. Vis. 23, 228–241. 
Zhang, Y., Li, T., Cai, X., Long, D., Wang, X., Liu, C., Wu, Q., 2022. Sirt5-mediated 
desuccinylation of OPTN protects retinal ganglion cells from autophagic flux 
blockade in diabetic retinopathy. Cell Death Dis. 8, 63. 
Zhang, Y., Xi, X., Mei, Y., Zhao, X., Zhou, L., Ma, M., Liu, S., Zha, X., Yang, Y., 2019. 
High-glucose induces retinal pigment epithelium mitochondrial pathways of 
apoptosis and inhibits mitophagy by regulating ROS/PINK1/Parkin signal pathway. 
Biomed. Pharmacother. 111, 1315 –1325 . 
Zhou, H.R., Ma, X.F., Lin, W.J., Hao, M., Yu, X.Y., Li, H.X., Xu, C.Y., Kuang, H.Y., 2020. 
Neuroprotective role of GLP-1 analog for retinal ganglion cells via PINK1/parkin- 
mediated mitophagy in diabetic retinopathy. Front. Pharmacol. 11, 589114 . 
Zhou, P., Xie, W., Meng, X., Zhai, Y., Dong, X., Zhang, X., Sun, G., Sun, X., 2019. 
Notoginsenoside R1 ameliorates diabetic retinopathy through PINK1-dependent 
activation of mitophagy. Cells 8. 
Zhou, Z., Doggett, T.A., Sene, A., Apte, R.S., Ferguson, T.A., 2015a. Autophagy supports 
survival and phototransduction protein levels in rod photoreceptors. Cell Death 
Differ. 22, 488–498. 
Zhou, Z., Vinberg, F., Schottler, F., Doggett, T.A., Kefalov, V.J., Ferguson, T.A., 2015b. 
Autophagy supports color vision. Autophagy 11, 1821 –1832 . J.I. Jim˘enez-Loygorri et al.                                                                                                                                                                                                                    